<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Cardiac Output & Perfusion - Comprehensive Study Guide</title>
    <style>
        :root {
            --primary: #1a365d;
            --secondary: #2c5282;
            --accent: #3182ce;
            --text: #1a202c;
            --light-bg: #f7fafc;
            --border: #e2e8f0;
            --pearl-bg: #ebf8ff;
            --pearl-border: #3182ce;
            --warning-bg: #fff5f5;
            --warning-border: #c53030;
            --memory-bg: #faf5ff;
            --memory-border: #805ad5;
            --sidebar-width: 220px;
        }

        * {
            box-sizing: border-box;
            margin: 0;
            padding: 0;
        }

        html {
            scroll-behavior: smooth;
        }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            line-height: 1.7;
            color: var(--text);
            background: #fff;
        }

        /* Main layout wrapper */
        .page-wrapper {
            display: flex;
            min-height: 100vh;
        }

        /* Sticky Sidebar */
        .sidebar {
            width: var(--sidebar-width);
            flex-shrink: 0;
            background: var(--light-bg);
            border-right: 1px solid var(--border);
        }

        .sidebar-inner {
            position: sticky;
            top: 0;
            height: 100vh;
            overflow-y: auto;
            padding: 1.5rem 1rem;
        }

        .sidebar-inner::-webkit-scrollbar {
            width: 6px;
        }

        .sidebar-inner::-webkit-scrollbar-track {
            background: transparent;
        }

        .sidebar-inner::-webkit-scrollbar-thumb {
            background: var(--border);
            border-radius: 3px;
        }

        .sidebar-inner::-webkit-scrollbar-thumb:hover {
            background: var(--accent);
        }

        .nav-toc {
            background: transparent;
            padding: 0;
            border-radius: 0;
            margin-bottom: 0;
        }

        .nav-toc h3 {
            margin-top: 0;
            margin-bottom: 1rem;
            color: var(--primary);
            font-size: 1.1rem;
            padding-bottom: 0.5rem;
            border-bottom: 2px solid var(--accent);
        }

        .nav-toc ul {
            list-style: none;
            margin: 0;
            padding: 0;
            columns: 1;
        }

        .nav-toc li {
            margin-bottom: 0.4rem;
        }

        .nav-toc a {
            color: var(--secondary);
            text-decoration: none;
            font-size: 0.85rem;
            display: block;
            padding: 0.3rem 0.5rem;
            border-radius: 4px;
            transition: all 0.2s ease;
        }

        .nav-toc a:hover {
            background: var(--pearl-bg);
            color: var(--accent);
            text-decoration: none;
        }

        /* Main content area */
        .main-content {
            flex: 1;
            min-width: 0;
            display: flex;
            justify-content: center;
            padding: 2rem;
        }

        .content-inner {
            max-width: 900px;
            width: 100%;
        }

        h1 {
            font-size: 2.5rem;
            color: var(--primary);
            border-bottom: 4px solid var(--accent);
            padding-bottom: 1rem;
            margin-bottom: 2rem;
        }

        h2 {
            font-size: 1.8rem;
            color: var(--primary);
            margin: 2.5rem 0 1.5rem;
            padding: 0.5rem 0;
            border-bottom: 2px solid var(--border);
        }

        h3 {
            font-size: 1.4rem;
            color: var(--secondary);
            margin: 2rem 0 1rem;
        }

        h4 {
            font-size: 1.15rem;
            color: var(--accent);
            margin: 1.5rem 0 0.75rem;
        }

        p {
            margin-bottom: 1rem;
        }

        .source-tag {
            display: inline-block;
            font-size: 0.7rem;
            background: var(--accent);
            color: white;
            padding: 0.15rem 0.4rem;
            border-radius: 3px;
            margin-left: 0.5rem;
            vertical-align: middle;
        }

        .source-tag.heavy {
            background: var(--primary);
        }

        .slide-ref {
            display: inline-block;
            font-size: 0.7rem;
            background: linear-gradient(135deg, #4a5568, #2d3748);
            color: #e2e8f0;
            padding: 0.2rem 0.6rem;
            border-radius: 4px;
            margin-left: 0.75rem;
            vertical-align: middle;
            font-weight: 500;
            letter-spacing: 0.02em;
            border: 1px solid rgba(255, 255, 255, 0.1);
        }

        .callout {
            padding: 1.25rem;
            border-radius: 8px;
            margin: 1.5rem 0;
            border-left: 4px solid;
        }

        .pearl {
            background: var(--pearl-bg);
            border-color: var(--pearl-border);
        }

        .pearl::before {
            content: "üíé Clinical Pearl";
            display: block;
            font-weight: 700;
            color: var(--pearl-border);
            margin-bottom: 0.5rem;
        }

        .warning {
            background: var(--warning-bg);
            border-color: var(--warning-border);
        }

        .warning::before {
            content: "‚ö†Ô∏è Critical Safety";
            display: block;
            font-weight: 700;
            color: var(--warning-border);
            margin-bottom: 0.5rem;
        }

        .memory {
            background: var(--memory-bg);
            border-color: var(--memory-border);
        }

        .memory::before {
            content: "üß† Memory Aid";
            display: block;
            font-weight: 700;
            color: var(--memory-border);
            margin-bottom: 0.5rem;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            margin: 1.5rem 0;
            font-size: 0.95rem;
        }

        th,
        td {
            padding: 0.75rem;
            border: 1px solid var(--border);
            text-align: left;
        }

        th {
            background: var(--primary);
            color: white;
            font-weight: 600;
        }

        tr:nth-child(even) {
            background: var(--light-bg);
        }

        .comparison-table th:first-child {
            width: 25%;
        }

        ul,
        ol {
            margin: 1rem 0 1rem 1.5rem;
        }

        li {
            margin-bottom: 0.5rem;
        }

        .formula-box {
            background: linear-gradient(135deg, var(--primary), var(--secondary));
            color: white;
            padding: 1.5rem;
            border-radius: 10px;
            text-align: center;
            font-size: 1.5rem;
            font-weight: 700;
            margin: 1.5rem 0;
        }

        .formula-box small {
            display: block;
            font-size: 0.9rem;
            font-weight: 400;
            margin-top: 0.5rem;
            opacity: 0.9;
        }

        svg {
            max-width: 100%;
            height: auto;
            display: block;
            margin: 1.5rem auto;
        }

        .key-value {
            font-weight: 700;
            color: var(--secondary);
        }

        .highlight {
            background: #fefcbf;
            padding: 0.1rem 0.3rem;
            border-radius: 3px;
        }

        /* Mobile toggle button */
        .sidebar-toggle {
            display: none;
            position: fixed;
            bottom: 20px;
            left: 20px;
            z-index: 1000;
            background: var(--primary);
            color: white;
            border: none;
            border-radius: 50%;
            width: 50px;
            height: 50px;
            font-size: 1.5rem;
            cursor: pointer;
            box-shadow: 0 2px 10px rgba(0, 0, 0, 0.2);
        }

        /* Responsive */
        @media (max-width: 1024px) {
            .sidebar {
                position: fixed;
                left: calc(-1 * var(--sidebar-width));
                top: 0;
                height: 100vh;
                z-index: 999;
                transition: left 0.3s ease;
                box-shadow: 2px 0 10px rgba(0, 0, 0, 0.1);
            }

            .sidebar.open {
                left: 0;
            }

            .sidebar-toggle {
                display: flex;
                align-items: center;
                justify-content: center;
            }

            .main-content {
                padding: 1.5rem;
            }
        }

        @media (max-width: 768px) {
            .main-content {
                padding: 1rem;
            }

            h1 {
                font-size: 1.8rem;
            }

            .formula-box {
                font-size: 1.2rem;
                padding: 1rem;
            }
        }
    </style>
</head>

<body>

    <div class="page-wrapper">
        <!-- Sticky Sidebar -->
        <aside class="sidebar" id="sidebar">
            <div class="sidebar-inner">
                <nav class="nav-toc">
                    <h3>Contents</h3>
                    <ul>
                        <li><a href="#foundations">1. Cardiac Foundations</a></li>
                        <li><a href="#assessment">2. Cardiac Assessment</a></li>
                        <li><a href="#ecg">3. ECG Interpretation</a></li>
                        <li><a href="#arrhythmias">4. Cardiac Arrhythmias</a></li>
                        <li><a href="#devices">5. Cardiac Devices</a></li>
                        <li><a href="#cad">6. Coronary Artery Disease</a></li>
                        <li><a href="#acs">7. Acute Coronary Syndrome</a></li>
                        <li><a href="#valvular">8. Valvular & Structural</a></li>
                        <li><a href="#hf">9. Heart Failure</a></li>
                        <li><a href="#emergencies">10. Cardiac Emergencies</a></li>
                        <li><a href="#vascular">11. Vascular Disorders</a></li>
                        <li><a href="#shock">12. Shock States</a></li>
                        <li><a href="#diagnostics">Reference: Diagnostics</a></li>
                        <li><a href="#practice">Practice Questions</a></li>
                    </ul>
                </nav>
            </div>
        </aside>

        <!-- Mobile toggle button -->
        <button class="sidebar-toggle" id="sidebarToggle" aria-label="Toggle navigation">
            ‚ò∞
        </button>

        <!-- Main Content -->
        <main class="main-content">
            <div class="content-inner">

                <h1>Cardiac Output & Perfusion</h1>
                <p><em>A comprehensive guide to cardiac function, arrhythmias, coronary disease, heart failure, and
                        circulatory disorders</em></p>

                <!-- SECTION 1: CARDIAC FOUNDATIONS -->
                <section id="foundations">
                    <h2>1. Cardiac Foundations <span class="slide-ref">üìë W1 Slides 2‚Äì10</span></h2>

                    <h3>1.1 Cardiac Anatomy</h3>

                    <!-- Heart Anatomy Diagram -->
                    <svg viewBox="0 0 500 380" style="max-width: 500px;">
                        <!-- Heart shape -->
                        <path
                            d="M250,350 C150,350 50,280 50,180 C50,80 150,40 200,40 C230,40 250,60 250,80 C250,60 270,40 300,40 C350,40 450,80 450,180 C450,280 350,350 250,350"
                            fill="#ffebee" stroke="#c53030" stroke-width="3" />

                        <!-- Septum -->
                        <line x1="250" y1="80" x2="250" y2="320" stroke="#c53030" stroke-width="2"
                            stroke-dasharray="5,5" />

                        <!-- Chamber labels -->
                        <rect x="100" y="90" width="80" height="50" rx="5" fill="#3182ce" opacity="0.7" />
                        <text x="140" y="120" font-size="11" fill="white" text-anchor="middle"
                            font-weight="bold">Right</text>
                        <text x="140" y="133" font-size="11" fill="white" text-anchor="middle"
                            font-weight="bold">Atrium</text>

                        <rect x="320" y="90" width="80" height="50" rx="5" fill="#c53030" opacity="0.7" />
                        <text x="360" y="120" font-size="11" fill="white" text-anchor="middle"
                            font-weight="bold">Left</text>
                        <text x="360" y="133" font-size="11" fill="white" text-anchor="middle"
                            font-weight="bold">Atrium</text>

                        <rect x="90" y="180" width="100" height="80" rx="5" fill="#3182ce" opacity="0.5" />
                        <text x="140" y="215" font-size="11" fill="white" text-anchor="middle"
                            font-weight="bold">Right</text>
                        <text x="140" y="230" font-size="11" fill="white" text-anchor="middle"
                            font-weight="bold">Ventricle</text>
                        <text x="140" y="250" font-size="9" fill="white" text-anchor="middle">(thin wall)</text>

                        <rect x="310" y="180" width="100" height="100" rx="5" fill="#c53030" opacity="0.5" />
                        <text x="360" y="220" font-size="11" fill="white" text-anchor="middle"
                            font-weight="bold">Left</text>
                        <text x="360" y="235" font-size="11" fill="white" text-anchor="middle"
                            font-weight="bold">Ventricle</text>
                        <text x="360" y="255" font-size="9" fill="white" text-anchor="middle">(2-3x thicker)</text>

                        <!-- Vessels -->
                        <path d="M120,40 L120,90" stroke="#3182ce" stroke-width="8" />
                        <text x="120" y="30" font-size="9" fill="#3182ce" text-anchor="middle">SVC/IVC</text>

                        <path d="M80,140 Q40,120 40,80 L40,40" stroke="#3182ce" stroke-width="6" />
                        <text x="30" y="30" font-size="9" fill="#3182ce" text-anchor="middle">PA</text>

                        <path d="M380,40 L380,90" stroke="#c53030" stroke-width="6" />
                        <text x="380" y="30" font-size="9" fill="#c53030" text-anchor="middle">Pulm Veins</text>

                        <path d="M420,140 Q460,120 460,80 L460,40" stroke="#c53030" stroke-width="8" />
                        <text x="470" y="30" font-size="9" fill="#c53030" text-anchor="middle">Aorta</text>

                        <!-- Flow arrows -->
                        <text x="250" y="370" font-size="10" fill="#666" text-anchor="middle">Blue = Deoxygenated | Red
                            = Oxygenated</text>
                    </svg>

                    <p>The heart functions as a dual pump, with the right side managing pulmonary circulation and the
                        left side driving systemic circulation. Understanding the structural differences between
                        chambers explains why certain conditions affect one side preferentially.</p>

                    <p>The <strong>right atrium</strong> receives deoxygenated blood from the superior and inferior vena
                        cava and directs it to the lungs via the pulmonary artery. The <strong>left atrium</strong>
                        receives oxygenated blood from the pulmonary veins for distribution to the body. This
                        arrangement means the right heart handles low-oxygen blood while the left heart handles
                        oxygen-rich blood.</p>

                    <p>The <strong>left ventricle</strong> is 2-3 times thicker than the right ventricle because it must
                        generate enough pressure to overcome systemic vascular resistance‚Äîpushing blood through the
                        entire body. The <strong>right ventricle</strong> operates as a low-pressure system because
                        pulmonary vascular resistance is much lower than systemic resistance. This thickness difference
                        has clinical implications: the left ventricle is more susceptible to hypertrophy from chronic
                        hypertension, while the right ventricle fails when pulmonary pressures rise (as in COPD or
                        pulmonary embolism).</p>

                    <p>The heart is rotated within the chest so that the left ventricle lies closest to the chest wall.
                        This positioning allows us to palpate the <strong>Point of Maximal Impulse (PMI)</strong> at the
                        5th intercostal space, midclavicular line. A displaced PMI suggests ventricular enlargement‚Äîif
                        shifted laterally, suspect left ventricular hypertrophy or dilation.</p>

                    <h3>1.2 Cardiac Conduction System <span class="slide-ref">üìë W1 Slide 3</span></h3>

                    <p>The heart generates its own electrical impulses through specialized conduction tissue. This
                        intrinsic automaticity means the heart can beat independently of nervous system input, though
                        autonomic influences modulate rate and force.</p>

                    <svg viewBox="0 0 500 300" style="max-width: 500px;">
                        <defs>
                            <marker id="arrowhead" markerWidth="10" markerHeight="7" refX="9" refY="3.5" orient="auto">
                                <polygon points="0 0, 10 3.5, 0 7" fill="#3182ce" />
                            </marker>
                        </defs>
                        <!-- Heart outline -->
                        <ellipse cx="250" cy="150" rx="180" ry="120" fill="#ebf8ff" stroke="#3182ce" stroke-width="2" />
                        <!-- SA Node -->
                        <circle cx="320" cy="80" r="15" fill="#c53030" />
                        <text x="340" y="85" font-size="12" fill="#1a202c">SA Node</text>
                        <text x="340" y="98" font-size="10" fill="#666">(60-100 bpm)</text>
                        <!-- AV Node -->
                        <circle cx="250" cy="130" r="12" fill="#dd6b20" />
                        <text x="268" y="135" font-size="12" fill="#1a202c">AV Node</text>
                        <text x="268" y="148" font-size="10" fill="#666">(40-60 bpm)</text>
                        <!-- Bundle of His -->
                        <rect x="245" y="145" width="10" height="30" fill="#d69e2e" />
                        <text x="260" y="165" font-size="11" fill="#1a202c">Bundle of His</text>
                        <!-- Bundle Branches -->
                        <line x1="250" y1="175" x2="200" y2="220" stroke="#38a169" stroke-width="3" />
                        <line x1="250" y1="175" x2="300" y2="220" stroke="#38a169" stroke-width="3" />
                        <text x="150" y="225" font-size="10" fill="#1a202c">Left Bundle</text>
                        <text x="305" y="225" font-size="10" fill="#1a202c">Right Bundle</text>
                        <!-- Purkinje -->
                        <path d="M200,220 Q180,250 160,260" stroke="#805ad5" stroke-width="2" fill="none" />
                        <path d="M200,220 Q200,250 190,260" stroke="#805ad5" stroke-width="2" fill="none" />
                        <path d="M300,220 Q320,250 340,260" stroke="#805ad5" stroke-width="2" fill="none" />
                        <path d="M300,220 Q300,250 310,260" stroke="#805ad5" stroke-width="2" fill="none" />
                        <text x="130" y="275" font-size="10" fill="#805ad5">Purkinje Fibers (20-40 bpm)</text>
                        <!-- Arrows showing conduction -->
                        <path d="M320,95 Q285,100 255,125" stroke="#3182ce" stroke-width="2" fill="none"
                            marker-end="url(#arrowhead)" />
                    </svg>

                    <p>The conduction pathway follows a precise sequence:</p>
                    <ol>
                        <li><strong>SA Node</strong> (sinoatrial): The primary pacemaker, located in the right atrium.
                            Intrinsic rate of 60-100 bpm. Sets the pace for the entire heart.</li>
                        <li><strong>Internodal pathways</strong> and <strong>Bachmann's bundle</strong>: Conduct impulse
                            across atria</li>
                        <li><strong>AV Node</strong> (atrioventricular): Secondary pacemaker (40-60 bpm). Creates a
                            brief delay allowing atrial contraction to complete before ventricular contraction begins.
                        </li>
                        <li><strong>Bundle of His</strong>: Conducts impulse from AV node to ventricles</li>
                        <li><strong>Right and Left Bundle Branches</strong>: Divide to serve each ventricle</li>
                        <li><strong>Purkinje Fibers</strong>: Terminal network ensuring rapid, coordinated ventricular
                            contraction. Intrinsic rate 20-40 bpm.</li>
                    </ol>

                    <div class="callout pearl">
                        The pacemaker hierarchy matters clinically. If the SA node fails, the AV node takes over at a
                        slower rate. If both fail, Purkinje fibers produce a very slow escape rhythm (20-40 bpm)‚Äîoften
                        insufficient to maintain adequate cardiac output. This is why complete heart block is an
                        emergency.
                    </div>

                    <h4>Electrical Properties of Cardiac Cells</h4>

                    <table>
                        <tr>
                            <th>Property</th>
                            <th>Definition</th>
                            <th>Clinical Relevance</th>
                        </tr>
                        <tr>
                            <td><strong>Automaticity</strong></td>
                            <td>Ability to spontaneously generate electrical impulse</td>
                            <td>Enhanced automaticity causes ectopic beats (PACs, PVCs)</td>
                        </tr>
                        <tr>
                            <td><strong>Excitability</strong></td>
                            <td>Ability to respond to electrical stimulus</td>
                            <td>Affected by electrolytes, medications, ischemia</td>
                        </tr>
                        <tr>
                            <td><strong>Conductivity</strong></td>
                            <td>Ability to transmit impulse from cell to cell</td>
                            <td>Impaired in heart blocks, bundle branch blocks</td>
                        </tr>
                    </table>

                    <h3>1.3 Action Potential and Refractory Periods <span class="slide-ref">üìë W1 Slides 4‚Äì5</span></h3>

                    <p>Cardiac cells undergo depolarization and repolarization with each heartbeat. Understanding this
                        cycle explains how antiarrhythmic drugs work and why certain timing matters for cardioversion.
                    </p>

                    <p><strong>Depolarization</strong> is electrical activation: sodium rapidly enters the cell while
                        potassium exits, reversing the cell's electrical charge. This triggers contraction.
                        <strong>Repolarization</strong> returns the cell to its resting state: potassium exits the cell
                        rapidly (Phase 3), and then the Na+/K+ ATPase pump restores resting ion concentrations (Phase
                        4), allowing the muscle to relax.
                    </p>

                    <p>The action potential has five phases:</p>

                    <!-- Action Potential Diagram -->
                    <svg viewBox="0 0 550 320" style="max-width: 550px;">
                        <!-- Grid -->
                        <rect x="60" y="20" width="450" height="250" fill="#f7fafc" stroke="#e2e8f0" />

                        <!-- Y-axis labels -->
                        <text x="50" y="45" font-size="10" fill="#666" text-anchor="end">+20</text>
                        <text x="50" y="95" font-size="10" fill="#666" text-anchor="end">0</text>
                        <text x="50" y="195" font-size="10" fill="#666" text-anchor="end">-70</text>
                        <text x="50" y="245" font-size="10" fill="#666" text-anchor="end">-90</text>
                        <text x="25" y="140" font-size="10" fill="#666" text-anchor="middle"
                            transform="rotate(-90,25,140)">mV</text>

                        <!-- Resting line -->
                        <line x1="60" y1="195" x2="510" y2="195" stroke="#ccc" stroke-dasharray="3,3" />

                        <!-- Action Potential Curve -->
                        <path d="M70,195 L100,195 L110,40 L130,60 L200,65 L280,195 L380,195 L400,195" stroke="#c53030"
                            stroke-width="3" fill="none" />

                        <!-- Phase labels with boxes -->
                        <rect x="100" y="25" width="35" height="20" rx="3" fill="#c53030" />
                        <text x="117" y="39" font-size="10" fill="white" text-anchor="middle" font-weight="bold">Ph
                            0</text>

                        <rect x="125" y="50" width="35" height="20" rx="3" fill="#dd6b20" />
                        <text x="142" y="64" font-size="10" fill="white" text-anchor="middle" font-weight="bold">Ph
                            1</text>

                        <rect x="155" y="75" width="60" height="20" rx="3" fill="#d69e2e" />
                        <text x="185" y="89" font-size="10" fill="white" text-anchor="middle" font-weight="bold">Ph 2
                            Plateau</text>

                        <rect x="230" y="130" width="35" height="20" rx="3" fill="#38a169" />
                        <text x="247" y="144" font-size="10" fill="white" text-anchor="middle" font-weight="bold">Ph
                            3</text>

                        <rect x="320" y="180" width="60" height="20" rx="3" fill="#3182ce" />
                        <text x="350" y="194" font-size="10" fill="white" text-anchor="middle" font-weight="bold">Ph 4
                            Rest</text>

                        <!-- Ion movements -->
                        <text x="105" y="280" font-size="9" fill="#c53030" font-weight="bold">Na+ IN</text>
                        <text x="170" y="295" font-size="9" fill="#d69e2e" font-weight="bold">Ca++ IN, K+ OUT</text>
                        <text x="250" y="280" font-size="9" fill="#38a169" font-weight="bold">K+ OUT</text>
                        <text x="340" y="295" font-size="9" fill="#3182ce" font-weight="bold">Na+/K+ pump
                            restores</text>

                        <!-- Refractory period bracket -->
                        <line x1="105" y1="10" x2="260" y2="10" stroke="#805ad5" stroke-width="2" />
                        <line x1="105" y1="5" x2="105" y2="15" stroke="#805ad5" stroke-width="2" />
                        <line x1="260" y1="5" x2="260" y2="15" stroke="#805ad5" stroke-width="2" />
                        <text x="182" y="8" font-size="9" fill="#805ad5" text-anchor="middle">Absolute Refractory</text>

                        <line x1="260" y1="10" x2="300" y2="10" stroke="#805ad5" stroke-width="2"
                            stroke-dasharray="3,3" />
                        <line x1="300" y1="5" x2="300" y2="15" stroke="#805ad5" stroke-width="2" />
                        <text x="280" y="8" font-size="8" fill="#805ad5" text-anchor="middle">Relative</text>
                    </svg>

                    <ul>
                        <li><strong>Phase 0</strong>: Rapid depolarization (sodium influx)</li>
                        <li><strong>Phase 1</strong>: Early rapid repolarization</li>
                        <li><strong>Phase 2</strong>: Plateau phase (calcium influx balances potassium efflux)</li>
                        <li><strong>Phase 3</strong>: Final repolarization (potassium efflux)</li>
                        <li><strong>Phase 4</strong>: Resting membrane potential</li>
                    </ul>

                    <h4>Refractory Periods</h4>

                    <table>
                        <tr>
                            <th>Period</th>
                            <th>What Happens</th>
                            <th>Clinical Significance</th>
                        </tr>
                        <tr>
                            <td><strong>Absolute (Effective) Refractory Period</strong></td>
                            <td>Cell cannot depolarize regardless of stimulus strength</td>
                            <td>Protects heart from tetanic contraction; no stimulus can trigger a beat</td>
                        </tr>
                        <tr>
                            <td><strong>Relative Refractory Period</strong></td>
                            <td>Cell can depolarize but requires stronger-than-normal stimulus</td>
                            <td>Vulnerable period‚Äîdefibrillation here can induce arrhythmia</td>
                        </tr>
                    </table>

                    <div class="callout warning">
                        The relative refractory period corresponds to the T wave on ECG. Shocking during this vulnerable
                        window can trigger ventricular fibrillation. This is why synchronized cardioversion uses
                        <strong>SYNC mode</strong>‚Äîit times the shock to the R wave (absolute refractory period),
                        avoiding the T wave.
                    </div>

                    <h3>1.4 The Cardiac Cycle <span class="slide-ref">üìë W1 Slides 6‚Äì7</span></h3>

                    <p>Each heartbeat consists of precisely coordinated mechanical events driven by electrical
                        activation. The cycle has three major phases:</p>

                    <!-- Cardiac Cycle Diagram -->
                    <svg viewBox="0 0 650 300" style="max-width: 650px;">
                        <!-- Timeline arrow -->
                        <line x1="30" y1="250" x2="620" y2="250" stroke="#1a365d" stroke-width="2"
                            marker-end="url(#arrowhead)" />
                        <text x="325" y="280" font-size="12" fill="#1a365d" text-anchor="middle" font-weight="bold">TIME
                            ‚Üí</text>

                        <!-- Diastole Box -->
                        <rect x="50" y="30" width="180" height="200" rx="10" fill="#ebf8ff" stroke="#3182ce"
                            stroke-width="2" />
                        <text x="140" y="55" font-size="14" fill="#3182ce" text-anchor="middle"
                            font-weight="bold">DIASTOLE</text>
                        <text x="140" y="72" font-size="10" fill="#3182ce"
                            text-anchor="middle">(Relaxation/Filling)</text>

                        <!-- Diastole details -->
                        <text x="60" y="95" font-size="10" fill="#1a202c">‚Ä¢ All chambers relaxed</text>
                        <text x="60" y="115" font-size="10" fill="#1a202c">‚Ä¢ AV valves OPEN</text>
                        <text x="60" y="135" font-size="10" fill="#1a202c">‚Ä¢ Semilunar valves CLOSED</text>
                        <text x="60" y="155" font-size="10" fill="#1a202c">‚Ä¢ Lowest pressure</text>
                        <text x="60" y="175" font-size="10" fill="#1a202c">‚Ä¢ Passive ventricular filling</text>
                        <text x="60" y="195" font-size="10" fill="#1a202c">‚Ä¢ (~75% of filling)</text>

                        <!-- Heart icon diastole -->
                        <circle cx="140" cy="215" r="15" fill="none" stroke="#3182ce" stroke-width="2" />
                        <text x="140" y="220" font-size="12" fill="#3182ce" text-anchor="middle">‚ô°</text>

                        <!-- Atrial Systole Box -->
                        <rect x="250" y="30" width="150" height="200" rx="10" fill="#faf5ff" stroke="#805ad5"
                            stroke-width="2" />
                        <text x="325" y="55" font-size="14" fill="#805ad5" text-anchor="middle"
                            font-weight="bold">ATRIAL SYSTOLE</text>
                        <text x="325" y="72" font-size="10" fill="#805ad5" text-anchor="middle">(Atrial Kick)</text>

                        <!-- Atrial systole details -->
                        <text x="260" y="95" font-size="10" fill="#1a202c">‚Ä¢ SA node fires</text>
                        <text x="260" y="115" font-size="10" fill="#1a202c">‚Ä¢ Atria contract</text>
                        <text x="260" y="135" font-size="10" fill="#1a202c">‚Ä¢ Adds 25% more</text>
                        <text x="260" y="150" font-size="10" fill="#1a202c"> volume to ventricles</text>
                        <text x="260" y="175" font-size="10" fill="#c53030" font-weight="bold">Loss of atrial
                            kick</text>
                        <text x="260" y="190" font-size="10" fill="#c53030">= ‚ÜìCO (A-fib!)</text>

                        <!-- Ventricular Systole Box -->
                        <rect x="420" y="30" width="180" height="200" rx="10" fill="#fff5f5" stroke="#c53030"
                            stroke-width="2" />
                        <text x="510" y="55" font-size="14" fill="#c53030" text-anchor="middle"
                            font-weight="bold">VENTRICULAR SYSTOLE</text>
                        <text x="510" y="72" font-size="10" fill="#c53030" text-anchor="middle">(Ejection)</text>

                        <!-- Ventricular systole details -->
                        <text x="430" y="95" font-size="10" fill="#1a202c">‚Ä¢ Ventricles contract</text>
                        <text x="430" y="115" font-size="10" fill="#1a202c">‚Ä¢ AV valves CLOSE ‚Üí S1</text>
                        <text x="430" y="135" font-size="10" fill="#1a202c">‚Ä¢ Semilunar valves OPEN</text>
                        <text x="430" y="155" font-size="10" fill="#1a202c">‚Ä¢ Blood ejected to</text>
                        <text x="430" y="170" font-size="10" fill="#1a202c"> PA and Aorta</text>
                        <text x="430" y="195" font-size="10" fill="#1a202c">‚Ä¢ At end: semilunar</text>
                        <text x="430" y="210" font-size="10" fill="#1a202c"> valves close ‚Üí S2</text>

                        <!-- Heart icon systole -->
                        <circle cx="510" cy="215" r="15" fill="#c53030" stroke="#c53030" stroke-width="2" />
                        <text x="510" y="220" font-size="12" fill="white" text-anchor="middle">‚ô•</text>

                        <!-- Arrows between phases -->
                        <path d="M235,130 L245,130" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)" />
                        <path d="M405,130 L415,130" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)" />
                    </svg>

                    <p><strong>Diastole</strong> (relaxation): All four chambers are relaxed. AV valves (tricuspid and
                        mitral) are open, allowing blood to flow from atria to ventricles. Semilunar valves (aortic and
                        pulmonic) are closed. Pressure in the chambers is at its lowest, facilitating passive
                        ventricular filling. About 75% of ventricular filling occurs passively during early diastole.
                    </p>

                    <p><strong>Atrial Systole</strong>: The SA node fires, triggering atrial contraction. This "atrial
                        kick" actively pushes the remaining 25% of blood into the ventricles. While 25% seems small,
                        losing atrial kick (as in atrial fibrillation) significantly reduces cardiac output, especially
                        when the heart rate is fast and diastolic filling time is shortened.</p>

                    <p><strong>Ventricular Systole</strong>: Following atrial contraction, the ventricles contract.
                        Rising ventricular pressure closes the AV valves (producing S1) and opens the semilunar valves,
                        ejecting blood into the pulmonary artery and aorta.</p>

                    <div class="callout pearl">
                        Fluid always flows from high pressure to low pressure. Understanding this principle explains why
                        valvular stenosis (narrowing) and regurgitation (backflow) disrupt normal hemodynamics. A
                        stenotic valve creates a pressure gradient; a regurgitant valve allows backflow when pressure
                        relationships reverse.
                    </div>

                    <h3>1.5 Cardiac Output: The Master Formula <span class="slide-ref">üìë W1 Slides 7‚Äì10</span></h3>

                    <div class="formula-box">
                        CO = SV √ó HR
                        <small>Cardiac Output (L/min) = Stroke Volume (mL/beat) √ó Heart Rate (beats/min)</small>
                        <small>Normal: 4-6 L/min</small>
                    </div>

                    <p><strong>Cardiac output</strong> is the total volume of blood pumped by the ventricle per minute.
                        It represents the heart's ability to meet the body's metabolic demands. Normal CO is 4-6 L/min,
                        but this can increase dramatically during exercise (up to 20-25 L/min in athletes).</p>

                    <p><strong>Stroke volume</strong> is the amount of blood ejected with each heartbeat. Three factors
                        determine SV:</p>

                    <svg viewBox="0 0 600 200" style="max-width: 600px;">
                        <rect x="200" y="70" width="200" height="60" rx="10" fill="#3182ce" />
                        <text x="300" y="105" text-anchor="middle" fill="white" font-weight="bold" font-size="16">STROKE
                            VOLUME</text>
                        <!-- Preload -->
                        <rect x="30" y="20" width="120" height="50" rx="8" fill="#38a169" />
                        <text x="90" y="50" text-anchor="middle" fill="white" font-weight="bold"
                            font-size="12">PRELOAD</text>
                        <line x1="150" y1="45" x2="200" y2="85" stroke="#38a169" stroke-width="2"
                            marker-end="url(#arrowhead)" />
                        <!-- Afterload -->
                        <rect x="30" y="130" width="120" height="50" rx="8" fill="#c53030" />
                        <text x="90" y="160" text-anchor="middle" fill="white" font-weight="bold"
                            font-size="12">AFTERLOAD</text>
                        <line x1="150" y1="155" x2="200" y2="115" stroke="#c53030" stroke-width="2"
                            marker-end="url(#arrowhead)" />
                        <!-- Contractility -->
                        <rect x="450" y="75" width="120" height="50" rx="8" fill="#805ad5" />
                        <text x="510" y="105" text-anchor="middle" fill="white" font-weight="bold"
                            font-size="12">CONTRACTILITY</text>
                        <line x1="400" y1="100" x2="450" y2="100" stroke="#805ad5" stroke-width="2"
                            marker-end="url(#arrowhead)" />
                    </svg>

                    <!-- Preload vs. Afterload Visual Comparison -->
                    <svg viewBox="0 0 680 330" style="max-width: 680px;" role="img"
                        aria-label="Preload versus Afterload visual comparison. Left panel shows ventricle filling with blood representing preload as volume and stretch. Right panel shows resistance arrows opposing ventricular ejection representing afterload.">
                        <defs>
                            <marker id="pv-arrow-blue" viewBox="0 0 10 10" refX="9" refY="5" markerWidth="6"
                                markerHeight="6" orient="auto-start-reverse">
                                <polygon points="0 0, 10 5, 0 10" fill="#3182ce" />
                            </marker>
                            <marker id="pv-arrow-red" viewBox="0 0 10 10" refX="9" refY="5" markerWidth="6"
                                markerHeight="6" orient="auto-start-reverse">
                                <polygon points="0 0, 10 5, 0 10" fill="#c53030" />
                            </marker>
                            <marker id="pv-arrow-dark" viewBox="0 0 10 10" refX="9" refY="5" markerWidth="6"
                                markerHeight="6" orient="auto-start-reverse">
                                <polygon points="0 0, 10 5, 0 10" fill="#9b2c2c" />
                            </marker>
                        </defs>

                        <!-- Title -->
                        <text x="340" y="22" text-anchor="middle" font-size="15" font-weight="700"
                            fill="#1a365d">Preload vs. Afterload ‚Äî Visual Comparison</text>

                        <!-- ========== LEFT PANEL: PRELOAD ========== -->
                        <rect x="10" y="36" width="320" height="280" rx="12" fill="#ebf8ff" stroke="#3182ce"
                            stroke-width="2" />
                        <text x="170" y="60" text-anchor="middle" font-size="14" font-weight="700"
                            fill="#2c5282">PRELOAD</text>
                        <text x="170" y="76" text-anchor="middle" font-size="11" fill="#3182ce">= Volume / Stretch at
                            End-Diastole</text>

                        <!-- Ventricle outline (relaxed, filling) -->
                        <path
                            d="M120,120 C100,120 80,150 80,185 C80,225 105,255 170,275 C235,255 260,225 260,185 C260,150 240,120 220,120 C210,115 195,110 170,110 C145,110 130,115 120,120Z"
                            fill="#bee3f8" stroke="#3182ce" stroke-width="2.5" />

                        <!-- Wavy lines = volume inside ventricle -->
                        <path d="M100,195 Q120,188 140,195 Q160,202 180,195 Q200,188 220,195 Q237,200 248,195"
                            fill="none" stroke="#3182ce" stroke-width="1.5" opacity="0.5" />
                        <path d="M96,212 Q116,205 136,212 Q156,219 176,212 Q196,205 216,212 Q233,217 250,212"
                            fill="none" stroke="#3182ce" stroke-width="1.5" opacity="0.5" />
                        <path d="M94,229 Q114,222 134,229 Q154,236 174,229 Q194,222 214,229 Q230,234 250,229"
                            fill="none" stroke="#3182ce" stroke-width="1.5" opacity="0.5" />
                        <text x="170" y="250" text-anchor="middle" font-size="10" fill="#2c5282"
                            font-weight="600">Volume</text>

                        <!-- Filling arrows pointing INTO ventricle -->
                        <line x1="55" y1="140" x2="78" y2="160" stroke="#3182ce" stroke-width="2.5"
                            marker-end="url(#pv-arrow-blue)" />
                        <line x1="55" y1="185" x2="78" y2="190" stroke="#3182ce" stroke-width="2.5"
                            marker-end="url(#pv-arrow-blue)" />
                        <line x1="285" y1="140" x2="262" y2="160" stroke="#3182ce" stroke-width="2.5"
                            marker-end="url(#pv-arrow-blue)" />
                        <line x1="285" y1="185" x2="262" y2="190" stroke="#3182ce" stroke-width="2.5"
                            marker-end="url(#pv-arrow-blue)" />
                        <text x="42" y="136" font-size="9" fill="#3182ce" text-anchor="end">Blood</text>
                        <text x="42" y="147" font-size="9" fill="#3182ce" text-anchor="end">filling</text>

                        <!-- Stretch double-arrow inside -->
                        <line x1="108" y1="170" x2="232" y2="170" stroke="#2c5282" stroke-width="1.5"
                            stroke-dasharray="4,3" />
                        <text x="170" y="166" text-anchor="middle" font-size="9" fill="#2c5282" font-weight="600">‚Üê
                            muscle stretch ‚Üí</text>

                        <!-- Result -->
                        <rect x="38" y="288" width="264" height="22" rx="5" fill="#3182ce" opacity="0.15" />
                        <text x="170" y="304" text-anchor="middle" font-size="12" fill="#2c5282" font-weight="700">‚Üë
                            Preload ‚Üí ‚Üë SV (to a point)</text>

                        <!-- ========== RIGHT PANEL: AFTERLOAD ========== -->
                        <rect x="350" y="36" width="320" height="280" rx="12" fill="#fff5f5" stroke="#c53030"
                            stroke-width="2" />
                        <text x="510" y="60" text-anchor="middle" font-size="14" font-weight="700"
                            fill="#c53030">AFTERLOAD</text>
                        <text x="510" y="76" text-anchor="middle" font-size="11" fill="#9b2c2c">= Resistance to
                            Ejection</text>

                        <!-- Ventricle outline (contracting) -->
                        <path
                            d="M465,130 C448,130 432,155 432,180 C432,212 452,238 510,254 C568,238 588,212 588,180 C588,155 572,130 555,130 C546,126 533,122 510,122 C487,122 474,126 465,130Z"
                            fill="#fed7d7" stroke="#c53030" stroke-width="2.5" />
                        <text x="510" y="195" text-anchor="middle" font-size="10" fill="#9b2c2c"
                            font-weight="600">Contracting</text>

                        <!-- Ejection arrow UP from ventricle -->
                        <line x1="510" y1="120" x2="510" y2="94" stroke="#c53030" stroke-width="3"
                            marker-end="url(#pv-arrow-red)" />
                        <text x="510" y="88" text-anchor="middle" font-size="10" fill="#c53030"
                            font-weight="600">Ejection</text>

                        <!-- Resistance barrier (thick bar above ventricle) -->
                        <rect x="460" y="98" width="100" height="8" rx="4" fill="#fc8181" opacity="0.7" />

                        <!-- Resistance arrows pushing BACK against ejection -->
                        <line x1="445" y1="85" x2="466" y2="100" stroke="#9b2c2c" stroke-width="2.5"
                            marker-end="url(#pv-arrow-dark)" />
                        <line x1="575" y1="85" x2="554" y2="100" stroke="#9b2c2c" stroke-width="2.5"
                            marker-end="url(#pv-arrow-dark)" />
                        <text x="420" y="80" font-size="9" fill="#9b2c2c" text-anchor="end">SVR</text>
                        <text x="600" y="80" font-size="9" fill="#9b2c2c">SVR</text>

                        <!-- Squeezing arrows on sides (must overcome) -->
                        <line x1="410" y1="180" x2="430" y2="180" stroke="#c53030" stroke-width="2"
                            marker-end="url(#pv-arrow-red)" />
                        <line x1="610" y1="180" x2="590" y2="180" stroke="#c53030" stroke-width="2"
                            marker-end="url(#pv-arrow-red)" />
                        <text x="400" y="200" font-size="9" fill="#c53030" text-anchor="end">Must</text>
                        <text x="400" y="212" font-size="9" fill="#c53030" text-anchor="end">overcome</text>

                        <!-- Result -->
                        <rect x="378" y="288" width="264" height="22" rx="5" fill="#c53030" opacity="0.12" />
                        <text x="510" y="304" text-anchor="middle" font-size="12" fill="#9b2c2c" font-weight="700">‚Üë
                            Afterload ‚Üí ‚Üì SV</text>
                    </svg>

                    <h4>Preload <span class="slide-ref">üìë W1 Slide 7</span></h4>

                    <p>Preload is the degree of stretch on cardiac muscle fibers at the end of diastole‚Äîessentially, how
                        much blood fills the ventricle before it contracts. It reflects left ventricular end-diastolic
                        pressure (LVEDP) and volume.</p>

                    <p>The <strong>Frank-Starling Law</strong> states: the greater the stretch (within physiologic
                        limits), the stronger the contraction, and the greater the stroke volume. Think of it like
                        stretching a rubber band‚Äîup to a point, more stretch means more snap-back force.</p>

                    <!-- Frank-Starling Curve -->
                    <svg viewBox="0 0 450 300" style="max-width: 450px;">
                        <!-- Axes -->
                        <line x1="60" y1="250" x2="420" y2="250" stroke="#1a365d" stroke-width="2" />
                        <line x1="60" y1="250" x2="60" y2="30" stroke="#1a365d" stroke-width="2" />

                        <!-- Axis labels -->
                        <text x="240" y="285" font-size="12" fill="#1a365d" text-anchor="middle"
                            font-weight="bold">Preload (Ventricular End-Diastolic Volume)</text>
                        <text x="25" y="140" font-size="12" fill="#1a365d" text-anchor="middle" font-weight="bold"
                            transform="rotate(-90,25,140)">Stroke Volume / Cardiac Output</text>

                        <!-- Normal curve -->
                        <path d="M70,230 Q150,180 200,100 Q250,60 300,55 Q350,55 380,60" stroke="#38a169"
                            stroke-width="3" fill="none" />
                        <text x="320" y="45" font-size="11" fill="#38a169" font-weight="bold">Normal Heart</text>

                        <!-- Failing heart curve -->
                        <path d="M70,230 Q130,200 180,170 Q230,150 280,145 Q330,145 380,150" stroke="#c53030"
                            stroke-width="3" fill="none" />
                        <text x="320" y="165" font-size="11" fill="#c53030" font-weight="bold">Failing Heart</text>

                        <!-- Enhanced contractility curve -->
                        <path d="M70,220 Q130,150 170,70 Q210,35 260,30 Q310,30 380,35" stroke="#3182ce"
                            stroke-width="3" fill="none" stroke-dasharray="8,4" />
                        <text x="280" y="22" font-size="11" fill="#3182ce" font-weight="bold">‚Üë Contractility</text>

                        <!-- Annotations -->
                        <circle cx="200" cy="100" r="5" fill="#38a169" />
                        <line x1="205" y1="95" x2="250" y2="80" stroke="#38a169" stroke-width="1" />
                        <text x="255" y="78" font-size="9" fill="#38a169">Optimal filling</text>

                        <!-- Overstretched region -->
                        <rect x="340" y="50" width="60" height="30" fill="#fff5f5" stroke="#c53030"
                            stroke-dasharray="3,3" />
                        <text x="370" y="70" font-size="8" fill="#c53030" text-anchor="middle">Overstretched</text>

                        <!-- Arrow showing increase -->
                        <path d="M100,210 L100,130" stroke="#666" stroke-width="1.5" marker-end="url(#arrowhead)" />
                        <text x="115" y="170" font-size="9" fill="#666">‚Üë Stretch</text>
                        <text x="115" y="182" font-size="9" fill="#666">‚Üë SV</text>
                    </svg>

                    <table class="comparison-table">
                        <tr>
                            <th>Preload Status</th>
                            <th>Causes</th>
                            <th>Clinical Action</th>
                        </tr>
                        <tr>
                            <td><strong>Decreased Preload</strong></td>
                            <td>Hemorrhage, dehydration, diuretics, vasodilators, blood loss, fluid volume deficit</td>
                            <td>"Fill the tank"‚ÄîIV fluids, blood products</td>
                        </tr>
                        <tr>
                            <td><strong>Increased Preload</strong></td>
                            <td>Fluid overload, heart failure, renal failure, excessive IV fluids</td>
                            <td>Diuretics, fluid restriction, vasodilators (nitrates)</td>
                        </tr>
                    </table>

                    <h4>Afterload <span class="slide-ref">üìë W1 Slide 7</span></h4>

                    <p>Afterload is the resistance the ventricle must overcome to eject blood. For the left ventricle,
                        this primarily reflects systemic vascular resistance (SVR). For the right ventricle, it reflects
                        pulmonary vascular resistance (PVR).</p>

                    <p>There is an <strong>inverse relationship</strong> between afterload and stroke volume: increased
                        afterload means the heart works harder but pumps less volume. This is why chronic hypertension
                        (high afterload) leads to heart failure over time‚Äîthe heart eventually cannot overcome the
                        resistance.</p>

                    <table class="comparison-table">
                        <tr>
                            <th>Afterload Status</th>
                            <th>Mechanism</th>
                            <th>Medications</th>
                        </tr>
                        <tr>
                            <td><strong>Decrease Afterload</strong></td>
                            <td>Vasodilation reduces resistance ‚Üí increases SV</td>
                            <td>ACE inhibitors, ARBs, Beta-blockers, Calcium channel blockers (ABC)</td>
                        </tr>
                        <tr>
                            <td><strong>Increase Afterload</strong></td>
                            <td>Vasoconstriction increases resistance ‚Üí supports BP in shock</td>
                            <td>Norepinephrine (Levophed), Vasopressin</td>
                        </tr>
                    </table>

                    <div class="callout memory">
                        <strong>ABC reduces afterload:</strong><br>
                        <strong>A</strong> ‚Äì ACE inhibitors and ARBs<br>
                        <strong>B</strong> ‚Äì Beta-blockers<br>
                        <strong>C</strong> ‚Äì Calcium channel blockers
                    </div>

                    <h4>Contractility <span class="slide-ref">üìë W1 Slides 8, 10</span></h4>

                    <p>Contractility (inotropy) is the inherent strength of cardiac muscle contraction, independent of
                        preload and afterload. Increased contractility = increased stroke volume.</p>

                    <table class="comparison-table">
                        <tr>
                            <th>Effect</th>
                            <th>Agents/Conditions</th>
                            <th>Examples</th>
                        </tr>
                        <tr>
                            <td><strong>Positive Inotropes</strong><br>(Increase force)</td>
                            <td>Catecholamines, SNS stimulation, certain medications</td>
                            <td>Dopamine, Epinephrine, Norepinephrine, Dobutamine, Digoxin, Milrinone</td>
                        </tr>
                        <tr>
                            <td><strong>Negative Inotropes</strong><br>(Decrease force)</td>
                            <td>Vagal stimulation, certain medications, pathologic states</td>
                            <td>Beta-blockers, Calcium channel blockers (diltiazem, verapamil), Hypoxemia, Acidosis</td>
                        </tr>
                    </table>

                    <h4>Related Cardiac Terminology</h4>

                    <table>
                        <tr>
                            <th>Term</th>
                            <th>Meaning</th>
                            <th>Example</th>
                        </tr>
                        <tr>
                            <td><strong>Chronotropy</strong></td>
                            <td>Effect on heart rate</td>
                            <td>Positive chronotrope (atropine) increases HR</td>
                        </tr>
                        <tr>
                            <td><strong>Dromotropy</strong></td>
                            <td>Effect on AV conduction velocity</td>
                            <td>Negative dromotrope (digoxin) slows AV conduction</td>
                        </tr>
                        <tr>
                            <td><strong>Inotropy</strong></td>
                            <td>Effect on contractile force</td>
                            <td>Positive inotrope (dobutamine) increases force</td>
                        </tr>
                    </table>

                    <h3>1.6 Ejection Fraction <span class="slide-ref">üìë W1 Slide 8</span></h3>

                    <p>Ejection fraction (EF) is the percentage of end-diastolic volume ejected with each heartbeat. It
                        primarily refers to the left ventricle and serves as a key measurement of contractility and
                        overall cardiac function.</p>

                    <table>
                        <tr>
                            <th>Ejection Fraction</th>
                            <th>Interpretation</th>
                            <th>Clinical Significance</th>
                        </tr>
                        <tr>
                            <td><span class="key-value">55-65%</span></td>
                            <td>Normal</td>
                            <td>Heart pumping efficiently</td>
                        </tr>
                        <tr>
                            <td><span class="key-value">40-54%</span></td>
                            <td>Mildly reduced</td>
                            <td>Early dysfunction, may need monitoring</td>
                        </tr>
                        <tr>
                            <td><span class="key-value">&lt;40%</span></td>
                            <td>Reduced (HFrEF)</td>
                            <td>Indicator of heart failure; guides treatment</td>
                        </tr>
                    </table>

                    <div class="callout pearl">
                        EF is measured via echocardiogram. A patient with EF &lt;35% who survives a cardiac event often
                        qualifies for ICD placement to prevent sudden cardiac death from ventricular arrhythmias.
                    </div>

                    <h3>1.7 Baroreceptors <span class="slide-ref">üìë W1 Slides 7, 10</span></h3>

                    <p>Baroreceptors are specialized nerve cells located in the aortic arch and bilateral internal
                        carotid arteries. They sense blood pressure changes and trigger compensatory responses:</p>

                    <table class="comparison-table">
                        <tr>
                            <th>Blood Pressure State</th>
                            <th>Baroreceptor Response</th>
                            <th>Result</th>
                        </tr>
                        <tr>
                            <td><strong>Hypertension detected</strong></td>
                            <td>Increased firing rate to brainstem</td>
                            <td>‚Üì Heart rate, ‚Üì BP (parasympathetic activation)</td>
                        </tr>
                        <tr>
                            <td><strong>Hypotension detected</strong></td>
                            <td>Decreased firing rate to brainstem</td>
                            <td>‚Üë Heart rate, ‚Üë BP, vasoconstriction (sympathetic activation)</td>
                        </tr>
                    </table>

                    <p>This reflex arc explains why position changes can cause orthostatic hypotension in patients with
                        impaired baroreceptor function (diabetic neuropathy, elderly patients, volume depletion).</p>

                    <h3>1.8 Gerontologic Considerations <span class="slide-ref">üìë W1 Slide 11</span></h3>

                    <p>Aging produces predictable changes in cardiac structure and function that affect how older
                        patients present and respond to treatment:</p>

                    <table>
                        <tr>
                            <th>Age-Related Change</th>
                            <th>Pathophysiology</th>
                            <th>Clinical Manifestation</th>
                        </tr>
                        <tr>
                            <td>Loss of conduction cells</td>
                            <td>SA node pacemaker cells decrease</td>
                            <td>Slower resting HR, increased risk of sick sinus syndrome</td>
                        </tr>
                        <tr>
                            <td>Myocardial hypertrophy</td>
                            <td>Muscle thickens but chamber volume decreases</td>
                            <td>Reduced CO, decreased exercise tolerance</td>
                        </tr>
                        <tr>
                            <td>Valve calcification/stiffening</td>
                            <td>Fibrosis limits valve mobility</td>
                            <td>Murmurs (especially aortic stenosis), increased backflow</td>
                        </tr>
                        <tr>
                            <td>Decreased arterial compliance</td>
                            <td>Vessels less elastic</td>
                            <td>Isolated systolic hypertension, widened pulse pressure</td>
                        </tr>
                        <tr>
                            <td>Slower compensatory mechanisms</td>
                            <td>Baroreceptor sensitivity decreases</td>
                            <td>Orthostatic hypotension, slower response to stress</td>
                        </tr>
                    </table>

                    <p>Older adults often present with <strong>atypical symptoms</strong>: SOB, fatigue, and
                        palpitations rather than classic chest pain. This delay in recognition contributes to worse
                        outcomes.</p>

                    <h3>1.9 Gender Differences <span class="slide-ref">üìë W1 Slide 11</span></h3>

                    <p>Women have distinct cardiovascular profiles compared to men:</p>

                    <ul>
                        <li><strong>Smaller heart and narrower vessels</strong> make angioplasty technically more
                            difficult</li>
                        <li><strong>Estrogen provides protection</strong>: increases HDL, decreases LDL, promotes
                            vasodilation, increases blood flow to heart</li>
                        <li><strong>CAD onset delayed ~10 years</strong> compared to men due to estrogen protection</li>
                        <li><strong>Risk equalizes post-menopause</strong>: Men at age 45 = Women at age 55 for CAD risk
                        </li>
                        <li><strong>Atypical presentations more common</strong>: Women often present with fatigue,
                            nausea, back pain rather than classic crushing chest pain</li>
                    </ul>

                    <div class="callout warning">
                        Women, African Americans, and older adults are more likely to <strong>delay seeking
                            care</strong> during MI due to atypical symptoms or dismissal of symptoms. This delay
                        worsens outcomes. Educate patients that jaw pain, back pain, unusual fatigue, and nausea can be
                        MI symptoms.
                    </div>

                </section>

                <!-- SECTION 2: CARDIAC ASSESSMENT -->
                <section id="assessment">
                    <h2>2. Cardiac Assessment <span class="slide-ref">üìë W1 Slides 12‚Äì21</span></h2>

                    <h3>2.1 Heart Auscultation</h3>

                    <p>The five classic auscultation points correspond to where blood flow through each valve is best
                        heard‚Äînot the anatomic valve location. Blood flow carries sound downstream.</p>

                    <svg viewBox="0 0 400 350" style="max-width: 400px;">
                        <!-- Chest outline -->
                        <ellipse cx="200" cy="180" rx="150" ry="140" fill="#f7fafc" stroke="#2c5282" stroke-width="2" />
                        <!-- Sternum -->
                        <rect x="185" y="60" width="30" height="200" fill="#e2e8f0" rx="5" />
                        <!-- Ribs suggestion -->
                        <line x1="80" y1="100" x2="185" y2="90" stroke="#cbd5e0" stroke-width="2" />
                        <line x1="320" y1="100" x2="215" y2="90" stroke="#cbd5e0" stroke-width="2" />
                        <line x1="70" y1="140" x2="185" y2="125" stroke="#cbd5e0" stroke-width="2" />
                        <line x1="330" y1="140" x2="215" y2="125" stroke="#cbd5e0" stroke-width="2" />
                        <line x1="65" y1="180" x2="185" y2="160" stroke="#cbd5e0" stroke-width="2" />
                        <line x1="335" y1="180" x2="215" y2="160" stroke="#cbd5e0" stroke-width="2" />
                        <line x1="70" y1="220" x2="185" y2="195" stroke="#cbd5e0" stroke-width="2" />
                        <line x1="330" y1="220" x2="215" y2="195" stroke="#cbd5e0" stroke-width="2" />
                        <!-- Auscultation points -->
                        <circle cx="255" cy="90" r="12" fill="#c53030" />
                        <text x="275" y="95" font-size="11" fill="#1a202c" font-weight="bold">A</text>
                        <text x="275" y="108" font-size="9" fill="#666">Aortic (R 2nd ICS)</text>

                        <circle cx="145" cy="90" r="12" fill="#dd6b20" />
                        <text x="90" y="95" font-size="11" fill="#1a202c" font-weight="bold">P</text>
                        <text x="55" y="108" font-size="9" fill="#666">Pulmonic (L 2nd ICS)</text>

                        <circle cx="175" cy="130" r="12" fill="#d69e2e" />
                        <text x="100" y="135" font-size="11" fill="#1a202c" font-weight="bold">E</text>
                        <text x="55" y="148" font-size="9" fill="#666">Erb's Point (L 3rd ICS)</text>

                        <circle cx="220" cy="175" r="12" fill="#38a169" />
                        <text x="240" y="180" font-size="11" fill="#1a202c" font-weight="bold">T</text>
                        <text x="240" y="193" font-size="9" fill="#666">Tricuspid (L 4th ICS)</text>

                        <circle cx="120" cy="210" r="12" fill="#3182ce" />
                        <text x="55" y="215" font-size="11" fill="#1a202c" font-weight="bold">M</text>
                        <text x="40" y="228" font-size="9" fill="#666">Mitral (L 5th ICS, MCL)</text>
                    </svg>

                    <div class="callout memory">
                        <strong>All People Enjoy Time Magazine</strong><br>
                        <strong>A</strong>ortic ‚Üí <strong>P</strong>ulmonic ‚Üí <strong>E</strong>rb's Point ‚Üí
                        <strong>T</strong>ricuspid ‚Üí <strong>M</strong>itral
                    </div>

                    <h3>2.2 Heart Sounds <span class="slide-ref">üìë W1 Slide 19</span></h3>

                    <table>
                        <tr>
                            <th>Sound</th>
                            <th>Timing</th>
                            <th>Mechanism</th>
                            <th>Clinical Meaning</th>
                        </tr>
                        <tr>
                            <td><strong>S1</strong> ("lub")</td>
                            <td>Beginning of ventricular systole</td>
                            <td>AV valves closing (tricuspid + mitral)</td>
                            <td>Normal; marks start of systole</td>
                        </tr>
                        <tr>
                            <td><strong>S2</strong> ("dub")</td>
                            <td>Beginning of ventricular diastole</td>
                            <td>Semilunar valves closing (aortic + pulmonic)</td>
                            <td>Normal; marks start of diastole</td>
                        </tr>
                        <tr>
                            <td><strong>S3</strong></td>
                            <td>Early diastole (after S2)</td>
                            <td>Rapid ventricular filling against a volume-overloaded ventricle</td>
                            <td><span class="highlight">ALWAYS PATHOLOGIC</span> = fluid overload, HF</td>
                        </tr>
                        <tr>
                            <td><strong>S4</strong></td>
                            <td>Late diastole (before S1)</td>
                            <td>Atrial contraction against a stiff, non-compliant ventricle</td>
                            <td><span class="highlight">ALWAYS PATHOLOGIC</span> = decreased compliance (HTN, CAD,
                                hypertrophy)</td>
                        </tr>
                    </table>

                    <div class="callout memory">
                        <strong>S3 = "Ken-TUC-ky"</strong> (S1-S2-S3) ‚Äî Think <strong>fluid</strong> (HF, volume
                        overload)<br>
                        <strong>S4 = "TEN-nes-see"</strong> (S4-S1-S2) ‚Äî Think <strong>stiff</strong> (hypertensive
                        heart, ischemia)
                    </div>

                    <h3>2.3 Heart Murmurs <span class="slide-ref">üìë W1 Slide 20</span></h3>

                    <p>Murmurs are abnormal sounds caused by turbulent blood flow through valves or abnormal
                        communications. They are characterized by:</p>

                    <table>
                        <tr>
                            <th>Characteristic</th>
                            <th>Description</th>
                        </tr>
                        <tr>
                            <td><strong>Location</strong></td>
                            <td>Where loudest (intercostal space, sternal border, etc.)</td>
                        </tr>
                        <tr>
                            <td><strong>Timing</strong></td>
                            <td>Systolic vs. diastolic; early, mid, or late</td>
                        </tr>
                        <tr>
                            <td><strong>Intensity</strong></td>
                            <td>Grade 1-6 scale (see below)</td>
                        </tr>
                        <tr>
                            <td><strong>Pitch</strong></td>
                            <td>High (use diaphragm) vs. low (use bell)</td>
                        </tr>
                        <tr>
                            <td><strong>Quality</strong></td>
                            <td>Blowing, rumbling, harsh, musical</td>
                        </tr>
                        <tr>
                            <td><strong>Radiation</strong></td>
                            <td>Where sound travels (neck, axilla, back)</td>
                        </tr>
                    </table>

                    <h4>Murmur Grading Scale</h4>
                    <table>
                        <tr>
                            <th>Grade</th>
                            <th>Description</th>
                            <th>Thrill Present?</th>
                        </tr>
                        <tr>
                            <td>1</td>
                            <td>Very faint, difficult for inexperienced clinician</td>
                            <td>No</td>
                        </tr>
                        <tr>
                            <td>2</td>
                            <td>Quiet but readily heard by experienced clinician</td>
                            <td>No</td>
                        </tr>
                        <tr>
                            <td>3</td>
                            <td>Moderately loud</td>
                            <td>No</td>
                        </tr>
                        <tr>
                            <td>4</td>
                            <td>Loud</td>
                            <td>Yes</td>
                        </tr>
                        <tr>
                            <td>5</td>
                            <td>Very loud, heard with stethoscope partially off chest</td>
                            <td>Yes</td>
                        </tr>
                        <tr>
                            <td>6</td>
                            <td>Extremely loud, heard with stethoscope completely off chest</td>
                            <td>Yes</td>
                        </tr>
                    </table>

                    <h3>2.4 Orthostatic Hypotension <span class="slide-ref">üìë W1 Slide 18</span></h3>

                    <p><strong>Definition:</strong> Sustained decrease of ‚â•20 mmHg systolic OR ‚â•10 mmHg diastolic within
                        3 minutes of moving from supine/sitting to standing.</p>

                    <p><strong>Symptoms:</strong> Dizziness, lightheadedness, syncope, visual changes</p>

                    <h4>Assessment Protocol</h4>
                    <ol>
                        <li>Patient supine for 10 minutes ‚Üí measure BP and HR</li>
                        <li>Sit patient with legs dependent ‚Üí wait 2 minutes ‚Üí remeasure</li>
                        <li>If no symptoms/significant drop: stand patient ‚Üí measure immediately and every 2 minutes for
                            up to 10 minutes</li>
                        <li>If orthostatic hypotension detected or patient symptomatic: return to supine</li>
                        <li>Document all measurements with position and symptoms</li>
                    </ol>

                    <h3>2.5 Physical Assessment Findings <span class="slide-ref">üìë W1 Slides 16‚Äì18</span></h3>

                    <table>
                        <tr>
                            <th>Finding</th>
                            <th>Pathophysiology</th>
                            <th>Associated Conditions</th>
                        </tr>
                        <tr>
                            <td><strong>Clubbing</strong></td>
                            <td>Chronic hemoglobin desaturation</td>
                            <td>Congenital heart disease, advanced pulmonary disease</td>
                        </tr>
                        <tr>
                            <td><strong>Cool/cold skin + diaphoresis</strong></td>
                            <td>Low CO ‚Üí SNS activation ‚Üí vasoconstriction</td>
                            <td>Cardiogenic shock, acute MI</td>
                        </tr>
                        <tr>
                            <td><strong>Central cyanosis</strong> (tongue, buccal mucosa)</td>
                            <td>Venous blood bypasses pulmonary oxygenation</td>
                            <td>Pulmonary edema, cardiogenic shock, congenital heart disease</td>
                        </tr>
                        <tr>
                            <td><strong>Peripheral cyanosis</strong> (nails, lips, ears)</td>
                            <td>Peripheral vasoconstriction ‚Üí prolonged O2 extraction</td>
                            <td>Cold exposure, anxiety, ‚ÜìCO</td>
                        </tr>
                        <tr>
                            <td><strong>JVD</strong> (jugular venous distension)</td>
                            <td>Elevated right atrial pressure</td>
                            <td>Right-sided HF, fluid overload, cardiac tamponade</td>
                        </tr>
                        <tr>
                            <td><strong>Dependent edema</strong></td>
                            <td>Fluid accumulation in interstitial spaces</td>
                            <td>HF, venous insufficiency, DVT</td>
                        </tr>
                        <tr>
                            <td><strong>Pallor with leg elevation</strong></td>
                            <td>Inadequate arterial perfusion</td>
                            <td>Peripheral arterial disease (PAD)</td>
                        </tr>
                        <tr>
                            <td><strong>Rubor</strong> (red-blue when dependent)</td>
                            <td>Dilated capillaries fill with deoxygenated blood</td>
                            <td>PAD</td>
                        </tr>
                    </table>

                    <h4>Pulse Pressure</h4>

                    <p><strong>Pulse pressure</strong> = Systolic BP ‚àí Diastolic BP. Normal is approximately <span
                            class="key-value">40 mmHg</span> (e.g., 120/80).</p>

                    <table class="comparison-table">
                        <tr>
                            <th>Pulse Pressure</th>
                            <th>Mechanism</th>
                            <th>Causes</th>
                        </tr>
                        <tr>
                            <td><strong>Narrow</strong> (&lt;25 mmHg)</td>
                            <td>Compensatory vasoconstriction to maintain perfusion</td>
                            <td>Shock, HF, hypovolemia, cardiac tamponade</td>
                        </tr>
                        <tr>
                            <td><strong>Wide</strong> (&gt;60 mmHg)</td>
                            <td>Increased SV or vasodilation</td>
                            <td>Anxiety, bradycardia, fever, septic shock, aortic regurgitation</td>
                        </tr>
                    </table>

                </section>

                <!-- SECTION 3: ECG INTERPRETATION -->
                <section id="ecg">
                    <h2>3. ECG Interpretation <span class="slide-ref">üìë W1 Slides 22‚Äì46</span></h2>

                    <!-- ECG Waveform with Cardiac Events -->
                    <svg viewBox="0 0 700 400" style="max-width: 700px;" role="img"
                        aria-label="ECG waveform showing labeled P wave, QRS complex, and T wave with PR interval, QRS duration, and QT interval brackets, plus corresponding cardiac cycle events below">
                        <!-- Background -->
                        <rect x="0" y="0" width="700" height="400" fill="#fff" rx="8" />

                        <!-- Title -->
                        <text x="350" y="22" text-anchor="middle" font-size="15" font-weight="700" fill="#1a365d">ECG
                            Waveform ‚Äî Components &amp; Cardiac Events</text>

                        <!-- ECG Grid background (subtle pink like real ECG paper) -->
                        <rect x="50" y="35" width="600" height="200" fill="#fff5f5" stroke="#fecaca" stroke-width="1"
                            rx="4" />
                        <!-- Major grid lines -->
                        <g stroke="#fecaca" stroke-width="0.8">
                            <line x1="50" y1="85" x2="650" y2="85" />
                            <line x1="50" y1="135" x2="650" y2="135" />
                            <line x1="50" y1="185" x2="650" y2="185" />
                        </g>

                        <!-- Baseline -->
                        <line x1="50" y1="155" x2="650" y2="155" stroke="#e2e8f0" stroke-width="1"
                            stroke-dasharray="4,4" />

                        <!-- ECG WAVEFORM TRACE -->
                        <path d="M60,155
             L110,155
             C115,155 118,145 122,135 C126,125 128,120 130,120 C132,120 134,128 138,145 L142,155
             L150,155
             L160,155 L162,160 L165,155
             L168,155 L170,80 L175,60 L180,175 L185,155
             L195,155
             C200,155 210,148 220,130 C230,112 238,105 245,105 C252,105 260,112 270,130 C280,148 288,155 295,155
             L310,155
             C315,155 318,145 322,135 C326,128 330,126 332,130 C334,135 336,150 340,155
             L370,155
             L420,155
             C425,155 428,145 432,135 C436,125 438,120 440,120 C442,120 444,128 448,145 L452,155
             L460,155
             L470,155 L472,160 L475,155
             L478,155 L480,80 L485,60 L490,175 L495,155
             L505,155
             C510,155 520,148 530,130 C540,112 548,105 555,105 C562,105 570,112 580,130 C590,148 598,155 605,155
             L620,155
             C625,155 628,148 630,142 C632,138 634,136 636,140 C638,145 640,152 645,155
             L650,155" fill="none" stroke="#c53030" stroke-width="2.5" stroke-linecap="round"
                            stroke-linejoin="round" />

                        <!-- P WAVE label (first complex) -->
                        <path d="M112,108 L130,108" fill="none" stroke="#3182ce" stroke-width="1.5" />
                        <line x1="112" y1="108" x2="112" y2="113" stroke="#3182ce" stroke-width="1.5" />
                        <line x1="140" y1="108" x2="140" y2="113" stroke="#3182ce" stroke-width="1.5" />
                        <text x="126" y="103" text-anchor="middle" font-size="12" font-weight="700"
                            fill="#3182ce">P</text>

                        <!-- QRS COMPLEX label -->
                        <path d="M160,50 L188,50" fill="none" stroke="#c53030" stroke-width="1.5" />
                        <line x1="160" y1="50" x2="160" y2="55" stroke="#c53030" stroke-width="1.5" />
                        <line x1="188" y1="50" x2="188" y2="55" stroke="#c53030" stroke-width="1.5" />
                        <text x="174" y="46" text-anchor="middle" font-size="12" font-weight="700"
                            fill="#c53030">QRS</text>

                        <!-- Individual Q, R, S labels -->
                        <text x="162" y="170" font-size="9" fill="#9b2c2c" font-weight="600">Q</text>
                        <text x="174" y="55" font-size="9" fill="#9b2c2c" font-weight="600">R</text>
                        <text x="183" y="182" font-size="9" fill="#9b2c2c" font-weight="600">S</text>

                        <!-- T WAVE label -->
                        <path d="M218,95" fill="none" />
                        <text x="245" y="95" text-anchor="middle" font-size="12" font-weight="700"
                            fill="#38a169">T</text>

                        <!-- U wave (small, after T) -->
                        <text x="335" y="122" font-size="9" fill="#805ad5" font-weight="600">U</text>
                        <text x="335" y="133" font-size="8" fill="#805ad5">(if present)</text>

                        <!-- INTERVAL BRACKETS below waveform -->
                        <!-- PR Interval -->
                        <line x1="112" y1="210" x2="165" y2="210" stroke="#3182ce" stroke-width="2" />
                        <line x1="112" y1="205" x2="112" y2="215" stroke="#3182ce" stroke-width="2" />
                        <line x1="165" y1="205" x2="165" y2="215" stroke="#3182ce" stroke-width="2" />
                        <text x="138" y="225" text-anchor="middle" font-size="10" font-weight="700" fill="#3182ce">PR
                            Interval</text>
                        <text x="138" y="236" text-anchor="middle" font-size="9" fill="#3182ce">0.12 ‚Äì 0.20 sec</text>

                        <!-- QRS Duration -->
                        <line x1="165" y1="245" x2="192" y2="245" stroke="#c53030" stroke-width="2" />
                        <line x1="165" y1="240" x2="165" y2="250" stroke="#c53030" stroke-width="2" />
                        <line x1="192" y1="240" x2="192" y2="250" stroke="#c53030" stroke-width="2" />
                        <text x="178" y="260" text-anchor="middle" font-size="10" font-weight="700"
                            fill="#c53030">QRS</text>
                        <text x="178" y="271" text-anchor="middle" font-size="9" fill="#c53030">&lt; 0.12 sec</text>

                        <!-- QT Interval -->
                        <line x1="165" y1="280" x2="310" y2="280" stroke="#805ad5" stroke-width="2" />
                        <line x1="165" y1="275" x2="165" y2="285" stroke="#805ad5" stroke-width="2" />
                        <line x1="310" y1="275" x2="310" y2="285" stroke="#805ad5" stroke-width="2" />
                        <text x="237" y="295" text-anchor="middle" font-size="10" font-weight="700" fill="#805ad5">QT
                            Interval</text>
                        <text x="237" y="306" text-anchor="middle" font-size="9" fill="#805ad5">0.36 ‚Äì 0.44 sec
                            (rate-dependent)</text>

                        <!-- CARDIAC EVENTS BAR (bottom section) -->
                        <text x="350" y="330" text-anchor="middle" font-size="12" font-weight="700"
                            fill="#1a365d">Cardiac Events During ECG</text>

                        <!-- Atrial events (blue) -->
                        <rect x="105" y="340" width="60" height="24" rx="5" fill="#3182ce" />
                        <text x="135" y="356" text-anchor="middle" font-size="9" font-weight="600"
                            fill="#fff">Atrial</text>
                        <text x="135" y="367" text-anchor="middle" font-size="8" fill="#bee3f8">Depol.</text>

                        <!-- AV delay -->
                        <rect x="170" y="340" width="50" height="24" rx="5" fill="#ebf8ff" stroke="#3182ce"
                            stroke-width="1" />
                        <text x="195" y="356" text-anchor="middle" font-size="8" fill="#3182ce">AV Delay</text>

                        <!-- Ventricular events (red) -->
                        <rect x="225" y="340" width="76" height="24" rx="5" fill="#c53030" />
                        <text x="263" y="356" text-anchor="middle" font-size="9" font-weight="600"
                            fill="#fff">Ventricular</text>
                        <text x="263" y="367" text-anchor="middle" font-size="8" fill="#fed7d7">Depolarization</text>

                        <!-- Ventricular repol (green) -->
                        <rect x="305" y="340" width="80" height="24" rx="5" fill="#38a169" />
                        <text x="345" y="356" text-anchor="middle" font-size="9" font-weight="600"
                            fill="#fff">Ventricular</text>
                        <text x="345" y="367" text-anchor="middle" font-size="8" fill="#c6f6d5">Repolarization</text>

                        <!-- Diastole -->
                        <rect x="390" y="340" width="50" height="24" rx="5" fill="#f7fafc" stroke="#e2e8f0"
                            stroke-width="1" />
                        <text x="415" y="356" text-anchor="middle" font-size="8" fill="#4a5568">Diastole</text>

                        <!-- Connecting dashed lines from events to ECG -->
                        <line x1="135" y1="340" x2="130" y2="200" stroke="#3182ce" stroke-width="1"
                            stroke-dasharray="3,3" opacity="0.5" />
                        <line x1="263" y1="340" x2="175" y2="200" stroke="#c53030" stroke-width="1"
                            stroke-dasharray="3,3" opacity="0.5" />
                        <line x1="345" y1="340" x2="250" y2="200" stroke="#38a169" stroke-width="1"
                            stroke-dasharray="3,3" opacity="0.5" />

                        <!-- Legend row -->
                        <rect x="115" y="380" width="14" height="10" rx="2" fill="#3182ce" />
                        <text x="135" y="389" font-size="9" fill="#4a5568">= Atrial Events (P wave)</text>
                        <rect x="285" y="380" width="14" height="10" rx="2" fill="#c53030" />
                        <text x="305" y="389" font-size="9" fill="#4a5568">= Ventricular Depol. (QRS)</text>
                        <rect x="470" y="380" width="14" height="10" rx="2" fill="#38a169" />
                        <text x="490" y="389" font-size="9" fill="#4a5568">= Ventricular Repol. (T wave)</text>
                    </svg>

                    <h3>3.1 ECG Paper and Timing</h3>

                    <p>Understanding ECG paper measurements is fundamental to rhythm interpretation. The paper runs at a
                        standard speed of 25 mm/second.</p>

                    <table>
                        <tr>
                            <th>Measurement</th>
                            <th>Value</th>
                            <th>Clinical Use</th>
                        </tr>
                        <tr>
                            <td>1 small box (horizontal)</td>
                            <td><span class="key-value">0.04 seconds</span></td>
                            <td>Measuring intervals</td>
                        </tr>
                        <tr>
                            <td>1 large box (5 small boxes)</td>
                            <td><span class="key-value">0.20 seconds</span></td>
                            <td>Quick interval estimates</td>
                        </tr>
                        <tr>
                            <td>5 large boxes</td>
                            <td>1.0 second</td>
                            <td>Rate calculation</td>
                        </tr>
                        <tr>
                            <td>30 large boxes</td>
                            <td>6 seconds</td>
                            <td>6-second strip method</td>
                        </tr>
                        <tr>
                            <td>300 large boxes</td>
                            <td>1 minute</td>
                            <td>Rate = 300 √∑ large boxes between R waves</td>
                        </tr>
                    </table>

                    <h4>Heart Rate Calculation Methods</h4>

                    <table>
                        <tr>
                            <th>Method</th>
                            <th>Formula</th>
                            <th>Best For</th>
                        </tr>
                        <tr>
                            <td><strong>6-Second Method</strong></td>
                            <td>Count R waves in 6 seconds √ó 10</td>
                            <td>Regular AND irregular rhythms</td>
                        </tr>
                        <tr>
                            <td><strong>1500 Method</strong></td>
                            <td>1500 √∑ small boxes between R-R</td>
                            <td>Regular rhythms only (most precise)</td>
                        </tr>
                        <tr>
                            <td><strong>300 Method</strong></td>
                            <td>Find R on bold line, count: 300, 150, 100, 75, 60, 50...</td>
                            <td>Regular rhythms (quick estimate)</td>
                        </tr>
                    </table>

                    <div class="callout memory">
                        <strong>300 Method Sequence:</strong> 300 ‚Üí 150 ‚Üí 100 ‚Üí 75 ‚Üí 60 ‚Üí 50 ‚Üí 43 ‚Üí 37 ‚Üí 33<br>
                        Each number represents the rate if the next R wave falls on that large box line.
                    </div>

                    <h3>3.2 ECG Waveforms and Intervals <span class="slide-ref">üìë W1 Slides 39‚Äì46</span></h3>

                    <svg viewBox="0 0 600 280" style="max-width: 600px;">
                        <!-- Grid background -->
                        <defs>
                            <pattern id="smallGrid" width="10" height="10" patternUnits="userSpaceOnUse">
                                <path d="M 10 0 L 0 0 0 10" fill="none" stroke="#ffcccc" stroke-width="0.5" />
                            </pattern>
                            <pattern id="largeGrid" width="50" height="50" patternUnits="userSpaceOnUse">
                                <rect width="50" height="50" fill="url(#smallGrid)" />
                                <path d="M 50 0 L 0 0 0 50" fill="none" stroke="#ff9999" stroke-width="1" />
                            </pattern>
                        </defs>
                        <rect x="20" y="20" width="560" height="200" fill="url(#largeGrid)" />

                        <!-- Isoelectric line -->
                        <line x1="20" y1="120" x2="580" y2="120" stroke="#999" stroke-width="1"
                            stroke-dasharray="5,5" />

                        <!-- ECG waveform -->
                        <path d="M30,120 L60,120 Q70,120 75,100 Q80,80 90,120 L100,120 L105,190 L115,40 L125,150 L135,120
             L180,120 Q190,90 200,90 Q210,90 220,120 L260,120" stroke="#c53030" stroke-width="3" fill="none" />

                        <!-- Labels -->
                        <text x="80" y="70" font-size="14" fill="#3182ce" font-weight="bold">P</text>
                        <text x="113" y="30" font-size="14" fill="#3182ce" font-weight="bold">QRS</text>
                        <text x="195" y="80" font-size="14" fill="#3182ce" font-weight="bold">T</text>

                        <!-- Interval brackets -->
                        <!-- PR interval -->
                        <line x1="65" y1="230" x2="105" y2="230" stroke="#38a169" stroke-width="2" />
                        <line x1="65" y1="225" x2="65" y2="235" stroke="#38a169" stroke-width="2" />
                        <line x1="105" y1="225" x2="105" y2="235" stroke="#38a169" stroke-width="2" />
                        <text x="68" y="250" font-size="11" fill="#38a169" font-weight="bold">PR interval</text>
                        <text x="68" y="262" font-size="9" fill="#38a169">0.12-0.20 sec</text>

                        <!-- QRS duration -->
                        <line x1="105" y1="200" x2="135" y2="200" stroke="#805ad5" stroke-width="2" />
                        <line x1="105" y1="195" x2="105" y2="205" stroke="#805ad5" stroke-width="2" />
                        <line x1="135" y1="195" x2="135" y2="205" stroke="#805ad5" stroke-width="2" />
                        <text x="105" y="215" font-size="10" fill="#805ad5" font-weight="bold">QRS &lt;0.12 sec</text>

                        <!-- QT interval -->
                        <line x1="105" y1="170" x2="220" y2="170" stroke="#dd6b20" stroke-width="2" />
                        <line x1="105" y1="165" x2="105" y2="175" stroke="#dd6b20" stroke-width="2" />
                        <line x1="220" y1="165" x2="220" y2="175" stroke="#dd6b20" stroke-width="2" />
                        <text x="140" y="185" font-size="10" fill="#dd6b20" font-weight="bold">QT interval (0.32-0.40
                            sec)</text>

                        <!-- ST segment -->
                        <line x1="135" y1="115" x2="180" y2="115" stroke="#c53030" stroke-width="2" />
                        <text x="145" y="108" font-size="10" fill="#c53030" font-weight="bold">ST segment</text>
                    </svg>

                    <table>
                        <tr>
                            <th>Component</th>
                            <th>What It Represents</th>
                            <th>Normal Value</th>
                            <th>Abnormal Significance</th>
                        </tr>
                        <tr>
                            <td><strong>P wave</strong></td>
                            <td>Atrial depolarization</td>
                            <td>‚â§0.11 seconds</td>
                            <td>Absent in A-fib; inverted in junctional rhythms</td>
                        </tr>
                        <tr>
                            <td><strong>PR interval</strong></td>
                            <td>Time from atrial depolarization through AV node to ventricular depolarization onset</td>
                            <td><span class="key-value">0.12-0.20 seconds</span></td>
                            <td>&gt;0.20 = AV block; &lt;0.12 = accessory pathway or junctional</td>
                        </tr>
                        <tr>
                            <td><strong>QRS complex</strong></td>
                            <td>Ventricular depolarization</td>
                            <td><span class="key-value">&lt;0.12 seconds</span></td>
                            <td>‚â•0.12 = bundle branch block or ventricular origin</td>
                        </tr>
                        <tr>
                            <td><strong>ST segment</strong></td>
                            <td>Early ventricular repolarization</td>
                            <td>Isoelectric (flat)</td>
                            <td>Elevation = injury/STEMI; Depression = ischemia</td>
                        </tr>
                        <tr>
                            <td><strong>T wave</strong></td>
                            <td>Ventricular repolarization</td>
                            <td>Upright in most leads</td>
                            <td>Inversion = ischemia; Peaked = hyperkalemia</td>
                        </tr>
                        <tr>
                            <td><strong>QT interval</strong></td>
                            <td>Total ventricular depolarization + repolarization</td>
                            <td><span class="key-value">0.32-0.40 seconds</span> (varies with HR)</td>
                            <td>Prolonged = risk of Torsades de Pointes</td>
                        </tr>
                        <tr>
                            <td><strong>U wave</strong></td>
                            <td>Purkinje fiber repolarization (rare)</td>
                            <td>Usually absent</td>
                            <td>Prominent U wave = hypokalemia</td>
                        </tr>
                    </table>

                    <h3>3.3 Systematic ECG Analysis <span class="slide-ref">üìë W1 Slides 41‚Äì43</span></h3>

                    <p>Always use a systematic approach to avoid missing abnormalities:</p>

                    <ol>
                        <li><strong>Rate</strong>: Calculate ventricular rate (and atrial rate if different)</li>
                        <li><strong>Rhythm</strong>: Regular or irregular? Regularly irregular or irregularly irregular?
                        </li>
                        <li><strong>P waves</strong>: Present? One before each QRS? Consistent shape?</li>
                        <li><strong>PR interval</strong>: Normal (0.12-0.20)? Constant or varying?</li>
                        <li><strong>QRS</strong>: Width (&lt;0.12)? Consistent shape?</li>
                        <li><strong>P:QRS ratio</strong>: 1:1? More P's than QRS's?</li>
                    </ol>

                    <h3>3.4 Lead Placement <span class="slide-ref">üìë W1 Slides 22, 36‚Äì37</span></h3>

                    <div class="callout memory">
                        <strong>Limb Lead Placement:</strong><br>
                        "White on Right" (RA)<br>
                        "Smoke over Fire" (Black LA over Red LL)<br>
                        "Clouds over Grass" (White RA over Green RL)<br>
                        "Chocolate on your Heart" (Brown V1 on chest)
                    </div>

                    <p>The 12-lead ECG primarily reflects left ventricular electrical activity. Incorrect lead placement
                        produces incorrect diagnoses‚Äîalways verify leads are properly positioned.</p>

                    <h3>3.5 Electrolyte Effects on ECG <span class="slide-ref">üìë W1 Slide 38</span></h3>

                    <p>Electrolyte imbalances produce characteristic ECG changes that can be life-threatening:</p>

                    <!-- Electrolyte ECG Changes Diagram -->
                    <svg viewBox="0 0 700 280" style="max-width: 700px;">
                        <!-- Title -->
                        <text x="350" y="20" font-size="14" fill="#1a365d" text-anchor="middle"
                            font-weight="bold">Potassium Effects on ECG</text>

                        <!-- Normal K+ -->
                        <g transform="translate(30,40)">
                            <rect x="0" y="0" width="130" height="100" rx="5" fill="#d4edda" stroke="#38a169"
                                stroke-width="2" />
                            <text x="65" y="20" font-size="11" fill="#38a169" text-anchor="middle"
                                font-weight="bold">Normal K+</text>
                            <text x="65" y="35" font-size="9" fill="#666" text-anchor="middle">(3.5-5.0 mEq/L)</text>
                            <!-- Normal ECG -->
                            <path
                                d="M20,70 L40,70 Q50,55 60,70 L65,70 L68,80 L75,40 L82,85 L88,70 L100,70 Q110,55 120,70"
                                stroke="#38a169" stroke-width="2" fill="none" />
                            <text x="65" y="95" font-size="9" fill="#38a169" text-anchor="middle">Normal T wave</text>
                        </g>

                        <!-- Hypokalemia -->
                        <g transform="translate(180,40)">
                            <rect x="0" y="0" width="130" height="100" rx="5" fill="#fff3cd" stroke="#dd6b20"
                                stroke-width="2" />
                            <text x="65" y="20" font-size="11" fill="#dd6b20" text-anchor="middle"
                                font-weight="bold">HYPOkalemia</text>
                            <text x="65" y="35" font-size="9" fill="#666" text-anchor="middle">(&lt;3.5 mEq/L)</text>
                            <!-- Flat T, prominent U -->
                            <path
                                d="M20,70 L40,70 Q50,65 60,70 L65,70 L68,78 L75,45 L82,82 L88,70 L95,70 Q100,68 105,72 Q110,68 115,72"
                                stroke="#dd6b20" stroke-width="2" fill="none" />
                            <text x="105" y="62" font-size="8" fill="#dd6b20">U wave!</text>
                            <text x="65" y="95" font-size="8" fill="#dd6b20" text-anchor="middle">Flat T, prominent
                                U</text>
                        </g>

                        <!-- Mild Hyperkalemia -->
                        <g transform="translate(330,40)">
                            <rect x="0" y="0" width="130" height="100" rx="5" fill="#feebc8" stroke="#c53030"
                                stroke-width="2" />
                            <text x="65" y="20" font-size="11" fill="#c53030" text-anchor="middle"
                                font-weight="bold">HYPERkalemia</text>
                            <text x="65" y="35" font-size="9" fill="#666" text-anchor="middle">(5.5-6.5 mEq/L)</text>
                            <!-- Peaked T waves -->
                            <path
                                d="M20,70 L40,70 Q50,60 60,70 L65,70 L68,80 L75,40 L82,85 L88,70 L100,70 Q110,30 120,70"
                                stroke="#c53030" stroke-width="2" fill="none" />
                            <text x="110" y="30" font-size="8" fill="#c53030">Peaked!</text>
                            <text x="65" y="95" font-size="8" fill="#c53030" text-anchor="middle">Tall, peaked T
                                waves</text>
                        </g>

                        <!-- Severe Hyperkalemia -->
                        <g transform="translate(480,40)">
                            <rect x="0" y="0" width="180" height="100" rx="5" fill="#fed7d7" stroke="#c53030"
                                stroke-width="3" />
                            <text x="90" y="20" font-size="11" fill="#c53030" text-anchor="middle"
                                font-weight="bold">SEVERE HyperK+</text>
                            <text x="90" y="35" font-size="9" fill="#666" text-anchor="middle">(&gt;6.5 mEq/L ‚Üí
                                EMERGENCY)</text>
                            <!-- Wide QRS -->
                            <path d="M20,70 L35,70 L40,85 L60,30 L80,90 L90,70 L140,70 Q155,25 170,70" stroke="#c53030"
                                stroke-width="3" fill="none" />
                            <text x="90" y="95" font-size="8" fill="#c53030" text-anchor="middle"
                                font-weight="bold">Wide QRS ‚Üí Sine wave ‚Üí Asystole</text>
                        </g>

                        <!-- Calcium section -->
                        <text x="350" y="165" font-size="14" fill="#1a365d" text-anchor="middle"
                            font-weight="bold">Calcium Effects on QT Interval</text>

                        <!-- Hypocalcemia -->
                        <g transform="translate(130,180)">
                            <rect x="0" y="0" width="200" height="80" rx="5" fill="#ebf8ff" stroke="#3182ce"
                                stroke-width="2" />
                            <text x="100" y="20" font-size="11" fill="#3182ce" text-anchor="middle"
                                font-weight="bold">HYPOcalcemia</text>
                            <!-- Long QT -->
                            <path d="M30,50 L50,50 L53,58 L60,25 L67,62 L73,50 L130,50 Q145,35 160,50" stroke="#3182ce"
                                stroke-width="2" fill="none" />
                            <line x1="53" y1="70" x2="160" y2="70" stroke="#c53030" stroke-width="1" />
                            <text x="107" y="78" font-size="8" fill="#c53030" text-anchor="middle">PROLONGED QT ‚Üí
                                Torsades</text>
                        </g>

                        <!-- Hypercalcemia -->
                        <g transform="translate(370,180)">
                            <rect x="0" y="0" width="200" height="80" rx="5" fill="#fff5f5" stroke="#c53030"
                                stroke-width="2" />
                            <text x="100" y="20" font-size="11" fill="#c53030" text-anchor="middle"
                                font-weight="bold">HYPERcalcemia</text>
                            <!-- Short QT -->
                            <path d="M30,50 L50,50 L53,58 L60,25 L67,62 L73,50 L90,50 Q100,38 110,50" stroke="#c53030"
                                stroke-width="2" fill="none" />
                            <line x1="53" y1="70" x2="110" y2="70" stroke="#805ad5" stroke-width="1" />
                            <text x="82" y="78" font-size="8" fill="#805ad5" text-anchor="middle">SHORT QT</text>
                        </g>
                    </svg>

                    <table>
                        <tr>
                            <th>Electrolyte</th>
                            <th>ECG Changes</th>
                            <th>Lethal Risk</th>
                        </tr>
                        <tr>
                            <td><strong>Hypokalemia</strong></td>
                            <td>Prominent U wave, flattened T wave, ST depression, prolonged QT (K+ &lt;2.0)</td>
                            <td>Ventricular irritability, arrhythmias</td>
                        </tr>
                        <tr>
                            <td><strong>Hyperkalemia</strong></td>
                            <td>&gt;5.5: Tall, peaked (tented) T waves<br>&gt;6.5: Widened QRS<br>&gt;8.0: Very wide QRS
                                ‚Üí sine wave ‚Üí asystole</td>
                            <td>Asystole, cardiac arrest</td>
                        </tr>
                        <tr>
                            <td><strong>Hypocalcemia</strong></td>
                            <td>Prolonged QT, prolonged ST segment</td>
                            <td>Torsades de Pointes</td>
                        </tr>
                        <tr>
                            <td><strong>Hypercalcemia</strong></td>
                            <td>Shortened QT, shortened ST segment</td>
                            <td>Agonal rhythm, asystole</td>
                        </tr>
                        <tr>
                            <td><strong>Hypomagnesemia</strong></td>
                            <td>Prolonged QT, broad flattened T wave</td>
                            <td>Torsades de Pointes</td>
                        </tr>
                        <tr>
                            <td><strong>Hypermagnesemia</strong></td>
                            <td>Prolonged PR, QT, QRS</td>
                            <td>Agonal rhythm, asystole</td>
                        </tr>
                    </table>

                    <div class="callout warning">
                        <strong>Hyperkalemia Emergency Treatment:</strong><br>
                        <strong>Temporary fixes</strong> (shift K+ into cells):<br>
                        ‚Ä¢ Calcium gluconate (cardioprotective‚Äîgive first!)<br>
                        ‚Ä¢ IV Insulin + D50 (drives K+ intracellularly)<br>
                        ‚Ä¢ Inhaled albuterol<br>
                        ‚Ä¢ Sodium bicarbonate<br>
                        ‚Ä¢ Kayexalate (binds K+ in gut)<br><br>
                        <strong>Permanent fix:</strong> Dialysis
                    </div>

                    <div class="callout pearl">
                        When you see a new U wave on ECG, <strong>check potassium level immediately</strong>. The safest
                        potassium replacement is oral. IV potassium must be given slowly (no faster than 10-20 mEq/hour
                        peripherally) and with cardiac monitoring.
                    </div>

                </section>

                <!-- SECTION 4: CARDIAC ARRHYTHMIAS -->
                <section id="arrhythmias">
                    <h2>4. Cardiac Arrhythmias <span class="slide-ref">üìë W1 Slides 47‚Äì80</span></h2>

                    <p>Arrhythmias are disorders of impulse formation, conduction, or both. They range from benign to
                        immediately life-threatening. Understanding the origin and mechanism guides treatment.</p>

                    <!-- Arrhythmia Classification Tree -->
                    <svg viewBox="0 0 780 480" style="max-width: 780px;" role="img"
                        aria-label="Arrhythmia classification tree organized by heart rate showing bradycardia types in green and tachycardia types in orange for supraventricular and red for ventricular">
                        <!-- Title -->
                        <text x="390" y="22" text-anchor="middle" font-size="15" font-weight="700"
                            fill="#1a365d">Arrhythmia Classification Tree</text>

                        <!-- ROOT: Arrhythmias -->
                        <rect x="305" y="36" width="170" height="38" rx="10" fill="#1a365d" />
                        <text x="390" y="60" text-anchor="middle" font-size="13" font-weight="700"
                            fill="#fff">ARRHYTHMIAS</text>

                        <!-- Branch lines from root -->
                        <line x1="350" y1="74" x2="350" y2="94" stroke="#4a5568" stroke-width="2" />
                        <line x1="430" y1="74" x2="430" y2="94" stroke="#4a5568" stroke-width="2" />
                        <line x1="155" y1="94" x2="625" y2="94" stroke="#4a5568" stroke-width="2" />
                        <line x1="155" y1="94" x2="155" y2="108" stroke="#4a5568" stroke-width="2" />
                        <line x1="625" y1="94" x2="625" y2="108" stroke="#4a5568" stroke-width="2" />

                        <!-- BRADYCARDIA BRANCH (Left - Green) -->
                        <rect x="60" y="108" width="190" height="38" rx="8" fill="#38a169" />
                        <text x="155" y="127" text-anchor="middle" font-size="12" font-weight="700"
                            fill="#fff">BRADYCARDIA</text>
                        <text x="155" y="140" text-anchor="middle" font-size="10" fill="#c6f6d5">&lt; 60 bpm</text>

                        <!-- Bradycardia children vertical line -->
                        <line x1="155" y1="146" x2="155" y2="166" stroke="#38a169" stroke-width="2" />

                        <!-- Bradycardia items -->
                        <rect x="40" y="168" width="230" height="30" rx="6" fill="#f0fff4" stroke="#38a169"
                            stroke-width="1.5" />
                        <text x="155" y="188" text-anchor="middle" font-size="11" fill="#276749" font-weight="600">Sinus
                            Bradycardia</text>

                        <line x1="155" y1="198" x2="155" y2="208" stroke="#38a169" stroke-width="1.5" />
                        <rect x="40" y="208" width="230" height="30" rx="6" fill="#f0fff4" stroke="#38a169"
                            stroke-width="1.5" />
                        <text x="155" y="228" text-anchor="middle" font-size="11" fill="#276749" font-weight="600">1¬∞
                            Heart Block (prolonged PR)</text>

                        <line x1="155" y1="238" x2="155" y2="248" stroke="#38a169" stroke-width="1.5" />
                        <rect x="40" y="248" width="230" height="46" rx="6" fill="#f0fff4" stroke="#38a169"
                            stroke-width="1.5" />
                        <text x="155" y="268" text-anchor="middle" font-size="11" fill="#276749" font-weight="600">2¬∞
                            Heart Block</text>
                        <text x="155" y="284" text-anchor="middle" font-size="10" fill="#4a5568">Type I (Wenckebach) |
                            Type II (Mobitz)</text>

                        <line x1="155" y1="294" x2="155" y2="304" stroke="#38a169" stroke-width="1.5" />
                        <rect x="40" y="304" width="230" height="30" rx="6" fill="#c6f6d5" stroke="#38a169"
                            stroke-width="2" />
                        <text x="155" y="324" text-anchor="middle" font-size="11" fill="#276749" font-weight="700">3¬∞
                            Heart Block (Complete)</text>

                        <line x1="155" y1="334" x2="155" y2="344" stroke="#38a169" stroke-width="1.5" />
                        <rect x="40" y="344" width="230" height="30" rx="6" fill="#f0fff4" stroke="#38a169"
                            stroke-width="1.5" />
                        <text x="155" y="364" text-anchor="middle" font-size="11" fill="#276749"
                            font-weight="600">Junctional Rhythms (40-60)</text>

                        <!-- Bradycardia treatment note -->
                        <rect x="40" y="388" width="230" height="30" rx="6" fill="#38a169" opacity="0.12" />
                        <text x="155" y="407" text-anchor="middle" font-size="10" fill="#276749" font-weight="600">Tx:
                            Atropine ‚Üí Pacing</text>

                        <!-- TACHYCARDIA BRANCH (Right - splits into SVT and VT) -->
                        <rect x="530" y="108" width="190" height="38" rx="8" fill="#dd6b20" />
                        <text x="625" y="127" text-anchor="middle" font-size="12" font-weight="700"
                            fill="#fff">TACHYCARDIA</text>
                        <text x="625" y="140" text-anchor="middle" font-size="10" fill="#fefcbf">&gt; 100 bpm</text>

                        <!-- Tachycardia branch splits into SVT and VT -->
                        <line x1="625" y1="146" x2="625" y2="164" stroke="#dd6b20" stroke-width="2" />
                        <line x1="490" y1="164" x2="755" y2="164" stroke="#dd6b20" stroke-width="2" />
                        <line x1="490" y1="164" x2="490" y2="178" stroke="#dd6b20" stroke-width="2" />
                        <line x1="755" y1="164" x2="755" y2="178" stroke="#dd6b20" stroke-width="2" />

                        <!-- SVT Branch (Center-Right - Orange) -->
                        <rect x="380" y="178" width="220" height="38" rx="8" fill="#dd6b20" opacity="0.85" />
                        <text x="490" y="196" text-anchor="middle" font-size="11" font-weight="700"
                            fill="#fff">SUPRAVENTRICULAR</text>
                        <text x="490" y="210" text-anchor="middle" font-size="10" fill="#fefcbf">Narrow QRS (&lt;
                            0.12s)</text>

                        <!-- SVT children -->
                        <line x1="490" y1="216" x2="490" y2="232" stroke="#dd6b20" stroke-width="1.5" />

                        <rect x="375" y="232" width="230" height="28" rx="6" fill="#fffbeb" stroke="#dd6b20"
                            stroke-width="1.5" />
                        <text x="490" y="250" text-anchor="middle" font-size="10" fill="#92400e" font-weight="600">Sinus
                            Tachycardia</text>

                        <line x1="490" y1="260" x2="490" y2="268" stroke="#dd6b20" stroke-width="1.5" />
                        <rect x="375" y="268" width="230" height="28" rx="6" fill="#fffbeb" stroke="#dd6b20"
                            stroke-width="1.5" />
                        <text x="490" y="286" text-anchor="middle" font-size="10" fill="#92400e"
                            font-weight="600">Atrial Fibrillation (irregularly irregular)</text>

                        <line x1="490" y1="296" x2="490" y2="304" stroke="#dd6b20" stroke-width="1.5" />
                        <rect x="375" y="304" width="230" height="28" rx="6" fill="#fffbeb" stroke="#dd6b20"
                            stroke-width="1.5" />
                        <text x="490" y="322" text-anchor="middle" font-size="10" fill="#92400e"
                            font-weight="600">Atrial Flutter (sawtooth pattern)</text>

                        <line x1="490" y1="332" x2="490" y2="340" stroke="#dd6b20" stroke-width="1.5" />
                        <rect x="375" y="340" width="230" height="28" rx="6" fill="#fffbeb" stroke="#dd6b20"
                            stroke-width="1.5" />
                        <text x="490" y="358" text-anchor="middle" font-size="10" fill="#92400e" font-weight="600">SVT /
                            PSVT (sudden onset/offset)</text>

                        <!-- SVT treatment note -->
                        <rect x="375" y="380" width="230" height="30" rx="6" fill="#dd6b20" opacity="0.1" />
                        <text x="490" y="399" text-anchor="middle" font-size="10" fill="#92400e" font-weight="600">Tx:
                            Vagal ‚Üí Adenosine ‚Üí Cardioversion</text>

                        <!-- VT Branch (Far Right - Red) -->
                        <rect x="635" y="178" width="140" height="38" rx="8" fill="#c53030" />
                        <text x="705" y="196" text-anchor="middle" font-size="11" font-weight="700"
                            fill="#fff">VENTRICULAR</text>
                        <text x="705" y="210" text-anchor="middle" font-size="10" fill="#fed7d7">Wide QRS (‚â•
                            0.12s)</text>

                        <!-- VT children -->
                        <line x1="705" y1="216" x2="705" y2="232" stroke="#c53030" stroke-width="1.5" />

                        <rect x="630" y="232" width="150" height="38" rx="6" fill="#fff5f5" stroke="#c53030"
                            stroke-width="1.5" />
                        <text x="705" y="250" text-anchor="middle" font-size="10" fill="#9b2c2c"
                            font-weight="600">V-Tach (VT)</text>
                        <text x="705" y="263" text-anchor="middle" font-size="9" fill="#4a5568">Pulsed ‚Üí
                            Amiodarone</text>

                        <line x1="705" y1="270" x2="705" y2="280" stroke="#c53030" stroke-width="1.5" />
                        <rect x="630" y="280" width="150" height="38" rx="6" fill="#fed7d7" stroke="#c53030"
                            stroke-width="2" />
                        <text x="705" y="298" text-anchor="middle" font-size="10" fill="#9b2c2c" font-weight="700">V-Fib
                            (VF)</text>
                        <text x="705" y="311" text-anchor="middle" font-size="9" fill="#4a5568">No pulse ‚Üí Defib
                            NOW</text>

                        <!-- VT treatment note -->
                        <rect x="630" y="332" width="150" height="30" rx="6" fill="#c53030" opacity="0.12" />
                        <text x="705" y="351" text-anchor="middle" font-size="10" fill="#9b2c2c" font-weight="600">Tx:
                            Defib ‚Üí CPR ‚Üí ACLS</text>

                        <!-- Legend -->
                        <rect x="280" y="440" width="220" height="32" rx="6" fill="#f7fafc" stroke="#e2e8f0"
                            stroke-width="1" />
                        <circle cx="310" cy="456" r="7" fill="#38a169" /><text x="325" y="460" font-size="9"
                            fill="#4a5568">Bradycardia</text>
                        <circle cx="400" cy="456" r="7" fill="#dd6b20" /><text x="415" y="460" font-size="9"
                            fill="#4a5568">SVT</text>
                        <circle cx="460" cy="456" r="7" fill="#c53030" /><text x="475" y="460" font-size="9"
                            fill="#4a5568">VT</text>
                    </svg>

                    <h3>4.1 Sinus Rhythms</h3>

                    <h4>Normal Sinus Rhythm (NSR)</h4>

                    <!-- NSR Rhythm Strip -->
                    <svg viewBox="0 0 600 120" style="max-width: 600px;">
                        <rect x="0" y="0" width="600" height="120" fill="#fff5f5" />
                        <!-- Grid lines -->
                        <g stroke="#ffcccc" stroke-width="0.5">
                            <line x1="0" y1="20" x2="600" y2="20" />
                            <line x1="0" y1="40" x2="600" y2="40" />
                            <line x1="0" y1="60" x2="600" y2="60" />
                            <line x1="0" y1="80" x2="600" y2="80" />
                            <line x1="0" y1="100" x2="600" y2="100" />
                        </g>
                        <!-- Baseline -->
                        <line x1="0" y1="70" x2="600" y2="70" stroke="#ff9999" stroke-width="1" />

                        <!-- NSR complexes -->
                        <g stroke="#c53030" stroke-width="2" fill="none">
                            <!-- Complex 1 -->
                            <path d="M30,70 L40,70 Q50,70 55,55 Q60,40 70,70" />
                            <path d="M75,70 L80,90 L90,20 L100,80 L105,70" />
                            <path d="M115,70 Q130,50 145,70" />
                            <!-- Complex 2 -->
                            <path d="M170,70 L180,70 Q190,70 195,55 Q200,40 210,70" />
                            <path d="M215,70 L220,90 L230,20 L240,80 L245,70" />
                            <path d="M255,70 Q270,50 285,70" />
                            <!-- Complex 3 -->
                            <path d="M310,70 L320,70 Q330,70 335,55 Q340,40 350,70" />
                            <path d="M355,70 L360,90 L370,20 L380,80 L385,70" />
                            <path d="M395,70 Q410,50 425,70" />
                            <!-- Complex 4 -->
                            <path d="M450,70 L460,70 Q470,70 475,55 Q480,40 490,70" />
                            <path d="M495,70 L500,90 L510,20 L520,80 L525,70" />
                            <path d="M535,70 Q550,50 565,70" />
                        </g>

                        <!-- Labels -->
                        <text x="55" y="35" font-size="9" fill="#3182ce">P</text>
                        <text x="90" y="15" font-size="9" fill="#3182ce">QRS</text>
                        <text x="130" y="45" font-size="9" fill="#3182ce">T</text>
                        <text x="300" y="110" font-size="11" fill="#1a365d" text-anchor="middle"
                            font-weight="bold">Normal Sinus Rhythm - Regular, P before each QRS, 1:1 ratio</text>
                    </svg>

                    <table>
                        <tr>
                            <th>Characteristic</th>
                            <th>Value</th>
                        </tr>
                        <tr>
                            <td>Rate</td>
                            <td>60-100 bpm</td>
                        </tr>
                        <tr>
                            <td>Rhythm</td>
                            <td>Regular</td>
                        </tr>
                        <tr>
                            <td>P waves</td>
                            <td>Present, consistent shape, one before each QRS</td>
                        </tr>
                        <tr>
                            <td>PR interval</td>
                            <td>0.12-0.20 seconds, constant</td>
                        </tr>
                        <tr>
                            <td>QRS</td>
                            <td>&lt;0.12 seconds</td>
                        </tr>
                        <tr>
                            <td>P:QRS</td>
                            <td>1:1</td>
                        </tr>
                    </table>

                    <div class="callout pearl">
                        An elevated resting heart rate (even within "normal" range) correlates with increased
                        cardiovascular risk. A resting HR increase of 10+ bpm increases risk for sudden cardiac death,
                        A-fib, CAD, and stroke.
                    </div>

                    <h4>Sinus Bradycardia</h4>
                    <p><strong>Rate:</strong> &lt;60 bpm with otherwise normal sinus characteristics</p>

                    <p><strong>Causes:</strong> Sleep, athletic training, hypothyroidism, vagal stimulation (vomiting,
                        suctioning, bearing down), severe pain, increased ICP, medications (beta-blockers, CCBs,
                        digoxin, antiarrhythmics)</p>

                    <p><strong>Treatment (if symptomatic):</strong></p>
                    <ul>
                        <li><strong>Unstable</strong> (hypotension, AMS, shock, ischemic chest pain): Atropine 0.5 mg IV
                            every 3-5 minutes, max 3 mg</li>
                        <li><strong>Persistent despite atropine:</strong> Transcutaneous pacing, dopamine or epinephrine
                            infusion</li>
                    </ul>

                    <h4>Sinus Tachycardia</h4>
                    <p><strong>Rate:</strong> &gt;100 bpm (usually &lt;120) with normal sinus characteristics (P may be
                        buried in preceding T wave)</p>

                    <p><strong>Causes:</strong> Physiologic/psychological stress, acute blood loss, shock,
                        hypo/hypervolemia, HF, fever, pain, exercise, caffeine, nicotine, amphetamines, cocaine</p>

                    <p><strong>Treatment:</strong> Identify and treat the underlying cause (sinus tachycardia is a
                        symptom, not a primary arrhythmia)</p>
                    <ul>
                        <li>Address the trigger: fever, pain, hypovolemia, anxiety, etc.</li>
                        <li>If diagnosis is uncertain (may be SVT rather than sinus tach): vagal maneuvers or adenosine
                            can help differentiate</li>
                        <li>IV beta-blockers or CCBs only when the underlying cause has been addressed and rate control
                            is still needed</li>
                    </ul>

                    <h3>4.2 Atrial Arrhythmias</h3>

                    <h4>Premature Atrial Complex (PAC)</h4>
                    <p>An early P wave that appears before the next expected sinus impulse. The early P wave may have a
                        different shape than sinus P waves.</p>

                    <p><strong>Causes:</strong> Caffeine, alcohol, nicotine, anxiety, hypokalemia, often seen with
                        tachycardia</p>

                    <p><strong>Patient may report:</strong> "My heart skipped a beat"</p>

                    <p><strong>Treatment:</strong> Treat underlying cause. If &gt;6/minute, may indicate worsening state
                        or impending A-fib.</p>

                    <h4>Atrial Fibrillation (A-fib) <span class="slide-ref">üìë W1 Slides 53‚Äì57</span></h4>

                    <p>The most common sustained arrhythmia, affecting 2.7-6.1 million Americans.</p>

                    <p><strong>Pathophysiology:</strong> Abnormal impulse formation creates rapid, disorganized,
                        uncoordinated atrial activity (300-600 bpm atrial rate). The AV node filters these impulses,
                        producing an irregular ventricular response (120-200 bpm untreated).</p>

                    <!-- A-fib Rhythm Strip -->
                    <svg viewBox="0 0 600 120" style="max-width: 600px;">
                        <rect x="0" y="0" width="600" height="120" fill="#fff5f5" />
                        <!-- Grid lines -->
                        <g stroke="#ffcccc" stroke-width="0.5">
                            <line x1="0" y1="20" x2="600" y2="20" />
                            <line x1="0" y1="40" x2="600" y2="40" />
                            <line x1="0" y1="60" x2="600" y2="60" />
                            <line x1="0" y1="80" x2="600" y2="80" />
                            <line x1="0" y1="100" x2="600" y2="100" />
                        </g>

                        <!-- Fibrillatory baseline (chaotic) -->
                        <path
                            d="M0,70 Q10,65 15,72 Q20,68 25,71 Q30,67 35,73 Q40,69 50,71 Q55,66 60,72 Q65,68 70,71 Q75,67 80,73 Q85,69 90,71 Q95,66 100,72 Q105,68 110,71 Q115,67 120,73 Q125,69 130,71 Q135,66 140,72 Q145,68 150,71 Q155,67 160,73 Q165,69 170,71 Q175,66 180,72 Q185,68 190,71 Q195,67 200,73 Q205,69 210,71 Q215,66 220,72 Q225,68 230,71 Q235,67 240,73 Q245,69 250,71 Q255,66 260,72 Q265,68 270,71 Q275,67 280,73 Q285,69 290,71 Q295,66 300,72 Q305,68 310,71 Q315,67 320,73 Q325,69 330,71 Q335,66 340,72 Q345,68 350,71 Q355,67 360,73 Q365,69 370,71 Q375,66 380,72 Q385,68 390,71 Q395,67 400,73 Q405,69 410,71 Q415,66 420,72 Q425,68 430,71 Q435,67 440,73 Q445,69 450,71 Q455,66 460,72 Q465,68 470,71 Q475,67 480,73 Q485,69 490,71 Q495,66 500,72 Q505,68 510,71 Q515,67 520,73 Q525,69 530,71 Q535,66 540,72 Q545,68 550,71 Q555,67 560,73 Q565,69 570,71 Q575,66 580,72 Q585,68 590,71 Q595,67 600,73"
                            stroke="#c53030" stroke-width="1" fill="none" />

                        <!-- Irregular QRS complexes (no P waves) -->
                        <g stroke="#c53030" stroke-width="2" fill="none">
                            <path d="M35,70 L40,85 L50,25 L60,78 L65,70" />
                            <path d="M115,70 L120,85 L130,25 L140,78 L145,70" />
                            <path d="M165,70 L170,85 L180,25 L190,78 L195,70" />
                            <path d="M260,70 L265,85 L275,25 L285,78 L290,70" />
                            <path d="M330,70 L335,85 L345,25 L355,78 L360,70" />
                            <path d="M420,70 L425,85 L435,25 L445,78 L450,70" />
                            <path d="M490,70 L495,85 L505,25 L515,78 L520,70" />
                            <path d="M560,70 L565,85 L575,25 L585,78 L590,70" />
                        </g>

                        <!-- Labels -->
                        <text x="300" y="110" font-size="11" fill="#1a365d" text-anchor="middle"
                            font-weight="bold">Atrial Fibrillation - IRREGULARLY IRREGULAR, No P waves, Fibrillatory (f)
                            waves</text>
                    </svg>

                    <table>
                        <tr>
                            <th>ECG Feature</th>
                            <th>Finding</th>
                        </tr>
                        <tr>
                            <td>Atrial rate</td>
                            <td>300-600 bpm</td>
                        </tr>
                        <tr>
                            <td>Ventricular rate</td>
                            <td>120-200 bpm (uncontrolled)</td>
                        </tr>
                        <tr>
                            <td>Rhythm</td>
                            <td><strong>Irregularly irregular</strong></td>
                        </tr>
                        <tr>
                            <td>P waves</td>
                            <td>Absent; fibrillatory (f) waves instead</td>
                        </tr>
                        <tr>
                            <td>PR interval</td>
                            <td>Cannot be measured</td>
                        </tr>
                        <tr>
                            <td>P:QRS</td>
                            <td>Many:1</td>
                        </tr>
                    </table>

                    <p><strong>Hemodynamic Consequences:</strong></p>
                    <ul>
                        <li>Loss of atrial kick (25-30% of CO)</li>
                        <li>Rapid rate reduces ventricular filling time ‚Üí smaller SV</li>
                        <li>Blood stasis in fibrillating atria ‚Üí thrombus formation ‚Üí stroke risk</li>
                    </ul>

                    <p><strong>A-fib Classifications:</strong></p>
                    <table>
                        <tr>
                            <th>Type</th>
                            <th>Duration</th>
                            <th>Characteristics</th>
                        </tr>
                        <tr>
                            <td>Paroxysmal</td>
                            <td>&lt;7 days</td>
                            <td>Sudden onset, terminates spontaneously or with intervention</td>
                        </tr>
                        <tr>
                            <td>Persistent</td>
                            <td>&gt;7 days</td>
                            <td>Continuous, doesn't self-terminate</td>
                        </tr>
                        <tr>
                            <td>Long-standing persistent</td>
                            <td>&gt;12 months</td>
                            <td>Continuous for extended period</td>
                        </tr>
                        <tr>
                            <td>Permanent</td>
                            <td>N/A</td>
                            <td>Decision made not to restore/maintain sinus rhythm</td>
                        </tr>
                    </table>

                    <div class="callout warning">
                        <strong>A-fib Stroke Prevention is Priority #1</strong><br>
                        ‚Ä¢ Anticoagulation is the cornerstone of A-fib management<br>
                        ‚Ä¢ A-fib &gt;48 hours requires anticoagulation BEFORE rhythm restoration<br>
                        ‚Ä¢ Patients with valvular disease + A-fib or mechanical heart valves should be on warfarin<br>
                        ‚Ä¢ DOACs (rivaroxaban, apixaban, etc.) used for nonvalvular A-fib
                    </div>

                    <p><strong>A-fib Treatment Goals:</strong></p>

                    <table class="comparison-table">
                        <tr>
                            <th>Strategy</th>
                            <th>Goal</th>
                            <th>Medications</th>
                        </tr>
                        <tr>
                            <td><strong>Rate Control</strong></td>
                            <td>HR ‚â§80 bpm</td>
                            <td>Beta-blockers (metoprolol, atenolol)<br>CCBs (diltiazem, verapamil)</td>
                        </tr>
                        <tr>
                            <td><strong>Rhythm Control</strong></td>
                            <td>Restore/maintain sinus rhythm</td>
                            <td>Flecainide, amiodarone<br>Cardioversion</td>
                        </tr>
                        <tr>
                            <td><strong>Anticoagulation</strong></td>
                            <td>Prevent thromboembolism</td>
                            <td>Warfarin, DOACs</td>
                        </tr>
                    </table>

                    <h4>Atrial Flutter</h4>
                    <p>An organized reentrant circuit in the atrium producing a characteristic pattern.</p>

                    <table>
                        <tr>
                            <th>Feature</th>
                            <th>Finding</th>
                        </tr>
                        <tr>
                            <td>Atrial rate</td>
                            <td>250-400 bpm</td>
                        </tr>
                        <tr>
                            <td>Ventricular rate</td>
                            <td>75-150 bpm (AV node creates "therapeutic block")</td>
                        </tr>
                        <tr>
                            <td>P waves</td>
                            <td><strong>Saw-toothed F waves</strong></td>
                        </tr>
                        <tr>
                            <td>P:QRS ratio</td>
                            <td>2:1, 3:1, or 4:1</td>
                        </tr>
                    </table>

                    <p><strong>Treatment:</strong> Vagal maneuvers, adenosine (diagnostically), rate/rhythm control,
                        anticoagulation, cardioversion</p>

                    <h4>Junctional Rhythm</h4>
                    <p>When the AV node becomes the pacemaker (SA node failure or block).</p>

                    <table>
                        <tr>
                            <th>Feature</th>
                            <th>Finding</th>
                        </tr>
                        <tr>
                            <td>Rate</td>
                            <td>40-60 bpm (junctional tachycardia: 70-120 bpm)</td>
                        </tr>
                        <tr>
                            <td>P wave</td>
                            <td>Absent, inverted before QRS, or after QRS</td>
                        </tr>
                        <tr>
                            <td>PR interval</td>
                            <td>&lt;0.12 seconds (if P before QRS)</td>
                        </tr>
                    </table>

                    <p><strong>Causes:</strong> Digoxin toxicity, acute MI, ischemia, hypokalemia, COPD</p>

                    <h3>4.3 Ventricular Arrhythmias</h3>

                    <h4>Premature Ventricular Complex (PVC)</h4>
                    <p>An impulse originating in the ventricle before the next normal sinus beat. The wide, bizarre QRS
                        (&ge;0.12 seconds) reflects abnormal ventricular depolarization.</p>

                    <p><strong>Causes:</strong> Caffeine, nicotine, alcohol, cardiac ischemia/infarction, digitalis
                        toxicity, acidosis, hypokalemia</p>

                    <p><strong>Patterns:</strong></p>
                    <ul>
                        <li><strong>Bigeminy:</strong> Every other beat is a PVC</li>
                        <li><strong>Trigeminy:</strong> Every 3rd beat is a PVC</li>
                        <li><strong>Quadrigeminy:</strong> Every 4th beat is a PVC</li>
                        <li><strong>Couplet:</strong> Two PVCs in a row</li>
                        <li><strong>Monomorphic (unifocal):</strong> All PVCs look the same (one irritable focus)</li>
                        <li><strong>Polymorphic (multifocal):</strong> PVCs have different shapes (multiple foci‚Äîmore
                            concerning)</li>
                    </ul>

                    <h4>Ventricular Tachycardia (V-Tach) <span class="slide-ref">üìë W1 Slides 58‚Äì62</span></h4>

                    <div class="callout warning">
                        <strong>V-TACH IS A MEDICAL EMERGENCY</strong><br>
                        Three or more PVCs in a row at rate &gt;100 bpm = Ventricular Tachycardia
                    </div>

                    <!-- V-Tach Rhythm Strip -->
                    <svg viewBox="0 0 600 120" style="max-width: 600px;">
                        <rect x="0" y="0" width="600" height="120" fill="#fff5f5" />
                        <!-- Grid lines -->
                        <g stroke="#ffcccc" stroke-width="0.5">
                            <line x1="0" y1="20" x2="600" y2="20" />
                            <line x1="0" y1="40" x2="600" y2="40" />
                            <line x1="0" y1="60" x2="600" y2="60" />
                            <line x1="0" y1="80" x2="600" y2="80" />
                            <line x1="0" y1="100" x2="600" y2="100" />
                        </g>

                        <!-- V-Tach: Wide, bizarre QRS, regular, rapid -->
                        <g stroke="#c53030" stroke-width="2.5" fill="none">
                            <path d="M10,60 L20,100 L40,15 L60,95 L70,60" />
                            <path d="M80,60 L90,100 L110,15 L130,95 L140,60" />
                            <path d="M150,60 L160,100 L180,15 L200,95 L210,60" />
                            <path d="M220,60 L230,100 L250,15 L270,95 L280,60" />
                            <path d="M290,60 L300,100 L320,15 L340,95 L350,60" />
                            <path d="M360,60 L370,100 L390,15 L410,95 L420,60" />
                            <path d="M430,60 L440,100 L460,15 L480,95 L490,60" />
                            <path d="M500,60 L510,100 L530,15 L550,95 L560,60" />
                            <path d="M570,60 L580,100 L600,40" />
                        </g>

                        <!-- Labels -->
                        <text x="300" y="110" font-size="11" fill="#c53030" text-anchor="middle"
                            font-weight="bold">Ventricular Tachycardia - Wide QRS (‚â•0.12s), Regular, 100-200 bpm, No P
                            waves</text>
                    </svg>

                    <table>
                        <tr>
                            <th>Feature</th>
                            <th>Finding</th>
                        </tr>
                        <tr>
                            <td>Rate</td>
                            <td>100-200 bpm</td>
                        </tr>
                        <tr>
                            <td>Rhythm</td>
                            <td>Usually regular</td>
                        </tr>
                        <tr>
                            <td>QRS</td>
                            <td>&ge;0.12 seconds, bizarre/abnormal shape</td>
                        </tr>
                        <tr>
                            <td>P waves</td>
                            <td>Usually not visible (may see AV dissociation)</td>
                        </tr>
                    </table>

                    <p><strong>Risk factors:</strong> Low EF, large MI, hypokalemia, hypomagnesemia, CHF, valvular
                        disease, hypoxemia</p>

                    <p><strong>Treatment:</strong></p>
                    <ul>
                        <li><strong>Monomorphic VT with pulse:</strong> Synchronized cardioversion</li>
                        <li><strong>Pulseless VT:</strong> CPR, defibrillation, ACLS algorithm</li>
                        <li><strong>Recurrent VT with EF &lt;35%:</strong> ICD placement</li>
                    </ul>

                    <h4>Torsades de Pointes</h4>
                    <p>A polymorphic VT with a characteristic "twisting of peaks" pattern. QRS complexes appear to twist
                        around the isoelectric line.</p>

                    <p><strong>Preceded by:</strong> Prolonged QT interval</p>

                    <p><strong>Causes:</strong></p>
                    <ul>
                        <li><strong>Medications:</strong> IV Haloperidol, fluoroquinolones (Cipro), azithromycin,
                            lithium, methadone</li>
                        <li><strong>Electrolytes:</strong> Hypokalemia, hypocalcemia, hypomagnesemia</li>
                        <li>Congenital long QT syndrome</li>
                    </ul>

                    <p><strong>Treatment:</strong></p>
                    <ul>
                        <li><strong>IVPB Magnesium Sulfate</strong> (even if Mg level normal)</li>
                        <li>Correct underlying electrolyte abnormality</li>
                        <li>If pulseless: CPR, defibrillation, Mag sulfate</li>
                    </ul>

                    <h4>Ventricular Fibrillation (V-Fib)</h4>

                    <div class="callout warning">
                        <strong>V-FIB = DEATH IS IMMINENT</strong><br>
                        No organized cardiac activity. Rapid, chaotic quivering. No cardiac output.<br>
                        <strong>Treatment: IMMEDIATE DEFIBRILLATION</strong>
                    </div>

                    <!-- V-Fib Rhythm Strip -->
                    <svg viewBox="0 0 600 120" style="max-width: 600px;">
                        <rect x="0" y="0" width="600" height="120" fill="#fff5f5" />
                        <!-- Grid lines -->
                        <g stroke="#ffcccc" stroke-width="0.5">
                            <line x1="0" y1="20" x2="600" y2="20" />
                            <line x1="0" y1="40" x2="600" y2="40" />
                            <line x1="0" y1="60" x2="600" y2="60" />
                            <line x1="0" y1="80" x2="600" y2="80" />
                            <line x1="0" y1="100" x2="600" y2="100" />
                        </g>

                        <!-- V-Fib: Chaotic, no recognizable pattern -->
                        <path
                            d="M0,60 Q10,20 20,80 Q30,30 40,90 Q50,40 60,70 Q70,100 80,30 Q90,85 100,25 Q110,75 120,45 Q130,95 140,35 Q150,80 160,20 Q170,70 180,50 Q190,100 200,40 Q210,85 220,30 Q230,70 240,55 Q250,90 260,25 Q270,75 280,35 Q290,95 300,45 Q310,80 320,20 Q330,65 340,55 Q350,100 360,30 Q370,75 380,40 Q390,90 400,25 Q410,70 420,50 Q430,95 440,35 Q450,80 460,20 Q470,65 480,55 Q490,100 500,30 Q510,75 520,40 Q530,90 540,25 Q550,70 560,50 Q570,95 580,35 Q590,80 600,45"
                            stroke="#c53030" stroke-width="2" fill="none" />

                        <!-- Labels -->
                        <text x="300" y="110" font-size="11" fill="#c53030" text-anchor="middle"
                            font-weight="bold">Ventricular Fibrillation - Chaotic, No recognizable QRS, PULSELESS</text>
                    </svg>

                    <table>
                        <tr>
                            <th>Feature</th>
                            <th>Finding</th>
                        </tr>
                        <tr>
                            <td>Rate</td>
                            <td>&gt;300 bpm (chaotic)</td>
                        </tr>
                        <tr>
                            <td>Rhythm</td>
                            <td>Grossly irregular</td>
                        </tr>
                        <tr>
                            <td>QRS</td>
                            <td>No recognizable QRS complexes</td>
                        </tr>
                        <tr>
                            <td>Clinical status</td>
                            <td>Pulseless, unconscious</td>
                        </tr>
                    </table>

                    <p>V-fib is the most common arrhythmia in cardiac arrest. Early defibrillation is the definitive
                        treatment‚Äî<strong>every minute of delay decreases survival by 7-10%</strong>.</p>

                    <h4>Idioventricular / Accelerated Idioventricular Rhythm (AIVR)</h4>

                    <p>A ventricular escape rhythm that occurs when higher pacemakers (SA node, AV node) fail or are
                        suppressed. Often seen as a <strong>reperfusion arrhythmia</strong> after successful
                        thrombolytic therapy or PCI ‚Äî actually considered a <strong>good sign</strong> that blood flow
                        has been restored.</p>

                    <table>
                        <tr>
                            <th>Feature</th>
                            <th>Finding</th>
                        </tr>
                        <tr>
                            <td>Rate</td>
                            <td><strong>Idioventricular:</strong> 20-40 bpm<br><strong>Accelerated (AIVR):</strong>
                                40-100 bpm</td>
                        </tr>
                        <tr>
                            <td>Rhythm</td>
                            <td>Usually regular</td>
                        </tr>
                        <tr>
                            <td>QRS</td>
                            <td>Wide (&ge;0.12 seconds) ‚Äî ventricular origin</td>
                        </tr>
                        <tr>
                            <td>P waves</td>
                            <td>Usually absent or dissociated</td>
                        </tr>
                    </table>

                    <p><strong>Treatment:</strong> Usually self-limiting and benign ‚Äî <strong>observe, do NOT suppress
                            with antiarrhythmics</strong> (it may be the patient's only rhythm). Treat only if
                        hemodynamically unstable. Atropine may help by speeding sinus rate to override the ventricular
                        focus.</p>

                    <div class="callout pearl">
                        Post-reperfusion AIVR is a <strong>marker of successful treatment</strong>, not a complication.
                        Do not treat a stable AIVR ‚Äî suppressing it could unmask an even slower or absent underlying
                        rhythm.
                    </div>

                    <h4>Asystole</h4>
                    <p>"Flatline"‚Äîabsence of any electrical activity. Confirm in two different leads to rule out lead
                        disconnection.</p>

                    <p><strong>Treatment:</strong> High-quality CPR, epinephrine, address reversible causes (H's and
                        T's). Defibrillation is NOT indicated for asystole.</p>

                    <h3>4.4 Conduction Blocks</h3>

                    <h4>First-Degree AV Block</h4>
                    <p>All impulses conduct, but slower than normal through the AV node.</p>

                    <!-- 1st Degree AV Block -->
                    <svg viewBox="0 0 600 100" style="max-width: 600px;">
                        <rect x="0" y="0" width="600" height="100" fill="#ebf8ff" />
                        <line x1="0" y1="55" x2="600" y2="55" stroke="#bdd6ee" stroke-width="1" />

                        <g stroke="#3182ce" stroke-width="2" fill="none">
                            <!-- Complex with LONG PR interval -->
                            <path d="M30,55 Q40,40 50,55" /><!-- P wave -->
                            <path d="M90,55 L95,65 L105,20 L115,70 L120,55" /><!-- QRS (delayed) -->
                            <path d="M135,55 Q150,40 165,55" /><!-- T wave -->

                            <path d="M200,55 Q210,40 220,55" />
                            <path d="M260,55 L265,65 L275,20 L285,70 L290,55" />
                            <path d="M305,55 Q320,40 335,55" />

                            <path d="M370,55 Q380,40 390,55" />
                            <path d="M430,55 L435,65 L445,20 L455,70 L460,55" />
                            <path d="M475,55 Q490,40 505,55" />
                        </g>

                        <!-- PR interval bracket -->
                        <line x1="40" y1="75" x2="95" y2="75" stroke="#c53030" stroke-width="2" />
                        <text x="67" y="90" font-size="10" fill="#c53030" text-anchor="middle" font-weight="bold">PR
                            &gt;0.20s</text>

                        <text x="300" y="15" font-size="11" fill="#1a365d" text-anchor="middle" font-weight="bold">1st
                            Degree AV Block - Prolonged but CONSTANT PR interval, 1:1 ratio</text>
                    </svg>

                    <table>
                        <tr>
                            <th>Feature</th>
                            <th>Finding</th>
                        </tr>
                        <tr>
                            <td>PR interval</td>
                            <td><strong>&gt;0.20 seconds</strong> but constant</td>
                        </tr>
                        <tr>
                            <td>P:QRS</td>
                            <td>1:1</td>
                        </tr>
                        <tr>
                            <td>QRS</td>
                            <td>Usually normal</td>
                        </tr>
                    </table>

                    <p><strong>Causes:</strong> Beta-blockers, CCBs, digoxin, inferior MI, aging</p>
                    <p><strong>Treatment:</strong> Usually observation; review medications</p>

                    <h4>Second-Degree AV Block Type I (Wenckebach/Mobitz I)</h4>
                    <p>Progressive PR prolongation until a beat is dropped, then the cycle repeats.</p>

                    <table>
                        <tr>
                            <th>Feature</th>
                            <th>Finding</th>
                        </tr>
                        <tr>
                            <td>PR interval</td>
                            <td>Gets progressively longer until dropped QRS</td>
                        </tr>
                        <tr>
                            <td>Pattern</td>
                            <td>Repeating cycle</td>
                        </tr>
                        <tr>
                            <td>P:QRS</td>
                            <td>3:2, 4:3, 5:4, etc.</td>
                        </tr>
                        <tr>
                            <td>QRS</td>
                            <td>Usually normal</td>
                        </tr>
                    </table>

                    <p><strong>Treatment:</strong> Usually benign; address underlying cause</p>

                    <h4>Second-Degree AV Block Type II (Mobitz II)</h4>
                    <p>Some impulses conduct, some don't‚Äîwithout progressive PR lengthening. More dangerous than Type I.
                    </p>

                    <table>
                        <tr>
                            <th>Feature</th>
                            <th>Finding</th>
                        </tr>
                        <tr>
                            <td>PR interval</td>
                            <td><strong>Constant</strong> for conducted beats</td>
                        </tr>
                        <tr>
                            <td>Dropped beats</td>
                            <td>Sudden, without warning</td>
                        </tr>
                        <tr>
                            <td>P:QRS</td>
                            <td>2:1, 3:1, 4:1, etc.</td>
                        </tr>
                        <tr>
                            <td>QRS</td>
                            <td>Usually <strong>wide/abnormal</strong></td>
                        </tr>
                    </table>

                    <div class="callout warning">
                        Mobitz II can suddenly progress to complete heart block. These patients often need pacemakers.
                    </div>

                    <h4>Third-Degree AV Block (Complete Heart Block) <span class="slide-ref">üìë W1 Slides 75‚Äì78</span>
                    </h4>
                    <p>NO atrial impulses conduct through the AV node. Atria and ventricles beat independently (AV
                        dissociation).</p>

                    <!-- 3rd Degree Heart Block -->
                    <svg viewBox="0 0 600 120" style="max-width: 600px;">
                        <rect x="0" y="0" width="600" height="120" fill="#fff5f5" />
                        <line x1="0" y1="60" x2="600" y2="60" stroke="#ffcccc" stroke-width="1" />

                        <!-- P waves (regular, marching through) -->
                        <g stroke="#3182ce" stroke-width="2" fill="none">
                            <path d="M20,60 Q30,45 40,60" />
                            <path d="M80,60 Q90,45 100,60" />
                            <path d="M140,60 Q150,45 160,60" />
                            <path d="M200,60 Q210,45 220,60" />
                            <path d="M260,60 Q270,45 280,60" />
                            <path d="M320,60 Q330,45 340,60" />
                            <path d="M380,60 Q390,45 400,60" />
                            <path d="M440,60 Q450,45 460,60" />
                            <path d="M500,60 Q510,45 520,60" />
                            <path d="M560,60 Q570,45 580,60" />
                        </g>
                        <text x="30" y="35" font-size="9" fill="#3182ce">P waves "march through" at regular rate</text>

                        <!-- QRS complexes (wide, slow, no relation to P waves) -->
                        <g stroke="#c53030" stroke-width="2.5" fill="none">
                            <path d="M55,60 L60,80 L75,20 L90,85 L100,60" />
                            <path d="M175,60 L180,80 L195,20 L210,85 L220,60" />
                            <path d="M295,60 L300,80 L315,20 L330,85 L340,60" />
                            <path d="M415,60 L420,80 L435,20 L450,85 L460,60" />
                            <path d="M535,60 L540,80 L555,20 L570,85 L580,60" />
                        </g>
                        <text x="300" y="100" font-size="9" fill="#c53030">Wide QRS at SLOW escape rate (20-60
                            bpm)</text>

                        <text x="300" y="115" font-size="11" fill="#1a365d" text-anchor="middle" font-weight="bold">3rd
                            Degree (Complete) Heart Block - NO relationship between P and QRS (AV Dissociation)</text>
                    </svg>

                    <table>
                        <tr>
                            <th>Feature</th>
                            <th>Finding</th>
                        </tr>
                        <tr>
                            <td>P waves</td>
                            <td>Present, regular, "marching through"</td>
                        </tr>
                        <tr>
                            <td>QRS</td>
                            <td>Present but at escape rate, no relationship to P waves</td>
                        </tr>
                        <tr>
                            <td>PR interval</td>
                            <td>Completely variable (no relationship)</td>
                        </tr>
                        <tr>
                            <td>Rate</td>
                            <td>Ventricular rate 20-60 bpm depending on escape pacemaker</td>
                        </tr>
                    </table>

                    <p><strong>Causes:</strong> MI, degenerative conduction disease, digoxin toxicity, acidosis,
                        post-cardiac surgery</p>

                    <p><strong>Treatment:</strong></p>
                    <ul>
                        <li>IV atropine (temporary measure)</li>
                        <li>Transcutaneous pacing if unresponsive to atropine</li>
                        <li>Permanent pacemaker usually required</li>
                        <li>If pulseless: treat as asystole</li>
                    </ul>

                    <h3>4.5 H's and T's: Reversible Causes <span class="slide-ref">üìë W2 Slides 52‚Äì54</span></h3>

                    <p>During cardiac arrest, always consider and treat reversible causes:</p>

                    <table>
                        <tr>
                            <th>H's</th>
                            <th>T's</th>
                        </tr>
                        <tr>
                            <td><strong>H</strong>ypovolemia</td>
                            <td><strong>T</strong>ension pneumothorax</td>
                        </tr>
                        <tr>
                            <td><strong>H</strong>ypoxia</td>
                            <td><strong>T</strong>amponade (cardiac)</td>
                        </tr>
                        <tr>
                            <td><strong>H</strong>ydrogen ion (acidosis)</td>
                            <td><strong>T</strong>oxins</td>
                        </tr>
                        <tr>
                            <td><strong>H</strong>ypo/hyperkalemia</td>
                            <td><strong>T</strong>hrombosis (pulmonary PE)</td>
                        </tr>
                        <tr>
                            <td><strong>H</strong>ypo/hyperglycemia</td>
                            <td><strong>T</strong>hrombosis (coronary MI)</td>
                        </tr>
                        <tr>
                            <td><strong>H</strong>ypothermia</td>
                            <td></td>
                        </tr>
                    </table>

                </section>

                <!-- SECTION 5: CARDIAC DEVICES -->
                <section id="devices">
                    <h2>5. Cardiac Devices & Interventions <span class="slide-ref">üìë W1 Slides 82‚Äì98</span></h2>

                    <h3>5.1 Cardioversion vs. Defibrillation <span class="slide-ref">üìë W1 Slides 82‚Äì84</span></h3>

                    <p>Both deliver electrical current to depolarize a critical mass of myocardial cells, allowing the
                        SA node to recapture pacemaker function. The key difference is timing:</p>

                    <table class="comparison-table">
                        <tr>
                            <th>Feature</th>
                            <th>Cardioversion</th>
                            <th>Defibrillation</th>
                        </tr>
                        <tr>
                            <td><strong>Timing</strong></td>
                            <td>SYNCHRONIZED with R wave</td>
                            <td>UNSYNCHRONIZED (immediate)</td>
                        </tr>
                        <tr>
                            <td><strong>SYNC mode</strong></td>
                            <td>ON</td>
                            <td>OFF</td>
                        </tr>
                        <tr>
                            <td><strong>Indications</strong></td>
                            <td>Organized tachyarrhythmias with pulse (A-fib, flutter, stable VT)</td>
                            <td>V-fib, pulseless VT</td>
                        </tr>
                        <tr>
                            <td><strong>Setting</strong></td>
                            <td>Elective or urgent</td>
                            <td>Emergency only</td>
                        </tr>
                        <tr>
                            <td><strong>Patient status</strong></td>
                            <td>Has pulse, may be conscious (sedation given)</td>
                            <td>Pulseless, unconscious</td>
                        </tr>
                    </table>

                    <div class="callout warning">
                        <strong>Why SYNC mode matters:</strong> Shocking during the relative refractory period (T wave)
                        can induce V-fib. SYNC mode ensures the shock is delivered during the absolute refractory period
                        (R wave), avoiding this danger.
                    </div>

                    <h4>Safety Protocol for Cardioversion/Defibrillation</h4>
                    <ol>
                        <li>Ensure good skin contact with pads/paddles</li>
                        <li>Remove pads/paddles from medication patches and ensure no contact with oxygen source</li>
                        <li>For women with large breasts: place left pad lateral to or under left breast</li>
                        <li>Apply 20-25 lb pressure when using paddles</li>
                        <li>Do NOT charge until ready to shock</li>
                        <li><strong>Call "CLEAR" THREE times</strong> with visual checks:
                            <ul>
                                <li>First: Check YOU are clear</li>
                                <li>Second: Check team members are clear</li>
                                <li>Third: Final visual sweep‚Äîeveryone clear</li>
                            </ul>
                        </li>
                        <li>Deliver shock, record energy level and resulting rhythm</li>
                        <li><strong>Resume CPR immediately after shock</strong> (start with compressions)</li>
                        <li>After 5 cycles (~2 minutes), recheck rhythm</li>
                        <li>Post-event: inspect skin for burns, restock supplies</li>
                    </ol>

                    <h4>Elective Cardioversion Preparation</h4>
                    <ul>
                        <li>If arrhythmia &gt;48 hours: may need anticoagulation for weeks before procedure</li>
                        <li>Moderate sedation and analgesia</li>
                        <li>Digoxin may be held 48 hours prior</li>
                        <li>NPO 4 hours before</li>
                        <li>O2 and suction at bedside; intubation tray available</li>
                        <li>Use SYNC mode</li>
                    </ul>

                    <h3>5.2 Pacemakers <span class="slide-ref">üìë W1 Slides 85‚Äì93</span></h3>

                    <p>Electronic devices that provide electrical stimulation to the heart when intrinsic conduction is
                        inadequate.</p>

                    <h4>Indications</h4>
                    <ul>
                        <li>Symptomatic bradycardia (dizziness, SOB, fatigue, syncope)</li>
                        <li>Heart blocks (especially Mobitz II, complete heart block)</li>
                        <li>Sick sinus syndrome</li>
                    </ul>

                    <h4>Types</h4>
                    <table>
                        <tr>
                            <th>Type</th>
                            <th>Duration</th>
                            <th>Notes</th>
                        </tr>
                        <tr>
                            <td><strong>Temporary (transcutaneous)</strong></td>
                            <td>Emergency/short-term</td>
                            <td>External pads; uncomfortable‚Äîuse only for emergencies</td>
                        </tr>
                        <tr>
                            <td><strong>Temporary (transvenous)</strong></td>
                            <td>Days to weeks</td>
                            <td>Wire threaded through vein to heart</td>
                        </tr>
                        <tr>
                            <td><strong>Permanent</strong></td>
                            <td>5-15 years (lithium battery)</td>
                            <td>Generator implanted subcutaneously; leads to heart</td>
                        </tr>
                    </table>

                    <h4>NASPE-BPEG Pacemaker Code</h4>
                    <p>The first three letters describe pacemaker function:</p>

                    <table>
                        <tr>
                            <th>Position</th>
                            <th>Meaning</th>
                            <th>Options</th>
                        </tr>
                        <tr>
                            <td><strong>1st Letter</strong></td>
                            <td>Chamber PACED</td>
                            <td>A=Atrium, V=Ventricle, D=Dual (both)</td>
                        </tr>
                        <tr>
                            <td><strong>2nd Letter</strong></td>
                            <td>Chamber SENSED</td>
                            <td>A, V, D, O=Off</td>
                        </tr>
                        <tr>
                            <td><strong>3rd Letter</strong></td>
                            <td>RESPONSE to sensing</td>
                            <td>I=Inhibited, T=Triggered, D=Dual, O=None</td>
                        </tr>
                    </table>

                    <p><strong>Example - VVI:</strong> Paces ventricle, senses ventricle, inhibited by sensed
                        ventricular activity. Most common single-chamber pacemaker. Can cause loss of AV synchrony (no
                        atrial kick).</p>

                    <p><strong>DDD:</strong> Paces both chambers, senses both, dual response. Maintains AV
                        synchrony‚Äîpreferred for most patients.</p>

                    <h4>Pacemaker Complications</h4>
                    <table>
                        <tr>
                            <th>Complication</th>
                            <th>Signs/Symptoms</th>
                        </tr>
                        <tr>
                            <td>Local infection</td>
                            <td>Redness, swelling, warmth, drainage at site</td>
                        </tr>
                        <tr>
                            <td>Pneumothorax/hemothorax</td>
                            <td>SOB, decreased breath sounds, chest pain</td>
                        </tr>
                        <tr>
                            <td>Lead dislodgement/perforation</td>
                            <td>Loss of capture, pericardial effusion</td>
                        </tr>
                        <tr>
                            <td>Phrenic nerve stimulation</td>
                            <td>Hiccupping with each paced beat</td>
                        </tr>
                        <tr>
                            <td>Cardiac tamponade</td>
                            <td>Hypotension, JVD, muffled heart sounds</td>
                        </tr>
                        <tr>
                            <td>Twiddler syndrome</td>
                            <td>Patient manipulates generator ‚Üí lead dislodgement</td>
                        </tr>
                        <tr>
                            <td>Pacemaker syndrome</td>
                            <td>Fatigue, dyspnea, hypotension from loss of AV synchrony</td>
                        </tr>
                    </table>

                    <h4>Pacemaker Troubleshooting</h4>
                    <table>
                        <tr>
                            <th>Problem</th>
                            <th>ECG Finding</th>
                            <th>Causes</th>
                        </tr>
                        <tr>
                            <td><strong>Failure to capture</strong></td>
                            <td>Spike present but no complex follows</td>
                            <td>Lead dislodgement, battery depletion, inadequate output</td>
                        </tr>
                        <tr>
                            <td><strong>Failure to sense (undersensing)</strong></td>
                            <td>Pacing spikes despite adequate intrinsic rhythm</td>
                            <td>Sensitivity set too low (threshold too high in mV), lead displacement</td>
                        </tr>
                        <tr>
                            <td><strong>Oversensing</strong></td>
                            <td>No pacing when intrinsic rhythm is inadequate</td>
                            <td>Sensitivity set too high (threshold too low in mV ‚Äî detects noise), interference</td>
                        </tr>
                        <tr>
                            <td><strong>Failure to pace</strong></td>
                            <td>No spikes when expected</td>
                            <td>Battery depletion, loose connections, lead fracture</td>
                        </tr>
                    </table>

                    <h4>Pacemaker Patient Education <span class="slide-ref">üìë W1 Slides 90‚Äì93</span></h4>

                    <p><strong>EMI (Electromagnetic Interference) Precautions:</strong></p>
                    <ul>
                        <li><strong>MRI:</strong> All patients with implantable cardiac devices must be <strong>screened
                                for MRI safety</strong> ‚Äî many older devices are NOT MRI-compatible</li>
                        <li><strong>Cell phones:</strong> Hold on opposite side of pacemaker; do not place in breast
                            pocket over device</li>
                        <li><strong>Airport security:</strong> Carry pacemaker ID card; request hand screening if
                            concerned (walk-through metal detectors generally OK; avoid prolonged exposure to hand-held
                            wands over the device)</li>
                        <li><strong>Avoid:</strong> Large magnets, arc welding, standing near anti-theft devices for
                            prolonged periods, electric blankets directly over generator</li>
                        <li>Household appliances (microwave, TV, radio) are safe at normal distance</li>
                    </ul>

                    <p><strong>Patient Teaching:</strong></p>
                    <ul>
                        <li><strong>Carry pacemaker identification card</strong> at all times (includes device type,
                            settings, manufacturer)</li>
                        <li><strong>Wear medical alert bracelet/necklace</strong></li>
                        <li><strong>Check pulse daily</strong> for 1 full minute ‚Äî report rate below programmed minimum
                        </li>
                        <li>Report signs of infection at generator site: redness, swelling, warmth, drainage, fever</li>
                        <li>Report: dizziness, syncope, prolonged hiccupping (phrenic nerve stimulation), chest pain,
                            SOB</li>
                        <li>Follow up for device checks (interrogation) as scheduled</li>
                        <li>Avoid contact sports or trauma to the generator site</li>
                        <li><strong>Do NOT manipulate the generator</strong> under the skin (Twiddler syndrome ‚Üí lead
                            dislodgement)</li>
                        <li>Battery life approximately <strong>5-15 years</strong>; declining battery detected during
                            device checks</li>
                    </ul>

                    <h3>5.3 Implantable Cardioverter Defibrillator (ICD) <span class="slide-ref">üìë W1 Slides
                            94‚Äì98</span></h3>

                    <p>ICDs detect and terminate life-threatening tachyarrhythmias through anti-tachycardia pacing or
                        internal shocks.</p>

                    <p><strong>Indications:</strong></p>
                    <ul>
                        <li>Survived V-fib or sustained VT</li>
                        <li>EF &lt;35% with history of MI or cardiomyopathy</li>
                        <li>High risk for sudden cardiac death</li>
                    </ul>

                    <p><strong>Functions:</strong></p>
                    <ul>
                        <li>Continuous rhythm monitoring</li>
                        <li>Anti-tachycardia pacing (may terminate VT without shock)</li>
                        <li>Low-energy cardioversion</li>
                        <li>High-energy defibrillation</li>
                        <li>Bradycardia pacing backup</li>
                    </ul>

                    <p><strong>Battery life:</strong> ~9 years</p>

                    <p><strong>Wearable ICD vest:</strong> May be used while awaiting permanent ICD placement; worn at
                        all times, battery changed daily</p>

                    <div class="callout pearl">
                        Patients with ICDs may still take antiarrhythmic medications to reduce the frequency of ICD
                        discharges. An ICD shock is uncomfortable‚Äîpatients describe it as "being kicked in the chest."
                    </div>

                </section>

                <!-- SECTION 6: CORONARY ARTERY DISEASE -->
                <section id="cad">
                    <h2>6. Coronary Artery Disease <span class="slide-ref">üìë W1 Slides 99‚Äì117</span></h2>

                    <h3>6.1 Atherosclerosis Pathophysiology</h3>

                    <p>Atherosclerosis is the abnormal accumulation of lipids, fibrous tissue, calcium, and cellular
                        debris within arterial walls. This process begins with endothelial injury and progresses over
                        decades.</p>

                    <svg viewBox="0 0 600 200" style="max-width: 600px;">
                        <!-- Normal artery -->
                        <g transform="translate(50,20)">
                            <text x="50" y="0" font-size="12" font-weight="bold" text-anchor="middle">Normal</text>
                            <ellipse cx="50" cy="90" rx="40" ry="60" fill="#fff" stroke="#c53030" stroke-width="3" />
                            <ellipse cx="50" cy="90" rx="30" ry="45" fill="#c53030" opacity="0.3" />
                        </g>
                        <!-- Early plaque -->
                        <g transform="translate(180,20)">
                            <text x="50" y="0" font-size="12" font-weight="bold" text-anchor="middle">Early
                                Plaque</text>
                            <ellipse cx="50" cy="90" rx="40" ry="60" fill="#fff" stroke="#c53030" stroke-width="3" />
                            <path d="M20,90 Q30,70 50,75 Q70,70 80,90 Q70,110 50,105 Q30,110 20,90" fill="#fbd38d" />
                            <ellipse cx="50" cy="90" rx="22" ry="35" fill="#c53030" opacity="0.3" />
                        </g>
                        <!-- Significant stenosis -->
                        <g transform="translate(310,20)">
                            <text x="50" y="0" font-size="12" font-weight="bold" text-anchor="middle">Stenosis</text>
                            <ellipse cx="50" cy="90" rx="40" ry="60" fill="#fff" stroke="#c53030" stroke-width="3" />
                            <path d="M15,90 Q30,50 50,55 Q70,50 85,90 Q70,130 50,125 Q30,130 15,90" fill="#fbd38d" />
                            <ellipse cx="50" cy="90" rx="12" ry="20" fill="#c53030" opacity="0.3" />
                        </g>
                        <!-- Rupture/thrombus -->
                        <g transform="translate(440,20)">
                            <text x="50" y="0" font-size="12" font-weight="bold" text-anchor="middle">Rupture +
                                Thrombus</text>
                            <ellipse cx="50" cy="90" rx="40" ry="60" fill="#fff" stroke="#c53030" stroke-width="3" />
                            <path d="M15,90 Q30,50 50,55 Q70,50 85,90 Q70,130 50,125 Q30,130 15,90" fill="#fbd38d" />
                            <ellipse cx="50" cy="90" rx="8" ry="12" fill="#742a2a" />
                            <circle cx="55" cy="85" r="6" fill="#c53030" />
                            <text x="50" y="170" font-size="10" fill="#c53030" text-anchor="middle">‚Üí MI</text>
                        </g>
                    </svg>

                    <p><strong>Progression:</strong></p>
                    <ol>
                        <li>Endothelial injury (from HTN, smoking, hyperlipidemia)</li>
                        <li>Lipid infiltration and inflammation</li>
                        <li>Atheroma (plaque) formation</li>
                        <li>Plaque growth narrows lumen ‚Üí reduced blood flow</li>
                        <li>Unstable plaque (thin cap, inflammation) may rupture</li>
                        <li>Rupture attracts platelets ‚Üí thrombus formation</li>
                        <li>Thrombus occludes vessel ‚Üí ischemia ‚Üí necrosis (MI)</li>
                        <li>Necrotic tissue replaced by scar ‚Üí cardiac dysfunction ‚Üí HF</li>
                    </ol>

                    <p><strong>CAD is the leading cause of death in the US</strong> across all racial/ethnic groups and
                        the most prevalent cardiovascular disease in adults.</p>

                    <h3>6.2 CAD Risk Factors <span class="slide-ref">üìë W1 Slides 100‚Äì103</span></h3>

                    <table>
                        <tr>
                            <th>Non-Modifiable</th>
                            <th>Modifiable (Major 4)</th>
                            <th>Contributing Factors</th>
                        </tr>
                        <tr>
                            <td>Family history<br>Age (&gt;45 men, &gt;55 women)<br>Gender<br>Race</td>
                            <td><strong>Hyperlipidemia</strong><br><strong>Tobacco
                                    use</strong><br><strong>Hypertension</strong><br><strong>Diabetes</strong></td>
                            <td>Obesity<br>Sedentary lifestyle<br>Stress<br>Metabolic syndrome</td>
                        </tr>
                    </table>

                    <h4>Metabolic Syndrome (3 or more criteria)</h4>
                    <ul>
                        <li>Enlarged waist circumference (&gt;40" men, &gt;35" women)</li>
                        <li>Elevated triglycerides (&ge;150 mg/dL)</li>
                        <li>Low HDL (&lt;40 mg/dL men, &lt;50 mg/dL women)</li>
                        <li>Elevated BP (&gt;130/80 mmHg)</li>
                        <li>Elevated fasting glucose (&gt;100 mg/dL on two occasions)</li>
                    </ul>

                    <h4>Highest Risk Populations</h4>
                    <ul>
                        <li>Known CAD</li>
                        <li>Diabetes mellitus</li>
                        <li>Peripheral arterial disease</li>
                        <li>Abdominal aortic aneurysm</li>
                        <li>Carotid artery disease</li>
                    </ul>

                    <h3>6.3 CAD Prevention <span class="slide-ref">üìë W1 Slides 104‚Äì107</span></h3>

                    <h4>Target Lipid Values</h4>
                    <table>
                        <tr>
                            <th>Lipid</th>
                            <th>Target</th>
                        </tr>
                        <tr>
                            <td>Total cholesterol</td>
                            <td>&lt;200 mg/dL</td>
                        </tr>
                        <tr>
                            <td>LDL ("bad")</td>
                            <td>&lt;100 mg/dL (or &lt;70 for high risk)</td>
                        </tr>
                        <tr>
                            <td>HDL ("good")</td>
                            <td>&gt;40 mg/dL (men), &gt;50 mg/dL (women)</td>
                        </tr>
                        <tr>
                            <td>Triglycerides</td>
                            <td>&lt;150 mg/dL</td>
                        </tr>
                    </table>

                    <h4>Physical Activity Recommendations</h4>
                    <ul>
                        <li>150 minutes/week moderate OR 75 minutes/week vigorous</li>
                        <li>Muscle-strengthening 2+ days/week</li>
                        <li>Should be able to talk during exercise (talk test)</li>
                        <li>Stop if: unexpected SOB, chest pain, dizziness, lightheadedness, nausea</li>
                    </ul>

                    <h4>Tobacco Effects on Cardiovascular System</h4>
                    <ul>
                        <li>‚ÜëCatecholamines ‚Üí ‚ÜëHR and BP</li>
                        <li>Arterial constriction</li>
                        <li>‚ÜëLDL, damages vascular endothelium</li>
                        <li>‚ÜëPlatelet aggregation and thrombus formation</li>
                        <li>‚ÜìBlood supply to heart</li>
                        <li>Smoke inhalation: ‚ÜëCO2, ‚ÜìO2 to myocardium</li>
                        <li>Secondhand smoke: ‚ÜëCAD risk 25-30%, ‚Üëstroke risk 20-30%</li>
                    </ul>

                    <h3>6.4 Angina Pectoris <span class="slide-ref">üìë W1 Slides 108‚Äì113</span></h3>

                    <p>Angina is chest pain or discomfort from myocardial ischemia‚Äîinsufficient coronary blood flow to
                        meet oxygen demand. It is the most common clinical manifestation of CAD.</p>

                    <h4>Precipitating Factors</h4>
                    <ul>
                        <li><strong>Physical exertion</strong> (‚ÜëO2 demand)</li>
                        <li><strong>Cold exposure</strong> (vasoconstriction)</li>
                        <li><strong>Heavy meals</strong> (blood flow diverted to GI tract)</li>
                        <li><strong>Emotional stress</strong> (‚ÜëBP and HR)</li>
                    </ul>

                    <h4>Types of Angina</h4>
                    <table>
                        <tr>
                            <th>Type</th>
                            <th>Characteristics</th>
                            <th>Relieved by Rest/NTG?</th>
                        </tr>
                        <tr>
                            <td><strong>Stable angina</strong></td>
                            <td>Predictable, consistent pattern with exertion</td>
                            <td>Yes</td>
                        </tr>
                        <tr>
                            <td><strong>Unstable angina</strong></td>
                            <td>‚ÜëFrequency/severity; occurs at rest; preinfarction</td>
                            <td><span class="highlight">NO</span> ‚Üí Medical emergency</td>
                        </tr>
                        <tr>
                            <td><strong>Variant (Prinzmetal's)</strong></td>
                            <td>Occurs at rest; coronary artery spasm; ST elevation</td>
                            <td>With spasm relief</td>
                        </tr>
                        <tr>
                            <td><strong>Silent ischemia</strong></td>
                            <td>ECG changes present but no reported pain</td>
                            <td>N/A</td>
                        </tr>
                    </table>

                    <h4>Angina Assessment</h4>
                    <p><strong>Classic presentation:</strong> Tightness, pressure, heaviness, or choking sensation.
                        Frequently retrosternal, may radiate to neck, jaw, shoulders, back, or arms (usually left inner
                        arm).</p>

                    <p><strong>Associated symptoms:</strong> Dyspnea, dizziness, pallor, diaphoresis, N/V, anxiety,
                        feeling of impending doom</p>

                    <div class="callout pearl">
                        <strong>Gerontologic consideration:</strong> Older adults may have diminished pain perception
                        and present with dyspnea or "silent" CAD rather than classic chest pain. Teach older adults to
                        recognize "chest pain-like" symptoms such as unusual fatigue or weakness.
                    </div>

                    <h3>6.5 Nitroglycerin <span class="slide-ref">üìë W1 Slides 114‚Äì117</span></h3>

                    <p>Nitroglycerin is a potent vasodilator used for angina relief and prevention.</p>

                    <p><strong>Mechanism:</strong></p>
                    <ul>
                        <li>Dilates veins (primarily) and arteries</li>
                        <li>Venous pooling ‚Üí ‚Üìpreload ‚Üí ‚Üìcardiac workload</li>
                        <li>Also reduces afterload</li>
                        <li>Dilates coronary arteries ‚Üí improves blood flow to heart</li>
                    </ul>

                    <p><strong>Forms:</strong> Sublingual tablets, spray, topical patches, IV</p>

                    <h4>Patient Teaching: NTG Self-Administration</h4>
                    <ul>
                        <li>Ensure mouth is moist; keep tongue still; don't swallow until tablet dissolves</li>
                        <li>For severe pain: crush tablet between teeth for faster absorption</li>
                        <li><strong>Carry medication at ALL times</strong></li>
                        <li>Keep in original container (capped dark glass bottle)</li>
                        <li>Never store in metal or plastic pillboxes (inactivates medication)</li>
                        <li>NTG is volatile‚Äîinactivated by heat, moisture, air, light, time</li>
                        <li>Renew supply every 6 months</li>
                        <li>Take prophylactically before angina-producing activity (exercise, stairs, sexual
                            intercourse)</li>
                        <li><strong>Sit down when taking</strong> to prevent hypotension and syncope</li>
                    </ul>

                    <div class="callout warning">
                        <strong>NTG Protocol for Chest Pain:</strong><br>
                        1. Take one sublingual tablet or spray<br>
                        2. Wait 5 minutes<br>
                        3. If pain persists, take second dose<br>
                        4. Wait 5 minutes<br>
                        5. If pain persists, take third dose<br>
                        6. <strong>If pain persists after 3 doses at 5-minute intervals ‚Üí CALL 911</strong>
                    </div>

                    <p><strong>Side effects:</strong> Flushing, throbbing headache (most common), hypotension,
                        tachycardia</p>

                    <h4>Priority Nursing Interventions for Angina</h4>
                    <ol>
                        <li>Stop all activity; position patient sitting or in semi-Fowler's</li>
                        <li>Assess VS, respiratory status, pain (use scale); obtain/assess ECG</li>
                        <li>Administer NTG as ordered; reassess after each dose; up to 3 doses</li>
                        <li>Administer O2 2 L/min via nasal cannula</li>
                        <li>Stay calm; reduce anxiety</li>
                    </ol>

                </section>

                <!-- SECTION 7: ACUTE CORONARY SYNDROME -->
                <section id="acs">
                    <h2>7. Acute Coronary Syndrome (ACS) <span class="slide-ref">üìë W1 Slides 118‚Äì135</span></h2>

                    <p>ACS is an umbrella term for emergent conditions caused by acute myocardial ischemia. Without
                        prompt intervention, ischemia progresses to infarction (tissue death).</p>

                    <div class="formula-box" style="background: linear-gradient(135deg, #c53030, #9b2c2c);">
                        TIME IS MUSCLE
                        <small>Every minute of delay = more myocardial death</small>
                    </div>

                    <h3>7.1 ACS Spectrum</h3>

                    <table>
                        <tr>
                            <th>Condition</th>
                            <th>ECG Changes</th>
                            <th>Cardiac Biomarkers</th>
                            <th>Pathology</th>
                        </tr>
                        <tr>
                            <td><strong>Unstable Angina</strong></td>
                            <td>May have ST depression or T-wave changes</td>
                            <td>Normal (no necrosis)</td>
                            <td>Severe ischemia, no cell death yet</td>
                        </tr>
                        <tr>
                            <td><strong>NSTEMI</strong></td>
                            <td>ST depression and/or T-wave inversion; NO ST elevation</td>
                            <td><span class="highlight">Elevated troponin</span></td>
                            <td>Partial-thickness infarction (subendocardial)</td>
                        </tr>
                        <tr>
                            <td><strong>STEMI</strong></td>
                            <td><span class="highlight">ST elevation</span> in ‚â•2 contiguous leads</td>
                            <td>Elevated troponin and CK-MB</td>
                            <td>Full-thickness infarction (transmural)</td>
                        </tr>
                    </table>

                    <h4>ECG Lead Territories ‚Äî Where Is the MI?</h4>

                    <p>STEMI requires ST elevation in <strong>&ge;2 contiguous leads</strong>. The leads that show
                        changes tell you <em>which wall</em> of the heart is infarcting and <em>which coronary
                            artery</em> is occluded:</p>

                    <table>
                        <tr>
                            <th>Leads with ST Elevation</th>
                            <th>Wall Affected</th>
                            <th>Coronary Artery</th>
                            <th>Anticipate</th>
                        </tr>
                        <tr>
                            <td><strong>II, III, aVF</strong></td>
                            <td>Inferior</td>
                            <td>Right Coronary Artery (RCA)</td>
                            <td>Bradycardia, heart blocks (AV node supplied by RCA); check right-sided leads for RV
                                involvement</td>
                        </tr>
                        <tr>
                            <td><strong>V1-V4</strong></td>
                            <td>Anterior</td>
                            <td>Left Anterior Descending (LAD)</td>
                            <td>Large area at risk ‚Äî "widow maker"; HF, cardiogenic shock, bundle branch blocks</td>
                        </tr>
                        <tr>
                            <td><strong>I, aVL, V5-V6</strong></td>
                            <td>Lateral</td>
                            <td>Left Circumflex (LCx)</td>
                            <td>May extend to posterior wall</td>
                        </tr>
                        <tr>
                            <td><strong>V1-V2</strong> (tall R waves, ST depression ‚Äî <em>reciprocal</em>)</td>
                            <td>Posterior</td>
                            <td>RCA or LCx</td>
                            <td>Mirror image; confirm with posterior leads (V7-V9)</td>
                        </tr>
                    </table>

                    <div class="callout pearl">
                        The chain: <strong>occluded artery &rarr; affected wall &rarr; lead changes &rarr; expected
                            complications</strong>. An inferior MI (RCA) may cause bradycardia because the RCA supplies
                        the SA and AV nodes. An anterior MI (LAD) carries the highest risk of cardiogenic shock because
                        the LAD supplies the largest area of myocardium.
                    </div>

                    <h3>7.2 ECG Changes in Ischemia/Injury/Infarction</h3>

                    <svg viewBox="0 0 600 180" style="max-width: 600px;">
                        <!-- Ischemia -->
                        <g transform="translate(20,20)">
                            <text x="80" y="10" font-size="12" font-weight="bold" text-anchor="middle">ISCHEMIA</text>
                            <text x="80" y="25" font-size="10" fill="#666" text-anchor="middle">(lack of O2)</text>
                            <line x1="0" y1="80" x2="160" y2="80" stroke="#ccc" stroke-width="1"
                                stroke-dasharray="3,3" />
                            <path d="M10,80 L40,80 L50,60 L60,80 L70,120 L80,50 L90,95 L100,80 L130,80 Q140,100 150,100"
                                stroke="#3182ce" stroke-width="2" fill="none" />
                            <text x="80" y="130" font-size="10" fill="#3182ce" text-anchor="middle">ST depression
                                OR</text>
                            <text x="80" y="145" font-size="10" fill="#3182ce" text-anchor="middle">T-wave
                                inversion</text>
                        </g>
                        <!-- Injury -->
                        <g transform="translate(210,20)">
                            <text x="80" y="10" font-size="12" font-weight="bold" text-anchor="middle">INJURY</text>
                            <text x="80" y="25" font-size="10" fill="#666" text-anchor="middle">(prolonged
                                ischemia)</text>
                            <line x1="0" y1="80" x2="160" y2="80" stroke="#ccc" stroke-width="1"
                                stroke-dasharray="3,3" />
                            <path d="M10,80 L40,80 L50,60 L60,80 L70,120 L80,50 L90,60 L100,60 L130,60 Q140,80 150,80"
                                stroke="#dd6b20" stroke-width="2" fill="none" />
                            <text x="80" y="130" font-size="10" fill="#dd6b20" text-anchor="middle"
                                font-weight="bold">ST ELEVATION</text>
                        </g>
                        <!-- Infarction -->
                        <g transform="translate(400,20)">
                            <text x="80" y="10" font-size="12" font-weight="bold" text-anchor="middle">INFARCTION</text>
                            <text x="80" y="25" font-size="10" fill="#666" text-anchor="middle">(tissue death)</text>
                            <line x1="0" y1="80" x2="160" y2="80" stroke="#ccc" stroke-width="1"
                                stroke-dasharray="3,3" />
                            <path d="M10,80 L30,80 L35,100 L45,60 L55,80 L65,120 L75,50 L85,80 L100,80 L130,80"
                                stroke="#c53030" stroke-width="2" fill="none" />
                            <text x="80" y="130" font-size="10" fill="#c53030" text-anchor="middle">Pathological Q
                                wave</text>
                            <text x="80" y="145" font-size="10" fill="#c53030" text-anchor="middle">(usually
                                permanent)</text>
                        </g>
                    </svg>

                    <div class="callout pearl">
                        During MI recovery, the <strong>ST segment often returns to normal first</strong>. Q-wave
                        changes are usually <strong>permanent</strong>‚Äîthey indicate an old, healed MI. An "old STEMI"
                        shows abnormal Q waves without acute ST/T changes.
                    </div>

                    <h3>7.3 ACS Assessment</h3>

                    <p><strong>Pain characteristics:</strong></p>
                    <ul>
                        <li>Sudden onset, continues despite rest and medication</li>
                        <li>May be described as crushing, squeezing, pressure, heaviness</li>
                        <li>May radiate to jaw, neck, shoulders, back, arms</li>
                    </ul>

                    <p><strong>Associated symptoms:</strong> SOB, indigestion, nausea, anxiety, cool/pale/clammy skin,
                        tachycardia, tachypnea</p>

                    <div class="callout warning">
                        <strong>Critical Time Targets:</strong><br>
                        ‚Ä¢ 12-lead ECG within <strong>10 minutes</strong> of ED arrival<br>
                        ‚Ä¢ Door-to-balloon (PCI) time: <strong>&lt;60 minutes</strong> (AHA standard &lt;90 min;
                        professor emphasizes &lt;60)<br>
                        ‚Ä¢ Door-to-needle (thrombolytics): <strong>&lt;30 minutes</strong>
                    </div>

                    <h3>7.4 ACS Treatment <span class="slide-ref">üìë W1 Slides 126‚Äì132</span></h3>

                    <div class="callout memory">
                        <strong>MONA for MI:</strong><br>
                        <strong>M</strong>orphine (reduces pain/anxiety, ‚Üìpreload/afterload; monitor BP and
                        respirations)<br>
                        <strong>O</strong>xygen (if SpO2 &lt;95%)<br>
                        <strong>N</strong>itroglycerin<br>
                        <strong>A</strong>spirin (162-325 mg chewed)
                    </div>

                    <h4>Complete ACS Treatment Protocol</h4>
                    <ol>
                        <li><strong>Rapid transit to hospital</strong></li>
                        <li><strong>12-lead ECG within 10 minutes</strong></li>
                        <li><strong>Labs:</strong> Cardiac biomarkers (troponin), CBC, BMP, coagulation studies</li>
                        <li><strong>MONA</strong> as above</li>
                        <li><strong>Beta-blocker</strong></li>
                        <li><strong>ACE inhibitor</strong> within 24 hours</li>
                        <li><strong>Anticoagulation:</strong> Heparin + platelet inhibitors (clopidogrel, glycoprotein
                            IIb/IIIa inhibitors)</li>
                        <li><strong>Reperfusion therapy:</strong>
                            <ul>
                                <li>PCI preferred for STEMI</li>
                                <li>Thrombolytics if PCI not available</li>
                            </ul>
                        </li>
                        <li><strong>Statin</strong> at discharge</li>
                        <li><strong>Bed rest</strong> minimum 12-24 hours</li>
                    </ol>

                    <h4>Thrombolytic Therapy</h4>
                    <p><strong>Indications:</strong></p>
                    <ul>
                        <li>Chest pain &gt;20 minutes, unrelieved by NTG</li>
                        <li>ST elevation in ‚â•2 leads facing same area</li>
                        <li>&lt;12 hours from symptom onset</li>
                    </ul>

                    <p><strong>Absolute Contraindications:</strong></p>
                    <ul>
                        <li>Active bleeding or known bleeding disorder</li>
                        <li>History of hemorrhagic stroke</li>
                        <li>History of intracranial vessel malformation</li>
                        <li>Recent major surgery or trauma</li>
                        <li>Uncontrolled hypertension</li>
                        <li>Pregnancy</li>
                    </ul>

                    <p><strong>Common agents:</strong> Alteplase (tPA), Tenecteplase</p>

                    <p><strong>Nursing considerations:</strong></p>
                    <ul>
                        <li>Minimize skin punctures and IM injections</li>
                        <li>Draw blood before starting therapy</li>
                        <li>Establish IV lines BEFORE therapy; designate one for blood draws</li>
                        <li>Monitor for reperfusion: resolution of pain, ST-segment normalization</li>
                        <li>Monitor for bleeding: ‚ÜìHct/Hgb, ‚ÜìBP, ‚ÜëHR, oozing at sites, back pain, headache, ‚ÜìLOC</li>
                    </ul>

                    <h3>7.5 Invasive Procedures</h3>

                    <h4>Cardiac Catheterization <span class="slide-ref">üìë W1 Slides 26‚Äì28</span></h4>

                    <p>Invasive diagnostic procedure used to evaluate structural and functional heart disease. Guides
                        treatment decisions for PCI or CABG.</p>

                    <table class="comparison-table">
                        <tr>
                            <th>Feature</th>
                            <th>Right Heart Cath</th>
                            <th>Left Heart Cath</th>
                        </tr>
                        <tr>
                            <td><strong>Access</strong></td>
                            <td>Venous (jugular, femoral, or subclavian)</td>
                            <td>Arterial (femoral or radial)</td>
                        </tr>
                        <tr>
                            <td><strong>Measures</strong></td>
                            <td>PA pressures, O2 saturations; myocardial biopsy possible</td>
                            <td>Coronary anatomy (with contrast); LV function</td>
                        </tr>
                        <tr>
                            <td><strong>Contrast</strong></td>
                            <td>Usually not needed</td>
                            <td>Required (nephrotoxic risk)</td>
                        </tr>
                    </table>

                    <p><strong>Pre-procedure:</strong></p>
                    <ul>
                        <li>NPO <strong>8-12 hours</strong></li>
                        <li>Baseline labs: CBC, electrolytes, glucose, BUN/creatinine, aPTT, PT, INR</li>
                        <li>Assess for <strong>kidney disease</strong> ‚Äî contrast-induced nephropathy (CIN) risk:
                            increase in baseline creatinine ‚â•25%</li>
                        <li><strong>N-acetylcysteine (Mucomyst)</strong> + increased IV fluids for patients with renal
                            insufficiency to prevent CIN</li>
                        <li>Previous contrast reaction ‚Üí premedicate with <strong>steroid + antihistamine</strong></li>
                        <li>Informed consent, allergy history, mark pedal pulses</li>
                    </ul>

                    <p><strong>Post-procedure nursing care:</strong></p>
                    <ul>
                        <li>Observe catheter site for <strong>bleeding and hematoma</strong></li>
                        <li>Assess <strong>peripheral pulses</strong> in affected extremity (compare to baseline)</li>
                        <li>Evaluate <strong>temperature, color, and capillary refill</strong> of affected extremity
                        </li>
                        <li>Screen for <strong>arrhythmias</strong> (continuous monitoring)</li>
                        <li>Maintain <strong>bed rest 2-6 hours</strong>, affected leg straight, HOB ‚â§30¬∞</li>
                        <li>Instruct patient to report chest pain or bleeding immediately</li>
                        <li>Monitor <strong>creatinine levels</strong> for contrast-induced nephropathy</li>
                        <li>Encourage oral fluids to flush contrast (unless fluid-restricted)</li>
                    </ul>

                    <div class="callout pearl">
                        <strong>Discharge teaching after cardiac cath:</strong><br>
                        ‚Ä¢ Wrist access: resume normal activities next day; avoid strenuous wrist use for a few days<br>
                        ‚Ä¢ Groin access: no bending at waist, straining, or heavy lifting for 24 hours<br>
                        ‚Ä¢ No tub baths (shower OK); don't submerge puncture site<br>
                        ‚Ä¢ If bleeding: lie down (groin) or sit (wrist) and apply firm pressure for 10 minutes; call
                        provider<br>
                        ‚Ä¢ Call 911 for large amount of bleeding<br>
                        ‚Ä¢ Report: swelling, new bruising, pain at site, or temp ‚â•101¬∞F
                    </div>

                    <h4>PCI (Percutaneous Coronary Intervention)</h4>
                    <p>Catheter-based procedure to open blocked coronary arteries. Includes balloon angioplasty and
                        stent placement.</p>

                    <h4>CABG (Coronary Artery Bypass Graft)</h4>
                    <p>Surgical procedure using vessel grafts (saphenous vein, internal mammary artery) to bypass
                        blocked coronary arteries.</p>

                    <div class="callout pearl">
                        <strong>Most common complication post-CABG: ATRIAL FIBRILLATION</strong><br>
                        Monitor closely for irregular rhythm in the days following surgery.
                    </div>

                    <h3>7.6 Cardiac Arrest vs. Heart Attack</h3>

                    <table class="comparison-table">
                        <tr>
                            <th>Heart Attack (MI)</th>
                            <th>Cardiac Arrest</th>
                        </tr>
                        <tr>
                            <td>Blood flow to heart is BLOCKED</td>
                            <td>Heart STOPS beating</td>
                        </tr>
                        <tr>
                            <td>Circulation problem (plaque/clot)</td>
                            <td>Electrical problem</td>
                        </tr>
                        <tr>
                            <td>Patient usually conscious initially</td>
                            <td>Patient unconscious, pulseless</td>
                        </tr>
                        <tr>
                            <td>Most MIs do NOT cause cardiac arrest</td>
                            <td>MI is one common cause of cardiac arrest</td>
                        </tr>
                    </table>

                </section>

                <!-- SECTION 8: VALVULAR AND STRUCTURAL DISORDERS -->
                <section id="valvular">
                    <h2>8. Valvular & Structural Disorders <span class="slide-ref">üìë W2 Slides 2‚Äì18</span></h2>

                    <h3>8.1 Types of Valve Dysfunction</h3>

                    <!-- Valve Dysfunction Diagram -->
                    <svg viewBox="0 0 600 200" style="max-width: 600px;">
                        <!-- Normal Valve -->
                        <g transform="translate(30,20)">
                            <text x="70" y="0" font-size="12" fill="#38a169" text-anchor="middle"
                                font-weight="bold">NORMAL</text>
                            <rect x="20" y="20" width="100" height="80" rx="5" fill="#d4edda" stroke="#38a169"
                                stroke-width="2" />
                            <!-- Open valve -->
                            <path d="M50,45 L70,30 L90,45" stroke="#38a169" stroke-width="3" fill="none" />
                            <path d="M50,75 L70,90 L90,75" stroke="#38a169" stroke-width="3" fill="none" />
                            <text x="70" y="65" font-size="10" fill="#38a169" text-anchor="middle">Opens</text>
                            <text x="70" y="115" font-size="9" fill="#666" text-anchor="middle">fully</text>
                            <!-- Flow arrow -->
                            <path d="M70,30 L70,15" stroke="#38a169" stroke-width="2" marker-end="url(#arrowhead)" />
                        </g>

                        <!-- Stenosis -->
                        <g transform="translate(200,20)">
                            <text x="70" y="0" font-size="12" fill="#dd6b20" text-anchor="middle"
                                font-weight="bold">STENOSIS</text>
                            <rect x="20" y="20" width="100" height="80" rx="5" fill="#fff3cd" stroke="#dd6b20"
                                stroke-width="2" />
                            <!-- Narrowed opening -->
                            <path d="M55,45 L70,38 L85,45" stroke="#dd6b20" stroke-width="3" fill="none" />
                            <path d="M55,75 L70,82 L85,75" stroke="#dd6b20" stroke-width="3" fill="none" />
                            <text x="70" y="65" font-size="9" fill="#dd6b20" text-anchor="middle">Narrowed!</text>
                            <text x="70" y="115" font-size="9" fill="#666" text-anchor="middle">‚Üì forward flow</text>
                            <!-- Small flow arrow -->
                            <path d="M70,38 L70,25" stroke="#dd6b20" stroke-width="1.5" marker-end="url(#arrowhead)" />
                        </g>

                        <!-- Regurgitation -->
                        <g transform="translate(370,20)">
                            <text x="70" y="0" font-size="12" fill="#c53030" text-anchor="middle"
                                font-weight="bold">REGURGITATION</text>
                            <rect x="20" y="20" width="100" height="80" rx="5" fill="#fff5f5" stroke="#c53030"
                                stroke-width="2" />
                            <!-- Leaky valve -->
                            <path d="M50,45 L70,30 L90,45" stroke="#c53030" stroke-width="3" fill="none" />
                            <path d="M50,75 L70,90 L90,75" stroke="#c53030" stroke-width="3" fill="none" />
                            <!-- Gap in middle -->
                            <line x1="65" y1="55" x2="75" y2="55" stroke="#fff5f5" stroke-width="4" />
                            <text x="70" y="65" font-size="9" fill="#c53030" text-anchor="middle">Leaks!</text>
                            <text x="70" y="115" font-size="9" fill="#666" text-anchor="middle">Backflow</text>
                            <!-- Backflow arrow -->
                            <path d="M70,95 L70,105" stroke="#c53030" stroke-width="2" marker-end="url(#arrowhead)" />
                            <path d="M70,30 L70,15" stroke="#38a169" stroke-width="1.5" marker-end="url(#arrowhead)" />
                        </g>

                        <!-- Legend -->
                        <text x="300" y="175" font-size="10" fill="#1a365d" text-anchor="middle"
                            font-weight="bold">Stenosis = obstruction to forward flow | Regurgitation = backward flow
                            (leakage)</text>
                    </svg>

                    <table>
                        <tr>
                            <th>Dysfunction</th>
                            <th>Mechanism</th>
                            <th>Hemodynamic Effect</th>
                        </tr>
                        <tr>
                            <td><strong>Stenosis</strong></td>
                            <td>Valve doesn't open completely</td>
                            <td>Obstruction to forward flow; pressure overload proximal to valve</td>
                        </tr>
                        <tr>
                            <td><strong>Regurgitation</strong> (insufficiency)</td>
                            <td>Valve doesn't close completely</td>
                            <td>Backflow of blood; volume overload</td>
                        </tr>
                        <tr>
                            <td><strong>Prolapse</strong></td>
                            <td>AV valve leaflet stretches into atrium during systole</td>
                            <td>May lead to regurgitation over time</td>
                        </tr>
                    </table>

                    <h3>8.2 Specific Valvular Disorders</h3>

                    <table>
                        <tr>
                            <th>Disorder</th>
                            <th>Pathophysiology</th>
                            <th>Murmur</th>
                            <th>Key Features</th>
                        </tr>
                        <tr>
                            <td><strong>Mitral Valve Prolapse</strong></td>
                            <td>Valve moves back into LA during systole; 2.5% of population, more common in women</td>
                            <td>Mid-systolic click</td>
                            <td>May be asymptomatic; can progress to regurgitation</td>
                        </tr>
                        <tr>
                            <td><strong>Mitral Regurgitation</strong></td>
                            <td>Blood flows from LV‚ÜíLA during systole; volume overload</td>
                            <td>Blowing systolic at apex, radiates to left axilla</td>
                            <td>Dyspnea, fatigue, weakness; ventricular hypertrophy</td>
                        </tr>
                        <tr>
                            <td><strong>Mitral Stenosis</strong></td>
                            <td>Reduced flow from LA‚ÜíLV; usually from rheumatic disease</td>
                            <td>Low-pitched diastolic rumble at apex</td>
                            <td>First symptom: DOE; prevent with early strep treatment</td>
                        </tr>
                        <tr>
                            <td><strong>Aortic Regurgitation</strong></td>
                            <td>Backward flow from aorta‚ÜíLV during diastole</td>
                            <td>High-pitched diastolic at 3rd-4th ICS, left sternal border</td>
                            <td>Pounding heartbeat, visible pulsations in neck; needs valve replacement</td>
                        </tr>
                        <tr>
                            <td><strong>Aortic Stenosis</strong></td>
                            <td>Narrowing between LV and aorta; calcification</td>
                            <td>Loud, harsh systolic over aortic area; may hear S4</td>
                            <td>Progresses over decades; asymptomatic until late; may cause LV failure</td>
                        </tr>
                    </table>

                    <h3>8.3 Valve Replacement</h3>

                    <table class="comparison-table">
                        <tr>
                            <th>Type</th>
                            <th>Mechanical Valves</th>
                            <th>Tissue (Bioprosthetic) Valves</th>
                        </tr>
                        <tr>
                            <td><strong>Durability</strong></td>
                            <td>More durable (20+ years)</td>
                            <td>Less durable (7-15 years)</td>
                        </tr>
                        <tr>
                            <td><strong>Anticoagulation</strong></td>
                            <td><span class="highlight">LIFELONG anticoagulation required</span></td>
                            <td>No long-term anticoagulation</td>
                        </tr>
                        <tr>
                            <td><strong>Best for</strong></td>
                            <td>Younger patients</td>
                            <td>Older patients, childbearing women, those who can't tolerate anticoagulation</td>
                        </tr>
                        <tr>
                            <td><strong>Thromboembolic risk</strong></td>
                            <td>HIGH</td>
                            <td>Lower</td>
                        </tr>
                    </table>

                    <h4>Additional Valve Graft Types</h4>
                    <table>
                        <tr>
                            <th>Type</th>
                            <th>Source</th>
                            <th>Anticoagulation</th>
                            <th>Key Points</th>
                        </tr>
                        <tr>
                            <td><strong>Autograft</strong></td>
                            <td>Patient's own tissue (e.g., pulmonary valve moved to aortic position ‚Äî Ross procedure)
                            </td>
                            <td>None needed</td>
                            <td>Can last 20+ years; grows with patient; ideal for young patients</td>
                        </tr>
                        <tr>
                            <td><strong>Heterograft (Xenograft)</strong></td>
                            <td>Animal tissue (porcine or bovine pericardium)</td>
                            <td>No lifelong anticoagulation</td>
                            <td>Low clot risk; limited durability (10-15 years); <strong>best for childbearing-age
                                    women</strong> (avoids teratogenic anticoagulants)</td>
                        </tr>
                        <tr>
                            <td><strong>Homograft (Allograft)</strong></td>
                            <td>Human donor cadaver valve</td>
                            <td>Usually none needed</td>
                            <td>Excellent hemodynamics; limited availability</td>
                        </tr>
                    </table>

                    <p><strong>TAVR</strong> (Transcatheter Aortic Valve Replacement): Minimally invasive approach for
                        high-surgical-risk patients.</p>

                    <h3>8.4 Cardiomyopathy <span class="slide-ref">üìë W2 Slides 13‚Äì21</span></h3>

                    <table>
                        <tr>
                            <th>Type</th>
                            <th>Pathology</th>
                            <th>Causes</th>
                            <th>Key Points</th>
                        </tr>
                        <tr>
                            <td><strong>Dilated</strong> (most common)</td>
                            <td>Ventricular dilation with impaired contraction</td>
                            <td>Viral infections, pregnancy, HTN, chemo, alcohol abuse (thiamine deficiency)</td>
                            <td>Eventually leads to HF</td>
                        </tr>
                        <tr>
                            <td><strong>Hypertrophic</strong></td>
                            <td>LV wall thickens, reducing blood flow</td>
                            <td>Often genetic</td>
                            <td><span class="highlight">Leading cause of sudden death in adolescents/athletes</span>;
                                avoid hot tubs, saunas (alter preload)</td>
                        </tr>
                        <tr>
                            <td><strong>Restrictive</strong> (least common)</td>
                            <td>Stiff heart muscle, impaired filling</td>
                            <td>Cancer treatment, radiation, scleroderma</td>
                            <td>Difficult to treat</td>
                        </tr>
                        <tr>
                            <td><strong>Arrhythmogenic RV</strong></td>
                            <td>RV muscle replaced by fibrous/fatty tissue</td>
                            <td>Often genetic</td>
                            <td>Sudden cardiac death may be first sign</td>
                        </tr>
                    </table>

                    <h3>8.5 Infectious Heart Diseases <span class="slide-ref">üìë W2 Slides 22‚Äì26</span></h3>

                    <h4>Rheumatic Fever</h4>
                    <p><strong>Preventable disease</strong> caused by Group A beta-hemolytic streptococcal pharyngitis.
                        Untreated strep throat can lead to rheumatic heart disease with valve damage.</p>
                    <p><strong>Prevention:</strong> Treat strep throat with complete course of penicillin or
                        amoxicillin.</p>

                    <h4>Infective Endocarditis</h4>
                    <p>Infection of heart valves or endocardium, more common with prosthetic valves and pacemakers.</p>
                    <p><strong>Symptoms:</strong> Fever, worsening heart murmur, petechiae</p>
                    <p><strong>Prevention:</strong> Prophylactic antibiotics before dental procedures (2g amoxicillin 1
                        hour prior); good oral hygiene</p>

                    <h4>Myocarditis</h4>
                    <p>Inflammation of myocardium causing heart dilation and potential thrombi formation.</p>
                    <p><strong>Causes:</strong> Viral (HIV, Influenza A, COVID), bacterial, fungal</p>
                    <p><strong>Symptoms:</strong> May be asymptomatic; fatigue, dyspnea, syncope, palpitations, flu-like
                        symptoms</p>
                    <p><strong>Prevention:</strong> IMMUNIZATIONS</p>

                    <h4>Pericarditis</h4>
                    <p>Inflammation of pericardial sac; may occur 10 days to 2 months post-MI.</p>
                    <p><strong>Symptoms:</strong> Chest pain beneath clavicle radiating to neck/scapula; worsens with
                        inspiration and turning; friction rub at left lower sternal border</p>
                    <p><strong>Complication:</strong> Pericardial effusion ‚Üí cardiac tamponade</p>
                    <p><strong>Treatment:</strong> NSAIDs (steroids if contraindicated); pericardiocentesis if effusion
                        develops</p>

                </section>

                <!-- SECTION 9: HEART FAILURE -->
                <section id="hf">
                    <h2>9. Heart Failure <span class="slide-ref">üìë W2 Slides 24‚Äì39</span></h2>

                    <p>Heart failure is a clinical syndrome resulting from structural or functional cardiac disorders
                        that impair the heart's ability to fill or eject blood. It's the <strong>most common reason for
                            hospitalization in patients &gt;65 years old</strong>.</p>

                    <p><strong>Primary cause:</strong> Coronary artery disease<br>
                        <strong>Other causes:</strong> MI, HTN, valvular disease, cardiomyopathy
                    </p>

                    <!-- Heart Failure Pathophysiology Cascade -->
                    <svg viewBox="0 0 640 660" style="max-width: 640px;" role="img"
                        aria-label="Heart failure pathophysiology cascade showing how cardiac injury leads to compensatory mechanisms, neurohormonal activation, and a worsening vicious cycle">
                        <defs>
                            <marker id="hf-arrow" viewBox="0 0 10 10" refX="9" refY="5" markerWidth="7" markerHeight="7"
                                orient="auto-start-reverse">
                                <polygon points="0 0, 10 5, 0 10" fill="#4a5568" />
                            </marker>
                            <linearGradient id="hf-grad" x1="0" y1="0" x2="0" y2="1">
                                <stop offset="0%" stop-color="#3182ce" />
                                <stop offset="40%" stop-color="#805ad5" />
                                <stop offset="75%" stop-color="#c53030" />
                                <stop offset="100%" stop-color="#9b2c2c" />
                            </linearGradient>
                        </defs>

                        <text x="320" y="24" text-anchor="middle" font-size="15" font-weight="700" fill="#1a365d">Heart
                            Failure ‚Äî The Vicious Cycle</text>

                        <!-- Gradient bar on left side -->
                        <rect x="16" y="42" width="8" height="560" rx="4" fill="url(#hf-grad)" opacity="0.6" />
                        <text x="12" y="90" font-size="9" fill="#3182ce" text-anchor="end"
                            transform="rotate(-90,12,90)">EARLY</text>
                        <text x="12" y="530" font-size="9" fill="#c53030" text-anchor="end"
                            transform="rotate(-90,12,530)">SEVERE</text>

                        <!-- BOX 1: Cardiac Injury -->
                        <rect x="160" y="42" width="320" height="52" rx="10" fill="#ebf8ff" stroke="#3182ce"
                            stroke-width="2.5" />
                        <text x="320" y="65" text-anchor="middle" font-size="13" font-weight="700"
                            fill="#2c5282">Cardiac Injury</text>
                        <text x="320" y="82" text-anchor="middle" font-size="10" fill="#4a5568">MI, Chronic HTN, Valve
                            Disease, Cardiomyopathy</text>

                        <!-- Arrow 1‚Üí2 -->
                        <line x1="320" y1="94" x2="320" y2="116" stroke="#4a5568" stroke-width="2"
                            marker-end="url(#hf-arrow)" />

                        <!-- BOX 2: Decreased CO -->
                        <rect x="200" y="118" width="240" height="44" rx="10" fill="#e9d8fd" stroke="#805ad5"
                            stroke-width="2" />
                        <text x="320" y="145" text-anchor="middle" font-size="13" font-weight="700" fill="#6b21a8">‚Üì
                            Cardiac Output</text>
                        <!-- Side annotation -->
                        <rect x="460" y="118" width="168" height="44" rx="6" fill="#faf5ff" stroke="#805ad5"
                            stroke-width="1" stroke-dasharray="4,3" />
                        <text x="544" y="137" text-anchor="middle" font-size="9" fill="#6b21a8">Fatigue, weakness</text>
                        <text x="544" y="150" text-anchor="middle" font-size="9" fill="#6b21a8">Exercise
                            intolerance</text>

                        <!-- Arrow 2‚Üí3 -->
                        <line x1="320" y1="162" x2="320" y2="184" stroke="#4a5568" stroke-width="2"
                            marker-end="url(#hf-arrow)" />

                        <!-- BOX 3: Compensatory Mechanisms -->
                        <rect x="140" y="186" width="360" height="52" rx="10" fill="#e9d8fd" stroke="#805ad5"
                            stroke-width="2" />
                        <text x="320" y="209" text-anchor="middle" font-size="13" font-weight="700"
                            fill="#6b21a8">Compensatory Mechanisms Activated</text>
                        <text x="320" y="226" text-anchor="middle" font-size="10" fill="#4a5568">Help short-term ‚Üí Harm
                            long-term</text>

                        <!-- Arrow 3‚Üí4 -->
                        <line x1="320" y1="238" x2="320" y2="260" stroke="#4a5568" stroke-width="2"
                            marker-end="url(#hf-arrow)" />

                        <!-- BOX 4: Neurohormonal Activation -->
                        <rect x="120" y="262" width="400" height="60" rx="10" fill="#fef2f2" stroke="#e53e3e"
                            stroke-width="2" />
                        <text x="320" y="285" text-anchor="middle" font-size="13" font-weight="700"
                            fill="#c53030">Neurohormonal Activation</text>
                        <text x="320" y="305" text-anchor="middle" font-size="10" fill="#4a5568">RAAS ‚Üë Aldosterone |
                            SNS ‚Üë Catecholamines | ADH ‚Üë Water Retention</text>
                        <!-- Side annotation -->
                        <rect x="460" y="266" width="168" height="52" rx="6" fill="#fff5f5" stroke="#e53e3e"
                            stroke-width="1" stroke-dasharray="4,3" />
                        <text x="544" y="286" text-anchor="middle" font-size="9" fill="#c53030">Tachycardia,
                            anxiety</text>
                        <text x="544" y="299" text-anchor="middle" font-size="9" fill="#c53030">Cool, clammy skin</text>
                        <text x="544" y="312" text-anchor="middle" font-size="9" fill="#c53030">‚Üì Urine output</text>

                        <!-- Arrow 4‚Üí5 -->
                        <line x1="320" y1="322" x2="320" y2="344" stroke="#4a5568" stroke-width="2"
                            marker-end="url(#hf-arrow)" />

                        <!-- BOX 5: Fluid Retention + Vasoconstriction -->
                        <rect x="140" y="346" width="360" height="44" rx="10" fill="#fef2f2" stroke="#c53030"
                            stroke-width="2" />
                        <text x="320" y="373" text-anchor="middle" font-size="13" font-weight="700" fill="#9b2c2c">Fluid
                            Retention + Vasoconstriction</text>
                        <!-- Side annotation -->
                        <rect x="460" y="346" width="168" height="44" rx="6" fill="#fff5f5" stroke="#c53030"
                            stroke-width="1" stroke-dasharray="4,3" />
                        <text x="544" y="365" text-anchor="middle" font-size="9" fill="#c53030">Edema, weight
                            gain</text>
                        <text x="544" y="378" text-anchor="middle" font-size="9" fill="#c53030">JVD, crackles, S3</text>

                        <!-- Arrow 5‚Üí6 -->
                        <line x1="320" y1="390" x2="320" y2="412" stroke="#4a5568" stroke-width="2"
                            marker-end="url(#hf-arrow)" />

                        <!-- BOX 6: Increased Preload + Afterload -->
                        <rect x="160" y="414" width="320" height="44" rx="10" fill="#fef2f2" stroke="#c53030"
                            stroke-width="2.5" />
                        <text x="320" y="441" text-anchor="middle" font-size="13" font-weight="700" fill="#9b2c2c">‚Üë
                            Preload + ‚Üë Afterload</text>

                        <!-- Arrow 6‚Üí7 -->
                        <line x1="320" y1="458" x2="320" y2="480" stroke="#4a5568" stroke-width="2"
                            marker-end="url(#hf-arrow)" />

                        <!-- BOX 7: Ventricular Remodeling -->
                        <rect x="160" y="482" width="320" height="52" rx="10" fill="#fef2f2" stroke="#9b2c2c"
                            stroke-width="2.5" />
                        <text x="320" y="505" text-anchor="middle" font-size="13" font-weight="700"
                            fill="#9b2c2c">Ventricular Remodeling</text>
                        <text x="320" y="522" text-anchor="middle" font-size="10" fill="#4a5568">Dilation, hypertrophy,
                            fibrosis ‚Üí ‚Üì EF</text>

                        <!-- Arrow 7‚Üí8 -->
                        <line x1="320" y1="534" x2="320" y2="556" stroke="#4a5568" stroke-width="2"
                            marker-end="url(#hf-arrow)" />

                        <!-- BOX 8: Further Decreased CO / Worsening HF -->
                        <rect x="120" y="558" width="400" height="52" rx="10" fill="#9b2c2c" stroke="#9b2c2c"
                            stroke-width="2" />
                        <text x="320" y="581" text-anchor="middle" font-size="14" font-weight="700" fill="#fff">Further
                            ‚Üì CO ‚Üí Worsening Heart Failure</text>
                        <text x="320" y="600" text-anchor="middle" font-size="10" fill="#fed7d7">MODS, cardiogenic shock
                            if cycle not broken</text>

                        <!-- Vicious cycle arrow curving back from box 8 to box 2 -->
                        <path d="M120,584 C50,584 36,400 36,280 C36,160 50,140 110,140 L198,140" stroke="#c53030"
                            stroke-width="2.5" fill="none" stroke-dasharray="8,4" marker-end="url(#hf-arrow)"
                            opacity="0.7" />
                        <text x="56" y="375" font-size="11" fill="#c53030" font-weight="700"
                            transform="rotate(-90,56,375)">VICIOUS CYCLE</text>

                        <!-- Treatment break-points annotation -->
                        <rect x="10" y="618" width="620" height="36" rx="6" fill="#f0fff4" stroke="#38a169"
                            stroke-width="1.5" />
                        <text x="320" y="636" text-anchor="middle" font-size="10" fill="#276749"
                            font-weight="600">Treatment Goals: Break the cycle ‚Äî ACEi/ARBs (‚Üì RAAS), Beta-blockers (‚Üì
                            SNS), Diuretics (‚Üì volume), Inotropes (‚Üë contractility)</text>
                        <text x="320" y="649" text-anchor="middle" font-size="9" fill="#38a169">Every HF medication
                            targets a specific step in this cascade</text>
                    </svg>

                    <h3>9.1 HF Classification</h3>

                    <h4>By Ejection Fraction</h4>
                    <table>
                        <tr>
                            <th>Classification</th>
                            <th>EF</th>
                            <th>What's Happening</th>
                            <th>Key Point</th>
                        </tr>
                        <tr>
                            <td><strong>HFrEF</strong> (reduced EF)</td>
                            <td>&le;40%</td>
                            <td>Heart can't <em>contract</em> effectively ‚Äî systolic failure</td>
                            <td>Most studied; most HF medications target this type</td>
                        </tr>
                        <tr>
                            <td><strong>HFmrEF</strong> (mid-range EF)</td>
                            <td>41-49%</td>
                            <td>Borderline ‚Äî may progress in either direction</td>
                            <td>Treatment guided by underlying cause and symptoms</td>
                        </tr>
                        <tr>
                            <td><strong>HFpEF</strong> (preserved EF)</td>
                            <td>&ge;50%</td>
                            <td>Heart can't <em>relax and fill</em> ‚Äî diastolic failure</td>
                            <td>Common in elderly, HTN, diabetes; fewer proven drug therapies</td>
                        </tr>
                    </table>

                    <div class="callout pearl">
                        <strong>Systolic vs. Diastolic:</strong> In HFrEF (systolic), the ventricle is weak and dilated
                        ‚Äî it can't squeeze. In HFpEF (diastolic), the ventricle is stiff and thickened ‚Äî it can't relax
                        and fill. Both result in decreased cardiac output, but the mechanisms (and treatments) differ.
                        Most common form is <strong>systolic HF with reduced EF</strong>.
                    </div>

                    <h4>NYHA Functional Classification</h4>
                    <table>
                        <tr>
                            <th>Class</th>
                            <th>Symptom Level</th>
                            <th>Activity Tolerance</th>
                        </tr>
                        <tr>
                            <td><strong>I</strong></td>
                            <td>No symptoms</td>
                            <td>Ordinary activity causes no fatigue, dyspnea, or palpitations</td>
                        </tr>
                        <tr>
                            <td><strong>II</strong></td>
                            <td>Mild</td>
                            <td>Comfortable at rest; ordinary activity causes symptoms</td>
                        </tr>
                        <tr>
                            <td><strong>III</strong></td>
                            <td>Moderate</td>
                            <td>Comfortable at rest; <em>less than</em> ordinary activity causes symptoms</td>
                        </tr>
                        <tr>
                            <td><strong>IV</strong></td>
                            <td>Severe</td>
                            <td>Symptoms at rest; any activity worsens them</td>
                        </tr>
                    </table>

                    <div class="callout memory">
                        NYHA class can change ‚Äî a Class III patient who responds to treatment may improve to Class II.
                        It describes <em>current</em> functional status, not permanent prognosis. ACC/AHA Stages (A-D),
                        by contrast, only progress forward.
                    </div>

                    <h3>9.2 Why HF Gets Worse: The Compensatory Cascade</h3>

                    <p>This is the most important concept in the HF section. When cardiac output drops, the body
                        activates three compensatory mechanisms. They help short-term but cause long-term damage ‚Äî
                        creating a <strong>vicious cycle</strong> that drives HF progression.</p>

                    <!-- HF Compensatory Mechanism Cascade -->
                    <svg viewBox="0 0 720 520" style="max-width: 720px;">
                        <!-- Title -->
                        <text x="360" y="25" font-size="15" fill="#1a365d" text-anchor="middle" font-weight="bold">The
                            Vicious Cycle of Heart Failure</text>

                        <!-- Central trigger -->
                        <rect x="260" y="40" width="200" height="50" rx="8" fill="#c53030" stroke="#9b2c2c"
                            stroke-width="2" />
                        <text x="360" y="62" font-size="12" fill="white" text-anchor="middle"
                            font-weight="bold">DECREASED CARDIAC OUTPUT</text>
                        <text x="360" y="78" font-size="10" fill="white" text-anchor="middle">Heart can't meet
                            demand</text>

                        <!-- Arrow down to three mechanisms -->
                        <path d="M360,90 L360,120" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)" />
                        <text x="360" y="115" font-size="9" fill="#666" text-anchor="middle">triggers</text>

                        <!-- SNS Box (left) -->
                        <rect x="20" y="130" width="200" height="120" rx="8" fill="#feebc8" stroke="#dd6b20"
                            stroke-width="2" />
                        <text x="120" y="152" font-size="11" fill="#dd6b20" text-anchor="middle" font-weight="bold">1.
                            SNS ACTIVATION</text>
                        <line x1="30" y1="160" x2="210" y2="160" stroke="#dd6b20" stroke-width="1" />
                        <g font-size="9" fill="#1a202c">
                            <text x="30" y="178">Epinephrine/norepinephrine</text>
                            <text x="30" y="195">SHORT-TERM: HR, contractility</text>
                            <text x="30" y="212">LONG-TERM: O2 demand,</text>
                            <text x="30" y="227">arrhythmias, myocyte death</text>
                            <text x="30" y="244" fill="#c53030" font-weight="bold">Beta-blockers block this</text>
                        </g>

                        <!-- RAAS Box (center) -->
                        <rect x="260" y="130" width="200" height="120" rx="8" fill="#fed7d7" stroke="#c53030"
                            stroke-width="2" />
                        <text x="360" y="152" font-size="11" fill="#c53030" text-anchor="middle" font-weight="bold">2.
                            RAAS ACTIVATION</text>
                        <line x1="270" y1="160" x2="450" y2="160" stroke="#c53030" stroke-width="1" />
                        <g font-size="9" fill="#1a202c">
                            <text x="270" y="178">Renin &rarr; Angiotensin II &rarr; Aldosterone</text>
                            <text x="270" y="195">SHORT-TERM: BP via</text>
                            <text x="270" y="210">vasoconstriction + Na/H2O retention</text>
                            <text x="270" y="227">LONG-TERM: afterload, fluid</text>
                            <text x="270" y="244" fill="#c53030" font-weight="bold">ACE-I / ARBs / Spironolactone</text>
                        </g>

                        <!-- Remodeling Box (right) -->
                        <rect x="500" y="130" width="200" height="120" rx="8" fill="#faf5ff" stroke="#805ad5"
                            stroke-width="2" />
                        <text x="600" y="152" font-size="11" fill="#805ad5" text-anchor="middle" font-weight="bold">3.
                            REMODELING</text>
                        <line x1="510" y1="160" x2="690" y2="160" stroke="#805ad5" stroke-width="1" />
                        <g font-size="9" fill="#1a202c">
                            <text x="510" y="178">Ventricle hypertrophies &amp; dilates</text>
                            <text x="510" y="195">SHORT-TERM: stroke volume</text>
                            <text x="510" y="210">(Frank-Starling)</text>
                            <text x="510" y="227">LONG-TERM: fibrosis, wall</text>
                            <text x="510" y="244">thinning, worsening EF</text>
                        </g>

                        <!-- Arrows from trigger to each box -->
                        <path d="M300,120 L120,130" stroke="#666" stroke-width="1.5" />
                        <path d="M360,90 L360,130" stroke="#666" stroke-width="1.5" />
                        <path d="M420,120 L600,130" stroke="#666" stroke-width="1.5" />

                        <!-- Combined harm box -->
                        <path d="M120,250 L120,290" stroke="#dd6b20" stroke-width="1.5" marker-end="url(#arrowhead)" />
                        <path d="M360,250 L360,290" stroke="#c53030" stroke-width="1.5" marker-end="url(#arrowhead)" />
                        <path d="M600,250 L600,290" stroke="#805ad5" stroke-width="1.5" marker-end="url(#arrowhead)" />

                        <rect x="40" y="295" width="640" height="60" rx="8" fill="#fff5f5" stroke="#c53030"
                            stroke-width="2" />
                        <text x="360" y="318" font-size="12" fill="#c53030" text-anchor="middle"
                            font-weight="bold">COMBINED LONG-TERM HARM</text>
                        <text x="360" y="340" font-size="10" fill="#1a202c" text-anchor="middle">Increased afterload +
                            fluid overload + increased O2 demand + structural damage</text>

                        <!-- Arrow back to top (vicious cycle) -->
                        <path d="M360,355 L360,380" stroke="#c53030" stroke-width="2" marker-end="url(#arrowhead)" />

                        <rect x="230" y="385" width="260" height="40" rx="8" fill="#c53030" stroke="#9b2c2c"
                            stroke-width="2" />
                        <text x="360" y="405" font-size="11" fill="white" text-anchor="middle"
                            font-weight="bold">FURTHER DECREASED CO</text>
                        <text x="360" y="418" font-size="9" fill="white" text-anchor="middle">Cycle repeats &amp;
                            worsens</text>

                        <!-- Curved arrow back to top -->
                        <path d="M230,405 Q10,405 10,65 Q10,50 20,50 L260,50" stroke="#c53030" stroke-width="2"
                            stroke-dasharray="6,3" fill="none" marker-end="url(#arrowhead)" />
                        <text x="15" y="240" font-size="10" fill="#c53030" transform="rotate(-90, 15, 240)"
                            text-anchor="middle" font-weight="bold">VICIOUS CYCLE</text>

                        <!-- Counter-regulatory -->
                        <rect x="230" y="440" width="260" height="60" rx="8" fill="#ebf8ff" stroke="#3182ce"
                            stroke-width="2" />
                        <text x="360" y="462" font-size="11" fill="#3182ce" text-anchor="middle"
                            font-weight="bold">COUNTER-REGULATORY: BNP</text>
                        <text x="360" y="478" font-size="9" fill="#1a202c" text-anchor="middle">Natriuretic peptides try
                            to oppose RAAS</text>
                        <text x="360" y="492" font-size="9" fill="#1a202c" text-anchor="middle">(vasodilation +
                            diuresis) ‚Äî but overwhelmed in HF</text>
                    </svg>

                    <div class="callout warning">
                        <strong>Why this matters for medications:</strong> Every major HF drug class targets a specific
                        part of this cascade:
                        <ul style="margin-top: 0.5rem;">
                            <li><strong>Beta-blockers</strong> (carvedilol, metoprolol) ‚Äî block SNS activation
                                (mechanism 1)</li>
                            <li><strong>ACE inhibitors / ARBs</strong> (lisinopril, valsartan) ‚Äî block RAAS at
                                angiotensin conversion (mechanism 2)</li>
                            <li><strong>Aldosterone antagonists</strong> (spironolactone) ‚Äî block RAAS at the end:
                                aldosterone-driven Na/H2O retention (mechanism 2)</li>
                            <li><strong>ARNIs</strong> (Entresto) ‚Äî block RAAS + enhance the protective natriuretic
                                peptide system</li>
                            <li><strong>Diuretics</strong> (furosemide) ‚Äî directly remove the excess fluid caused by
                                RAAS activation</li>
                            <li><strong>Digoxin / Inotropes</strong> ‚Äî directly increase contractility to compensate for
                                the weakened pump</li>
                        </ul>
                        <strong>You're not giving random drugs. You're interrupting a specific harmful cascade at
                            specific points.</strong>
                    </div>

                    <h3>9.3 Left-Sided vs. Right-Sided Heart Failure</h3>

                    <!-- Heart Failure Comparison Diagram -->
                    <svg viewBox="0 0 700 400" style="max-width: 700px;">
                        <!-- Left Sided HF -->
                        <rect x="20" y="20" width="300" height="360" rx="10" fill="#ebf8ff" stroke="#3182ce"
                            stroke-width="2" />
                        <text x="170" y="50" font-size="16" fill="#3182ce" text-anchor="middle"
                            font-weight="bold">LEFT-SIDED HF</text>
                        <text x="170" y="70" font-size="11" fill="#3182ce" text-anchor="middle">(Pulmonary
                            Congestion)</text>

                        <!-- Lungs icon -->
                        <ellipse cx="130" cy="130" rx="40" ry="50" fill="#c53030" opacity="0.3" stroke="#c53030"
                            stroke-width="2" />
                        <ellipse cx="210" cy="130" rx="40" ry="50" fill="#c53030" opacity="0.3" stroke="#c53030"
                            stroke-width="2" />
                        <text x="170" y="135" font-size="24" fill="#c53030" text-anchor="middle">ü´Å</text>
                        <text x="170" y="195" font-size="10" fill="#c53030" text-anchor="middle"
                            font-weight="bold">Blood backs up into LUNGS</text>

                        <!-- Left HF symptoms -->
                        <g font-size="11" fill="#1a202c">
                            <text x="40" y="225">‚Ä¢ Crackles/rales</text>
                            <text x="40" y="245">‚Ä¢ S3 gallop ("Ken-TUC-ky")</text>
                            <text x="40" y="265">‚Ä¢ Dyspnea on exertion</text>
                            <text x="40" y="285">‚Ä¢ Orthopnea</text>
                            <text x="40" y="305">‚Ä¢ Paroxysmal nocturnal dyspnea</text>
                            <text x="40" y="325">‚Ä¢ Pink frothy sputum</text>
                            <text x="40" y="345">‚Ä¢ Dry cough ‚Üí productive</text>
                            <text x="40" y="365">‚Ä¢ ‚ÜìO2 saturation</text>
                        </g>

                        <!-- Right Sided HF -->
                        <rect x="380" y="20" width="300" height="360" rx="10" fill="#fff5f5" stroke="#c53030"
                            stroke-width="2" />
                        <text x="530" y="50" font-size="16" fill="#c53030" text-anchor="middle"
                            font-weight="bold">RIGHT-SIDED HF</text>
                        <text x="530" y="70" font-size="11" fill="#c53030" text-anchor="middle">(Systemic
                            Congestion)</text>

                        <!-- Body icon -->
                        <ellipse cx="530" cy="130" rx="50" ry="60" fill="#3182ce" opacity="0.2" stroke="#3182ce"
                            stroke-width="2" />
                        <text x="530" y="140" font-size="30" fill="#3182ce" text-anchor="middle">üßç</text>
                        <text x="530" y="195" font-size="10" fill="#3182ce" text-anchor="middle"
                            font-weight="bold">Blood backs up into BODY</text>

                        <!-- Right HF symptoms -->
                        <g font-size="11" fill="#1a202c">
                            <text x="400" y="225">‚Ä¢ JVD (jugular venous distension)</text>
                            <text x="400" y="245">‚Ä¢ Dependent edema (legs, sacrum)</text>
                            <text x="400" y="265">‚Ä¢ Hepatomegaly</text>
                            <text x="400" y="285">‚Ä¢ Ascites ‚Üí anorexia</text>
                            <text x="400" y="305">‚Ä¢ Weight gain</text>
                            <text x="400" y="325">‚Ä¢ Pitting edema</text>
                            <text x="400" y="345"> (appears at ~10 lb fluid gain)</text>
                            <text x="400" y="365">‚Ä¢ Often caused by LEFT HF!</text>
                        </g>

                        <!-- Arrow showing progression -->
                        <path d="M325,200 L355,200" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)" />
                        <text x="340" y="220" font-size="9" fill="#666" text-anchor="middle">can lead to</text>
                    </svg>

                    <table class="comparison-table">
                        <tr>
                            <th>Feature</th>
                            <th>Left-Sided HF</th>
                            <th>Right-Sided HF (Cor Pulmonale)</th>
                        </tr>
                        <tr>
                            <td><strong>Problem</strong></td>
                            <td>LV can't eject into systemic circulation</td>
                            <td>RV can't eject into pulmonary circulation</td>
                        </tr>
                        <tr>
                            <td><strong>Congestion location</strong></td>
                            <td>PULMONARY (blood backs up into lungs)</td>
                            <td>SYSTEMIC (blood backs up into body)</td>
                        </tr>
                        <tr>
                            <td><strong>Key symptoms</strong></td>
                            <td>
                                ‚Ä¢ Crackles/rales<br>
                                ‚Ä¢ S3 gallop<br>
                                ‚Ä¢ Dyspnea on exertion<br>
                                ‚Ä¢ Orthopnea<br>
                                ‚Ä¢ Paroxysmal nocturnal dyspnea<br>
                                ‚Ä¢ Pink frothy sputum<br>
                                ‚Ä¢ Dry cough initially<br>
                                ‚Ä¢ Low O2 saturation
                            </td>
                            <td>
                                ‚Ä¢ JVD<br>
                                ‚Ä¢ Dependent edema (legs, sacrum)<br>
                                ‚Ä¢ Hepatomegaly<br>
                                ‚Ä¢ Ascites ‚Üí anorexia<br>
                                ‚Ä¢ Weight gain<br>
                                ‚Ä¢ Pitting edema
                            </td>
                        </tr>
                        <tr>
                            <td><strong>Common causes</strong></td>
                            <td>CAD, MI, HTN, aortic/mitral valve disease</td>
                            <td>Chronic lung disease, pulmonary HTN, LEFT-sided HF</td>
                        </tr>
                    </table>

                    <div class="callout pearl">
                        <strong>Paroxysmal Nocturnal Dyspnea (PND)</strong> is a hallmark of worsening left-sided HF.
                        When the patient lies flat, fluid from dependent edema redistributes to the central circulation,
                        increasing preload and causing pulmonary congestion. Patient awakens suddenly short of breath
                        and must sit up or stand for relief.
                    </div>

                    <div class="callout warning">
                        <strong>Weight Monitoring Rule:</strong><br>
                        Call provider if weight gain of <strong>2 lbs in 1 day</strong> or <strong>&gt;5 lbs in 1
                            week</strong>.<br>
                        Pitting edema doesn't appear until ~10 lbs (4.5 L) of fluid retention.
                    </div>

                    <h3>9.4 Heart Failure Medications <span class="slide-ref">üìë W2 Slides 33‚Äì36</span></h3>

                    <p>Each drug class targets a specific point in the compensatory cascade described above.
                        Understanding <em>which mechanism you're interrupting</em> tells you why you give the drug, what
                        to monitor, and when to hold it.</p>

                    <table>
                        <tr>
                            <th>Class</th>
                            <th>Examples</th>
                            <th>Cascade Target</th>
                            <th>Why It Helps in HF</th>
                            <th>Key Nursing Considerations</th>
                        </tr>
                        <tr>
                            <td><strong>ACE Inhibitors</strong></td>
                            <td>Lisinopril, Enalapril</td>
                            <td style="background: #fed7d7;">RAAS ‚Äî blocks angiotensin conversion</td>
                            <td>‚ÜìAfterload (vasodilation) + ‚Üìfluid retention ‚Üí heart pumps against less resistance</td>
                            <td>Dry cough (common); monitor K+ (hyperkalemia), renal function, BP</td>
                        </tr>
                        <tr>
                            <td><strong>ARBs</strong></td>
                            <td>Valsartan, Losartan</td>
                            <td style="background: #fed7d7;">RAAS ‚Äî blocks angiotensin II receptors</td>
                            <td>Same effect as ACE-I via different mechanism</td>
                            <td>Alternative if ACE-I cough develops; same monitoring</td>
                        </tr>
                        <tr>
                            <td><strong>ARNIs</strong></td>
                            <td>Sacubitril-Valsartan (Entresto)</td>
                            <td style="background: #fed7d7;">RAAS + enhances natriuretic peptides</td>
                            <td>Blocks harmful RAAS + boosts protective BNP system (dual mechanism)</td>
                            <td>First-line for HFrEF; superior to ACE-I alone; do NOT combine with ACE-I (36h washout)
                            </td>
                        </tr>
                        <tr>
                            <td><strong>Aldosterone Antagonists</strong></td>
                            <td>Spironolactone</td>
                            <td style="background: #fed7d7;">RAAS ‚Äî blocks aldosterone</td>
                            <td>Stops aldosterone-driven Na+/H2O retention at the collecting duct; K+-sparing; proven
                                survival benefit</td>
                            <td>Monitor K+ (hyperkalemia risk ‚Äî opposite of loop diuretics)</td>
                        </tr>
                        <tr>
                            <td><strong>Beta-Blockers</strong></td>
                            <td>Carvedilol, Metoprolol succinate, Bisoprolol</td>
                            <td style="background: #feebc8;">SNS ‚Äî blocks catecholamine effects</td>
                            <td>‚ÜìHR (more filling time) + ‚ÜìO2 demand + prevents arrhythmias from SNS overstimulation
                            </td>
                            <td><strong>Start low, titrate slow;</strong> may worsen HF initially before helping;
                                monitor HR, BP</td>
                        </tr>
                        <tr>
                            <td><strong>Loop Diuretics</strong></td>
                            <td>Furosemide (Lasix)</td>
                            <td style="background: #e2e8f0;">Fluid overload ‚Äî removes excess volume</td>
                            <td>Directly eliminates the fluid the RAAS has retained; rapid symptom relief</td>
                            <td>Monitor K+ (hypokalemia), renal function, BP; give in AM; daily weights</td>
                        </tr>
                        <tr>
                            <td><strong>Thiazide Diuretics</strong></td>
                            <td>HCTZ, Metolazone</td>
                            <td style="background: #e2e8f0;">Fluid overload ‚Äî moderate diuresis</td>
                            <td>Often combined with loops for synergistic effect when loops alone are insufficient</td>
                            <td>Monitor K+; metolazone given 30 min before furosemide for synergy</td>
                        </tr>
                        <tr>
                            <td><strong>Digoxin</strong></td>
                            <td>Digoxin</td>
                            <td style="background: #faf5ff;">Pump ‚Äî positive inotrope</td>
                            <td>‚ÜëContractility directly; also ‚ÜìHR (vagal effect) ‚Äî treats the weak pump</td>
                            <td>Narrow therapeutic window (0.5-2.0 ng/mL); toxicity: N/V, visual changes (halos),
                                bradycardia; CHECK K+ (hypokalemia increases toxicity risk)</td>
                        </tr>
                        <tr>
                            <td><strong>IV Inotropes</strong></td>
                            <td>Dobutamine, Milrinone</td>
                            <td style="background: #faf5ff;">Pump ‚Äî emergency contractility support</td>
                            <td>‚ÜëContractility for acute decompensation when oral meds are insufficient</td>
                            <td>ICU setting; continuous cardiac monitoring; short-term bridge only</td>
                        </tr>
                    </table>

                    <h3>9.5 Heart Failure Patient Education</h3>
                    <ul>
                        <li><strong>Medications:</strong> Take as prescribed; don't stop abruptly</li>
                        <li><strong>Low-sodium diet:</strong> &lt;2g/day; read labels; avoid processed foods</li>
                        <li><strong>Fluid restriction:</strong> If prescribed, typically 1.5-2 L/day</li>
                        <li><strong>Daily weights:</strong> Same time, same scale, same clothing</li>
                        <li><strong>Activity:</strong> Cardiac rehab, avoid overexertion, rest between activities</li>
                        <li><strong>Monitor for:</strong> Worsening SOB, edema, weight gain, fatigue</li>
                        <li><strong>Avoid:</strong> NSAIDs (worsen fluid retention), excessive alcohol</li>
                        <li><strong>Know when to call provider</strong></li>
                    </ul>

                    <h3>9.6 Pulmonary Edema <span class="slide-ref">üìë W2 Slides 40‚Äì41</span></h3>

                    <p>Acute event from left ventricular failure‚Äîblood backs up into pulmonary circulation causing fluid
                        to leak into alveoli.</p>

                    <p><strong>Symptoms:</strong> Restlessness, anxiety, severe dyspnea, cool/clammy skin, cyanosis,
                        weak/rapid pulse, cough, moist/noisy respirations, <strong>pink frothy sputum</strong>,
                        progressive confusion</p>

                    <div class="callout warning">
                        <strong>Pulmonary edema is easier to PREVENT than TREAT.</strong><br>
                        Early recognition: Monitor lung sounds, activity tolerance, fluid status.
                    </div>

                    <p><strong>Management:</strong></p>
                    <ul>
                        <li>Position <strong>upright with legs dangling</strong> (decreases venous return)</li>
                        <li>High-flow O2 (nonrebreather or BiPAP)</li>
                        <li>IV furosemide (rapid diuresis)</li>
                        <li>IV nitroglycerin (‚Üìpreload)</li>
                        <li>Morphine (reduces anxiety, ‚Üìpreload) ‚Äì use cautiously</li>
                        <li>Minimize exertion and stress</li>
                        <li>Monitor I&O closely</li>
                    </ul>

                </section>

                <!-- SECTION 10: CARDIAC EMERGENCIES -->
                <section id="emergencies">
                    <h2>10. Cardiac Emergencies <span class="slide-ref">üìë W2 Slides 40‚Äì63</span></h2>

                    <h3>10.1 Cardiogenic Shock</h3>

                    <p>Life-threatening condition where the heart fails to pump adequately, causing inadequate tissue
                        perfusion. <strong>HIGH mortality‚Äî50% survive with immediate care.</strong></p>

                    <p><strong>Most common cause:</strong> Post-MI (loss of &gt;40% of LV function)<br>
                        <strong>Risk factors:</strong> HF, older age, CAD, DM, HTN, female
                    </p>

                    <p><strong>Symptoms:</strong> Angina, arrhythmias, fatigue, impending doom, tachypnea, hypotension,
                        tachycardia, loss of consciousness, sweating, pale cool extremities</p>

                    <p><strong>Management:</strong></p>
                    <ul>
                        <li>Correct underlying problem (may need fibrinolytics, PCI, CABG)</li>
                        <li>Reduce preload/afterload</li>
                        <li>Improve oxygenation, restore tissue perfusion</li>
                        <li>Correct acidosis and electrolyte imbalances</li>
                        <li>Inotropes: dobutamine, milrinone, dopamine</li>
                        <li>Vasopressors: norepinephrine, phenylephrine, vasopressin</li>
                        <li>Aspirin, clopidogrel, heparin</li>
                        <li>Therapeutic hypothermia (32-36¬∞C) if post-arrest for neuroprotection</li>
                    </ul>

                    <h3>10.2 Cardiac Tamponade <span class="slide-ref">üìë W2 Slides 48‚Äì50</span></h3>

                    <p>Accumulation of fluid in pericardial space compresses the heart, restricting filling and reducing
                        cardiac output. Normal pericardial fluid is ~20 mL. <strong>Speed of accumulation matters more
                            than volume</strong>‚Äîacute tamponade can occur with as little as 100-200 mL of rapid fluid
                        accumulation, while chronic effusions may reach 1-2 L before causing symptoms because the
                        pericardium stretches gradually.</p>

                    <!-- Cardiac Tamponade / Beck's Triad Diagram -->
                    <svg viewBox="0 0 550 280" style="max-width: 550px;">
                        <!-- Heart with fluid -->
                        <ellipse cx="275" cy="140" rx="120" ry="100" fill="#fbd38d" stroke="#dd6b20" stroke-width="3" />
                        <text x="275" y="60" font-size="10" fill="#dd6b20" text-anchor="middle">Pericardial fluid</text>

                        <!-- Compressed heart inside -->
                        <path
                            d="M275,220 C200,220 160,160 160,120 C160,70 210,50 245,50 C265,50 275,65 275,80 C275,65 285,50 305,50 C340,50 390,70 390,120 C390,160 350,220 275,220"
                            fill="#c53030" stroke="#9b2c2c" stroke-width="2" />
                        <text x="275" y="145" font-size="12" fill="white" text-anchor="middle"
                            font-weight="bold">Compressed</text>
                        <text x="275" y="160" font-size="12" fill="white" text-anchor="middle"
                            font-weight="bold">Heart</text>

                        <!-- Beck's Triad boxes -->
                        <rect x="20" y="50" width="110" height="60" rx="5" fill="#c53030" />
                        <text x="75" y="75" font-size="11" fill="white" text-anchor="middle" font-weight="bold">‚Üì
                            Systolic BP</text>
                        <text x="75" y="95" font-size="9" fill="white" text-anchor="middle">(Hypotension)</text>

                        <rect x="20" y="130" width="110" height="60" rx="5" fill="#c53030" />
                        <text x="75" y="150" font-size="10" fill="white" text-anchor="middle"
                            font-weight="bold">Narrowed</text>
                        <text x="75" y="165" font-size="10" fill="white" text-anchor="middle" font-weight="bold">Pulse
                            Pressure</text>

                        <rect x="20" y="210" width="110" height="60" rx="5" fill="#c53030" />
                        <text x="75" y="235" font-size="11" fill="white" text-anchor="middle"
                            font-weight="bold">JVD</text>
                        <text x="75" y="255" font-size="9" fill="white" text-anchor="middle">(‚Üë Venous pressure)</text>

                        <rect x="420" y="130" width="110" height="60" rx="5" fill="#c53030" />
                        <text x="475" y="150" font-size="10" fill="white" text-anchor="middle"
                            font-weight="bold">Muffled/Distant</text>
                        <text x="475" y="170" font-size="10" fill="white" text-anchor="middle" font-weight="bold">Heart
                            Sounds</text>

                        <!-- Arrows pointing to heart -->
                        <line x1="130" y1="80" x2="160" y2="100" stroke="#c53030" stroke-width="2" />
                        <line x1="130" y1="160" x2="160" y2="140" stroke="#c53030" stroke-width="2" />
                        <line x1="130" y1="240" x2="160" y2="180" stroke="#c53030" stroke-width="2" />
                        <line x1="420" y1="160" x2="390" y2="140" stroke="#c53030" stroke-width="2" />

                        <!-- Title -->
                        <text x="275" y="275" font-size="14" fill="#1a365d" text-anchor="middle"
                            font-weight="bold">Beck's Triad of Cardiac Tamponade</text>
                    </svg>

                    <h4>Cardinal Signs of Tamponade (Beck's Triad)</h4>
                    <ol>
                        <li><strong>Hypotension</strong> (falling systolic BP with narrowing pulse pressure)</li>
                        <li><strong>Elevated venous pressure</strong> (JVD)</li>
                        <li><strong>Distant/muffled heart sounds</strong></li>
                    </ol>

                    <p><strong>Pulsus Paradoxus:</strong> SBP drops &gt;10 mmHg during inspiration (peripheral pulse
                        diminishes with inspiration). Assess using manual BP and careful auscultation.</p>

                    <p><strong>Treatment:</strong> Pericardiocentesis (needle aspiration of fluid) or pericardiotomy
                        (surgical window)</p>

                    <h3>10.3 Code Blue Protocol <span class="slide-ref">üìë W2 Slides 52‚Äì60</span></h3>

                    <!-- Code Blue Algorithm Flowchart -->
                    <svg viewBox="0 0 700 400" style="max-width: 700px;">
                        <!-- Start -->
                        <rect x="280" y="10" width="140" height="40" rx="20" fill="#c53030" />
                        <text x="350" y="35" font-size="12" fill="white" text-anchor="middle"
                            font-weight="bold">UNRESPONSIVE?</text>

                        <line x1="350" y1="50" x2="350" y2="70" stroke="#1a365d" stroke-width="2" />

                        <!-- Check pulse -->
                        <rect x="270" y="70" width="160" height="35" rx="5" fill="#1a365d" />
                        <text x="350" y="92" font-size="10" fill="white" text-anchor="middle" font-weight="bold">Check
                            pulse (&lt;10 sec)</text>

                        <!-- Branch -->
                        <line x1="350" y1="105" x2="350" y2="120" stroke="#1a365d" stroke-width="2" />

                        <!-- Decision diamond -->
                        <polygon points="350,120 420,150 350,180 280,150" fill="#dd6b20" stroke="#dd6b20" />
                        <text x="350" y="155" font-size="10" fill="white" text-anchor="middle"
                            font-weight="bold">Pulse?</text>

                        <!-- No pulse branch -->
                        <line x1="280" y1="150" x2="150" y2="150" stroke="#1a365d" stroke-width="2" />
                        <text x="215" y="143" font-size="9" fill="#c53030" font-weight="bold">NO</text>
                        <line x1="150" y1="150" x2="150" y2="170" stroke="#1a365d" stroke-width="2" />

                        <!-- Start CPR -->
                        <rect x="70" y="170" width="160" height="50" rx="5" fill="#c53030" />
                        <text x="150" y="190" font-size="11" fill="white" text-anchor="middle" font-weight="bold">START
                            CPR</text>
                        <text x="150" y="208" font-size="9" fill="white" text-anchor="middle">100-120/min, 2"
                            deep</text>

                        <line x1="150" y1="220" x2="150" y2="240" stroke="#1a365d" stroke-width="2" />

                        <!-- Attach defib -->
                        <rect x="70" y="240" width="160" height="35" rx="5" fill="#3182ce" />
                        <text x="150" y="262" font-size="10" fill="white" text-anchor="middle" font-weight="bold">Attach
                            defibrillator</text>

                        <line x1="150" y1="275" x2="150" y2="295" stroke="#1a365d" stroke-width="2" />

                        <!-- Check rhythm diamond -->
                        <polygon points="150,295 220,325 150,355 80,325" fill="#dd6b20" />
                        <text x="150" y="325" font-size="9" fill="white" text-anchor="middle"
                            font-weight="bold">Shockable?</text>

                        <!-- Shockable (VF/pVT) -->
                        <line x1="80" y1="325" x2="30" y2="325" stroke="#1a365d" stroke-width="2" />
                        <text x="55" y="318" font-size="8" fill="#38a169" font-weight="bold">YES</text>
                        <line x1="30" y1="325" x2="30" y2="360" stroke="#1a365d" stroke-width="2" />

                        <rect x="-30" y="360" width="120" height="35" rx="5" fill="#38a169" />
                        <text x="30" y="382" font-size="10" fill="white" text-anchor="middle" font-weight="bold">SHOCK ‚Üí
                            CPR</text>

                        <!-- Non-shockable (Asystole/PEA) -->
                        <line x1="220" y1="325" x2="280" y2="325" stroke="#1a365d" stroke-width="2" />
                        <text x="250" y="318" font-size="8" fill="#c53030" font-weight="bold">NO</text>
                        <line x1="280" y1="325" x2="280" y2="360" stroke="#1a365d" stroke-width="2" />

                        <rect x="220" y="360" width="120" height="35" rx="5" fill="#805ad5" />
                        <text x="280" y="382" font-size="10" fill="white" text-anchor="middle" font-weight="bold">CPR +
                            Epi q3-5min</text>

                        <!-- Has pulse branch -->
                        <line x1="420" y1="150" x2="550" y2="150" stroke="#1a365d" stroke-width="2" />
                        <text x="485" y="143" font-size="9" fill="#38a169" font-weight="bold">YES</text>
                        <line x1="550" y1="150" x2="550" y2="170" stroke="#1a365d" stroke-width="2" />

                        <rect x="470" y="170" width="160" height="50" rx="5" fill="#38a169" />
                        <text x="550" y="190" font-size="10" fill="white" text-anchor="middle"
                            font-weight="bold">Post-arrest care</text>
                        <text x="550" y="208" font-size="9" fill="white" text-anchor="middle">‚Ä¢ Monitor rhythm</text>

                        <!-- CPR cycle note -->
                        <rect x="400" y="270" width="280" height="80" rx="5" fill="#ebf8ff" stroke="#3182ce"
                            stroke-width="2" />
                        <text x="540" y="290" font-size="10" fill="#3182ce" text-anchor="middle" font-weight="bold">CPR
                            CYCLE</text>
                        <text x="540" y="308" font-size="9" fill="#1a202c" text-anchor="middle">‚Ä¢ 5 cycles = ~2
                            minutes</text>
                        <text x="540" y="323" font-size="9" fill="#1a202c" text-anchor="middle">‚Ä¢ Switch compressor q2
                            min</text>
                        <text x="540" y="338" font-size="9" fill="#1a202c" text-anchor="middle">‚Ä¢ Minimize interruptions
                            (&lt;10 sec)</text>
                    </svg>

                    <h4>High-Quality Chest Compressions: THE MOST IMPORTANT ELEMENT</h4>

                    <table>
                        <tr>
                            <th>Parameter</th>
                            <th>Standard</th>
                        </tr>
                        <tr>
                            <td>Rate</td>
                            <td><span class="key-value">100-120 compressions/min</span></td>
                        </tr>
                        <tr>
                            <td>Depth (adult)</td>
                            <td><span class="key-value">At least 2 inches (5 cm)</span></td>
                        </tr>
                        <tr>
                            <td>Depth (child)</td>
                            <td>At least 2 inches (1/3 chest depth)</td>
                        </tr>
                        <tr>
                            <td>Depth (infant)</td>
                            <td>At least 1.5 inches (1/3 chest depth)</td>
                        </tr>
                        <tr>
                            <td>Recoil</td>
                            <td>Allow complete chest recoil between compressions</td>
                        </tr>
                        <tr>
                            <td>Interruptions</td>
                            <td>MINIMIZE‚Äîgoal &lt;10 seconds for any pause</td>
                        </tr>
                        <tr>
                            <td>Compressor rotation</td>
                            <td>Switch every 2 minutes or when fatigued</td>
                        </tr>
                        <tr>
                            <td>Surface</td>
                            <td>Firm (use backboard)</td>
                        </tr>
                    </table>

                    <h4>First 5 Minutes of Code Blue</h4>
                    <ol>
                        <li>Check responsiveness, pulse, respirations (no longer than 10 seconds)</li>
                        <li>Call for help / push code button</li>
                        <li>Position patient flat, remove pillows, drop head of bed</li>
                        <li>Start high-quality compressions with complete recoil</li>
                        <li>Attach defibrillator pads, assess rhythm</li>
                        <li>If shockable rhythm (VF/pulseless VT): defibrillate within 2 minutes</li>
                        <li>Establish IV access</li>
                        <li>Assign team roles</li>
                    </ol>

                    <h4>Code Team Roles</h4>
                    <table>
                        <tr>
                            <th>Role</th>
                            <th>Responsibilities</th>
                        </tr>
                        <tr>
                            <td><strong>Team Leader</strong></td>
                            <td>Assigns roles, makes treatment decisions, provides feedback</td>
                        </tr>
                        <tr>
                            <td><strong>Compressor</strong></td>
                            <td>High-quality compressions, alternates every 2 minutes</td>
                        </tr>
                        <tr>
                            <td><strong>Monitor/Defibrillator</strong></td>
                            <td>Applies pads, calls "CLEAR," delivers shocks</td>
                        </tr>
                        <tr>
                            <td><strong>Airway</strong></td>
                            <td>Opens/manages airway, bag-mask ventilations</td>
                        </tr>
                        <tr>
                            <td><strong>IV/Medications</strong></td>
                            <td>IV access, prepares and administers medications</td>
                        </tr>
                        <tr>
                            <td><strong>Recorder</strong></td>
                            <td>Documents interventions, tracks time, calls for compressor switches</td>
                        </tr>
                    </table>

                    <h4>Closed-Loop Communication</h4>
                    <ol>
                        <li>Sender gives order: "Give 1 mg Epinephrine IV push"</li>
                        <li>Receiver confirms: "I will give 1 mg Epinephrine IV push"</li>
                        <li>Sender verifies: "That's correct"</li>
                    </ol>

                    <h4>Code Medications</h4>
                    <table>
                        <tr>
                            <th>Medication</th>
                            <th>Dose</th>
                            <th>Indication</th>
                        </tr>
                        <tr>
                            <td><strong>Epinephrine</strong></td>
                            <td>1 mg IV/IO every 3-5 min; flush with 20 mL, elevate extremity</td>
                            <td>All cardiac arrest rhythms</td>
                        </tr>
                        <tr>
                            <td><strong>Amiodarone</strong></td>
                            <td>300 mg IV first dose; 150 mg second dose (3-5 min later)</td>
                            <td>Pulseless VT/VF</td>
                        </tr>
                        <tr>
                            <td><strong>Atropine</strong></td>
                            <td>0.5 mg IV; may repeat to max 3 mg</td>
                            <td>Symptomatic bradycardia (NOT for asystole)</td>
                        </tr>
                        <tr>
                            <td><strong>Magnesium Sulfate</strong></td>
                            <td>1-2 g diluted in 10 mL D5W over 5-20 min</td>
                            <td>Torsades de Pointes</td>
                        </tr>
                        <tr>
                            <td><strong>Sodium Bicarbonate</strong></td>
                            <td>1 mEq/kg IV</td>
                            <td>Refractory metabolic acidosis, hyperkalemia</td>
                        </tr>
                    </table>

                    <h3>10.4 Targeted Temperature Management (TTM)</h3>

                    <p>Previously called therapeutic hypothermia. Goal is to optimize neurological outcomes after
                        cardiac arrest.</p>

                    <p><strong>Candidates:</strong> Patients who don't follow commands after ROSC (return of spontaneous
                        circulation)</p>

                    <p><strong>Target temperature:</strong> 32-36¬∞C</p>

                    <p><strong>Three phases:</strong></p>
                    <ol>
                        <li><strong>Initial Cooling (0-8 hours):</strong> Achieve target ASAP; 20% mortality increase
                            per hour of delay</li>
                        <li><strong>Maintenance (24 hours):</strong> Maintain at target temperature</li>
                        <li><strong>Rewarming (6-18 hours):</strong> Slowly return to normothermia</li>
                    </ol>

                </section>

                <!-- SECTION 11: VASCULAR DISORDERS -->
                <section id="vascular">
                    <h2>11. Vascular Disorders <span class="slide-ref">üìë W2 Slides 78‚Äì96</span></h2>

                    <h3>11.1 Hypertension <span class="slide-ref">üìë W2 Slides 78‚Äì96</span></h3>

                    <p><strong>"The Silent Killer"</strong>‚Äîoften asymptomatic until target organ damage occurs.</p>

                    <h4>ACC/AHA 2017 Classification</h4>
                    <table>
                        <tr>
                            <th>Category</th>
                            <th>Systolic</th>
                            <th>Diastolic</th>
                        </tr>
                        <tr>
                            <td>Normal</td>
                            <td>&lt;120 mmHg</td>
                            <td>&lt;80 mmHg</td>
                        </tr>
                        <tr>
                            <td>Elevated</td>
                            <td>120-129 mmHg</td>
                            <td>&lt;80 mmHg</td>
                        </tr>
                        <tr>
                            <td>Stage 1 HTN</td>
                            <td>130-139 mmHg</td>
                            <td>80-89 mmHg</td>
                        </tr>
                        <tr>
                            <td>Stage 2 HTN</td>
                            <td>‚â•140 mmHg</td>
                            <td>‚â•90 mmHg</td>
                        </tr>
                    </table>

                    <p><strong>Target BP for ALL patients:</strong> &lt;130/80 mmHg</p>

                    <p><strong>Types:</strong></p>
                    <ul>
                        <li><strong>Primary (essential):</strong> 95% of cases, no identifiable cause</li>
                        <li><strong>Secondary:</strong> 5-10%, identifiable cause (renal disease, sleep apnea,
                            pregnancy, obesity)</li>
                    </ul>

                    <p><strong>Statistics:</strong></p>
                    <ul>
                        <li>46% of US adults have HTN under new guidelines</li>
                        <li>35.3% don't know they have it</li>
                        <li>45.4% don't have it controlled</li>
                        <li>African Americans have highest prevalence worldwide</li>
                    </ul>

                    <h4>HTN Management</h4>
                    <p><strong>Lifestyle modifications:</strong></p>
                    <ul>
                        <li>Weight reduction (BMI &lt;25)</li>
                        <li><strong>DASH diet</strong> (sodium 1,500-3,200 mg daily): low sodium, whole grains, fresh
                            vegetables and fruits, lean proteins, nuts/seeds/legumes, low-fat/fat-free dairy</li>
                        <li>Physical activity (40 min, 3-4x/week)</li>
                        <li>Limit alcohol</li>
                        <li>Smoking cessation</li>
                    </ul>

                    <p><strong>Medications:</strong></p>
                    <ul>
                        <li>ACE inhibitors, ARBs</li>
                        <li>Calcium channel blockers</li>
                        <li>Thiazide diuretics</li>
                        <li><strong>African Americans without HF or CKD:</strong> Start with CCB or thiazide (NOT
                            ACE/ARB)</li>
                    </ul>

                    <h4>Hypertensive Crises</h4>
                    <table class="comparison-table">
                        <tr>
                            <th>Feature</th>
                            <th>Hypertensive Emergency</th>
                            <th>Hypertensive Urgency</th>
                        </tr>
                        <tr>
                            <td><strong>BP</strong></td>
                            <td>&gt;180/120 mmHg</td>
                            <td>Very elevated</td>
                        </tr>
                        <tr>
                            <td><strong>Target organ damage</strong></td>
                            <td>YES (stroke, MI, renal failure, encephalopathy)</td>
                            <td>NO</td>
                        </tr>
                        <tr>
                            <td><strong>Treatment urgency</strong></td>
                            <td>Immediate; IV medications in ICU</td>
                            <td>Oral agents; reduce over 24-48 hours</td>
                        </tr>
                        <tr>
                            <td><strong>BP reduction goal</strong></td>
                            <td>‚Üì25% in first hour; then 160/100 over 2-6 hours</td>
                            <td>Normalize within 24-48 hours</td>
                        </tr>
                    </table>

                    <p><strong>IV Vasodilators for Hypertensive Emergency:</strong></p>
                    <ul>
                        <li><strong>Nitroglycerin (NTG)</strong> ‚Äî vasodilation reduces preload and afterload</li>
                        <li><strong>Labetalol</strong> ‚Äî combined alpha/beta blockade</li>
                        <li><strong>Clevidipine</strong> ‚Äî IV calcium channel blocker, ultra-short acting</li>
                        <li><strong>Nicardipine</strong> ‚Äî IV calcium channel blocker</li>
                    </ul>

                    <div class="callout warning">
                        <strong>Exception ‚Äî Aortic Dissection (AAA):</strong> Reduce BP more aggressively ‚Äî goal SBP
                        &lt;120 mmHg within 20 minutes. The 25% rule does NOT apply; uncontrolled BP can extend the
                        dissection.
                    </div>

                    <h3>11.2 Arterial Disorders</h3>

                    <h4>Peripheral Arterial Disease (PAD)</h4>

                    <p>Atherosclerotic disease of arteries supplying the extremities (usually legs). Progressive
                        narrowing reduces blood flow, causing ischemia.</p>

                    <p><strong>Key assessment findings:</strong></p>
                    <ul>
                        <li><strong>Intermittent claudication:</strong> Cramping leg pain with walking, relieved by rest
                            (classic symptom)</li>
                        <li>Diminished or absent peripheral pulses</li>
                        <li>Cool, pale extremities; shiny, hairless skin</li>
                        <li>Pallor with leg elevation (feet develop pallor after elevating 60¬∞ from supine)</li>
                        <li>Rubor when dependent (reddish-blue discoloration within 20 seconds to 2 minutes of hanging
                            legs down)</li>
                        <li>Thickened toenails, muscle atrophy</li>
                    </ul>

                    <div class="callout warning">
                        <strong>6 P's of Acute Arterial Occlusion</strong> ‚Äî vascular emergency requiring immediate
                        intervention:<br>
                        1. <strong>P</strong>ain (sudden, severe)<br>
                        2. <strong>P</strong>allor (pale, white limb)<br>
                        3. <strong>P</strong>ulselessness (absent distal pulses)<br>
                        4. <strong>P</strong>aresthesia (numbness, tingling)<br>
                        5. <strong>P</strong>aralysis (cannot move affected limb)<br>
                        6. <strong>P</strong>oikilothermia (cold limb ‚Äî cannot regulate temperature)
                    </div>

                    <p><strong>Diagnostics:</strong> ABI (ankle-brachial index) &lt;0.9 = PAD; duplex ultrasound;
                        angiography</p>

                    <p><strong>Management:</strong></p>
                    <ul>
                        <li>Smoking cessation (most important modifiable risk factor)</li>
                        <li>Exercise program (supervised walking)</li>
                        <li>Antiplatelet therapy (aspirin, clopidogrel)</li>
                        <li>Statin therapy for lipid management</li>
                        <li>Foot care: inspect daily, avoid injury, proper footwear</li>
                        <li>Position legs <strong>below heart level</strong> (do NOT elevate ‚Äî unlike venous disease)
                        </li>
                        <li>Surgical: angioplasty, stenting, bypass grafting for severe disease</li>
                    </ul>

                    <h4>Raynaud's Phenomenon</h4>
                    <p>Intermittent arterial vasoconstriction affecting fingertips and toes. 5x more common in women;
                        onset typically &lt;30 years old.</p>

                    <p><strong>Triggers:</strong> Cold exposure, stress</p>
                    <p><strong>Symptoms:</strong> Color changes (white‚Üíblue‚Üíred), numbness, tingling, burning pain</p>
                    <p><strong>Management:</strong> Avoid triggers (cold, nicotine, stress); wear gloves/hats; CCBs may
                        help</p>

                    <h3>11.3 Venous Disorders</h3>

                    <h4>Virchow's Triad (DVT Risk Factors)</h4>
                    <ol>
                        <li><strong>Endothelial damage</strong></li>
                        <li><strong>Venous stasis</strong></li>
                        <li><strong>Hypercoagulability</strong></li>
                    </ol>

                    <p><strong>DVT risk factors:</strong> Bedrest, HF, obesity, age &gt;65, surgery, trauma, cancer,
                        oral contraceptives, pregnancy, central lines, COVID-19</p>

                    <p><strong>PE symptoms:</strong> Sudden dyspnea, pleuritic chest pain, tachypnea, cough, hemoptysis
                    </p>

                    <h4>Arterial vs. Venous Ulcers</h4>
                    <table class="comparison-table">
                        <tr>
                            <th>Feature</th>
                            <th>Arterial Ulcers</th>
                            <th>Venous Ulcers</th>
                        </tr>
                        <tr>
                            <td><strong>Pain</strong></td>
                            <td>Severe, acute</td>
                            <td>Minimal to none</td>
                        </tr>
                        <tr>
                            <td><strong>Appearance</strong></td>
                            <td>Small, circular, deep; pale/black base</td>
                            <td>Large, superficial, irregular; heavy drainage</td>
                        </tr>
                        <tr>
                            <td><strong>Location</strong></td>
                            <td>Pressure points (toes, heels)</td>
                            <td>Medial malleolus</td>
                        </tr>
                        <tr>
                            <td><strong>Cause</strong></td>
                            <td>Ischemia from PAD</td>
                            <td>Venous insufficiency</td>
                        </tr>
                        <tr>
                            <td><strong>Position for relief</strong></td>
                            <td>Legs dependent (hanging down)</td>
                            <td>Legs elevated</td>
                        </tr>
                        <tr>
                            <td><strong>Treatment</strong></td>
                            <td>Revascularization; avoid compression</td>
                            <td>Compression stockings; elevation</td>
                        </tr>
                    </table>

                </section>

                <!-- SECTION 12: SHOCK -->
                <section id="shock">
                    <h2>12. Shock States <span class="slide-ref">üìë W2 Slides 97‚Äì127</span></h2>

                    <p>Shock is a life-threatening condition of inadequate tissue perfusion. Without treatment, it
                        progresses to multiple organ failure and death.</p>

                    <p><strong>The unifying concept:</strong> Shock is always a <strong>perfusion problem</strong>.
                        Something is broken in the system that delivers blood to tissues. To understand and treat shock,
                        ask one question: <strong>Is the problem the pump, the volume, or the pipes?</strong></p>

                    <!-- Shock States Comparison Wheel -->
                    <svg viewBox="0 0 660 580" style="max-width: 660px;" role="img"
                        aria-label="Shock states comparison wheel showing four types: hypovolemic, cardiogenic, distributive, and obstructive with key hemodynamic parameters and treatments">
                        <defs>
                            <marker id="shock-arrow" viewBox="0 0 10 10" refX="9" refY="5" markerWidth="6"
                                markerHeight="6" orient="auto-start-reverse">
                                <polygon points="0 0, 10 5, 0 7" fill="#1a365d" />
                            </marker>
                        </defs>

                        <text x="330" y="26" text-anchor="middle" font-size="16" font-weight="700" fill="#1a365d">Four
                            Shock States ‚Äî At a Glance</text>

                        <!-- Center circle -->
                        <circle cx="330" cy="260" r="60" fill="#1a365d" />
                        <text x="330" y="250" text-anchor="middle" font-size="14" font-weight="700"
                            fill="#fff">SHOCK</text>
                        <text x="330" y="268" text-anchor="middle" font-size="10" fill="#bee3f8">Inadequate</text>
                        <text x="330" y="280" text-anchor="middle" font-size="10" fill="#bee3f8">Tissue Perfusion</text>

                        <!-- QUADRANT 1: HYPOVOLEMIC (top-left) ‚Äî Blue -->
                        <path d="M330,260 L330,60 A200,200 0 0,0 130,260 Z" fill="#ebf8ff" stroke="#3182ce"
                            stroke-width="2.5" />
                        <!-- Icon: droplet -->
                        <path
                            d="M210,140 C210,140 195,160 195,172 C195,180 202,188 210,188 C218,188 225,180 225,172 C225,160 210,140 210,140Z"
                            fill="#3182ce" opacity="0.3" stroke="#3182ce" stroke-width="1.5" />
                        <text x="210" y="210" text-anchor="middle" font-size="14" font-weight="700"
                            fill="#2c5282">HYPOVOLEMIC</text>
                        <text x="210" y="226" text-anchor="middle" font-size="10" fill="#2c5282"
                            font-style="italic">Volume Loss</text>

                        <!-- QUADRANT 2: CARDIOGENIC (top-right) ‚Äî Red -->
                        <path d="M330,260 L530,260 A200,200 0 0,0 330,60 Z" fill="#fff5f5" stroke="#c53030"
                            stroke-width="2.5" />
                        <!-- Icon: broken heart -->
                        <path
                            d="M450,135 C440,120 420,120 420,140 C420,155 450,170 450,170 C450,170 480,155 480,140 C480,120 460,120 450,135Z"
                            fill="#c53030" opacity="0.3" stroke="#c53030" stroke-width="1.5" />
                        <line x1="440" y1="130" x2="460" y2="165" stroke="#c53030" stroke-width="1.5"
                            stroke-dasharray="3,2" />
                        <text x="450" y="210" text-anchor="middle" font-size="14" font-weight="700"
                            fill="#9b2c2c">CARDIOGENIC</text>
                        <text x="450" y="226" text-anchor="middle" font-size="10" fill="#9b2c2c"
                            font-style="italic">Pump Failure</text>

                        <!-- QUADRANT 3: DISTRIBUTIVE (bottom-right) ‚Äî Amber/Orange -->
                        <path d="M330,260 L330,460 A200,200 0 0,0 530,260 Z" fill="#fffbeb" stroke="#d97706"
                            stroke-width="2.5" />
                        <!-- Icon: diverging arrows (vasodilation) -->
                        <line x1="435" y1="310" x2="420" y2="295" stroke="#d97706" stroke-width="2"
                            marker-end="url(#shock-arrow)" />
                        <line x1="465" y1="310" x2="480" y2="295" stroke="#d97706" stroke-width="2"
                            marker-end="url(#shock-arrow)" />
                        <line x1="435" y1="310" x2="420" y2="325" stroke="#d97706" stroke-width="2"
                            marker-end="url(#shock-arrow)" />
                        <line x1="465" y1="310" x2="480" y2="325" stroke="#d97706" stroke-width="2"
                            marker-end="url(#shock-arrow)" />
                        <text x="450" y="355" text-anchor="middle" font-size="14" font-weight="700"
                            fill="#92400e">DISTRIBUTIVE</text>
                        <text x="450" y="371" text-anchor="middle" font-size="10" fill="#92400e"
                            font-style="italic">Vasodilation / Pipe Failure</text>

                        <!-- QUADRANT 4: OBSTRUCTIVE (bottom-left) ‚Äî Purple -->
                        <path d="M330,260 L130,260 A200,200 0 0,0 330,460 Z" fill="#faf5ff" stroke="#805ad5"
                            stroke-width="2.5" />
                        <!-- Icon: blocked pipe -->
                        <rect x="190" y="300" width="40" height="14" rx="7" fill="none" stroke="#805ad5"
                            stroke-width="2" />
                        <line x1="206" y1="300" x2="218" y2="314" stroke="#805ad5" stroke-width="2.5" />
                        <line x1="218" y1="300" x2="206" y2="314" stroke="#805ad5" stroke-width="2.5" />
                        <text x="210" y="355" text-anchor="middle" font-size="14" font-weight="700"
                            fill="#6b21a8">OBSTRUCTIVE</text>
                        <text x="210" y="371" text-anchor="middle" font-size="10" fill="#6b21a8"
                            font-style="italic">Mechanical Block</text>

                        <!-- Detail boxes below the wheel -->
                        <!-- Hypovolemic details -->
                        <rect x="10" y="478" width="148" height="92" rx="8" fill="#ebf8ff" stroke="#3182ce"
                            stroke-width="1.5" />
                        <text x="84" y="496" text-anchor="middle" font-size="11" font-weight="700"
                            fill="#2c5282">Hypovolemic</text>
                        <text x="84" y="512" text-anchor="middle" font-size="10" fill="#1a202c">‚Üì CO, ‚Üë SVR</text>
                        <text x="84" y="528" text-anchor="middle" font-size="10" fill="#1a202c">‚Üì Preload</text>
                        <rect x="24" y="537" width="120" height="20" rx="4" fill="#3182ce" opacity="0.15" />
                        <text x="84" y="551" text-anchor="middle" font-size="10" fill="#2c5282" font-weight="600">Tx:
                            Fluids / Blood</text>

                        <!-- Cardiogenic details -->
                        <rect x="172" y="478" width="148" height="92" rx="8" fill="#fff5f5" stroke="#c53030"
                            stroke-width="1.5" />
                        <text x="246" y="496" text-anchor="middle" font-size="11" font-weight="700"
                            fill="#9b2c2c">Cardiogenic</text>
                        <text x="246" y="512" text-anchor="middle" font-size="10" fill="#1a202c">‚Üì CO, ‚Üë SVR</text>
                        <text x="246" y="528" text-anchor="middle" font-size="10" fill="#1a202c">‚Üë Preload
                            (backup)</text>
                        <rect x="186" y="537" width="120" height="20" rx="4" fill="#c53030" opacity="0.12" />
                        <text x="246" y="551" text-anchor="middle" font-size="10" fill="#9b2c2c" font-weight="600">Tx:
                            Inotropes</text>

                        <!-- Distributive details -->
                        <rect x="334" y="478" width="148" height="92" rx="8" fill="#fffbeb" stroke="#d97706"
                            stroke-width="1.5" />
                        <text x="408" y="496" text-anchor="middle" font-size="11" font-weight="700"
                            fill="#92400e">Distributive</text>
                        <text x="408" y="512" text-anchor="middle" font-size="10" fill="#1a202c">‚Üì CO (variable), ‚Üì
                            SVR</text>
                        <text x="408" y="528" text-anchor="middle" font-size="10" fill="#1a202c">Vasodilation</text>
                        <rect x="348" y="537" width="120" height="20" rx="4" fill="#d97706" opacity="0.12" />
                        <text x="408" y="551" text-anchor="middle" font-size="10" fill="#92400e" font-weight="600">Tx:
                            Vasopressors</text>

                        <!-- Obstructive details -->
                        <rect x="496" y="478" width="154" height="92" rx="8" fill="#faf5ff" stroke="#805ad5"
                            stroke-width="1.5" />
                        <text x="573" y="496" text-anchor="middle" font-size="11" font-weight="700"
                            fill="#6b21a8">Obstructive</text>
                        <text x="573" y="512" text-anchor="middle" font-size="10" fill="#1a202c">‚Üì CO, ‚Üë SVR</text>
                        <text x="573" y="528" text-anchor="middle" font-size="10" fill="#1a202c">Mechanical cause</text>
                        <rect x="510" y="537" width="126" height="20" rx="4" fill="#805ad5" opacity="0.12" />
                        <text x="573" y="551" text-anchor="middle" font-size="10" fill="#6b21a8" font-weight="600">Tx:
                            Remove obstruction</text>
                    </svg>

                    <h3>12.1 Pump, Volume, Pipes: The Shock Framework</h3>

                    <!-- Pump Volume Pipes Visual -->
                    <svg viewBox="0 0 720 380" style="max-width: 720px;">
                        <text x="360" y="22" font-size="14" fill="#1a365d" text-anchor="middle" font-weight="bold">Shock
                            = Perfusion Failure ‚Äî What's Broken?</text>

                        <!-- PUMP (Cardiogenic) -->
                        <rect x="20" y="40" width="160" height="200" rx="10" fill="#faf5ff" stroke="#805ad5"
                            stroke-width="3" />
                        <text x="100" y="65" font-size="13" fill="#805ad5" text-anchor="middle"
                            font-weight="bold">PUMP</text>
                        <text x="100" y="82" font-size="10" fill="#805ad5" text-anchor="middle">Cardiogenic</text>
                        <line x1="30" y1="90" x2="170" y2="90" stroke="#805ad5" stroke-width="1" />
                        <g font-size="9" fill="#1a202c">
                            <text x="30" y="108">Heart can't contract</text>
                            <text x="30" y="125" font-weight="bold">Hemodynamics:</text>
                            <text x="30" y="140">CO: LOW</text>
                            <text x="30" y="155">Preload: HIGH (backs up)</text>
                            <text x="30" y="170">SVR: HIGH (compensating)</text>
                            <text x="30" y="190" font-weight="bold" fill="#805ad5">Treatment:</text>
                            <text x="30" y="205">Inotropes, IABP, revascularize</text>
                            <text x="30" y="220">Do NOT give fluids</text>
                            <text x="30" y="232" fill="#c53030" font-weight="bold">Avoid volume loading!</text>
                        </g>

                        <!-- VOLUME (Hypovolemic) -->
                        <rect x="200" y="40" width="160" height="200" rx="10" fill="#fed7d7" stroke="#c53030"
                            stroke-width="3" />
                        <text x="280" y="65" font-size="13" fill="#c53030" text-anchor="middle"
                            font-weight="bold">VOLUME</text>
                        <text x="280" y="82" font-size="10" fill="#c53030" text-anchor="middle">Hypovolemic</text>
                        <line x1="210" y1="90" x2="350" y2="90" stroke="#c53030" stroke-width="1" />
                        <g font-size="9" fill="#1a202c">
                            <text x="210" y="108">Tank is empty</text>
                            <text x="210" y="125" font-weight="bold">Hemodynamics:</text>
                            <text x="210" y="140">CO: LOW</text>
                            <text x="210" y="155">Preload: LOW (nothing to fill)</text>
                            <text x="210" y="170">SVR: HIGH (compensating)</text>
                            <text x="210" y="190" font-weight="bold" fill="#c53030">Treatment:</text>
                            <text x="210" y="205">VOLUME ‚Äî crystalloids (LR),</text>
                            <text x="210" y="220">blood products if hemorrhage</text>
                            <text x="210" y="232" fill="#c53030" font-weight="bold">Replace what's lost</text>
                        </g>

                        <!-- PIPES (Distributive) -->
                        <rect x="380" y="40" width="160" height="200" rx="10" fill="#feebc8" stroke="#dd6b20"
                            stroke-width="3" />
                        <text x="460" y="65" font-size="13" fill="#dd6b20" text-anchor="middle"
                            font-weight="bold">PIPES</text>
                        <text x="460" y="82" font-size="10" fill="#dd6b20" text-anchor="middle">Distributive</text>
                        <line x1="390" y1="90" x2="530" y2="90" stroke="#dd6b20" stroke-width="1" />
                        <g font-size="9" fill="#1a202c">
                            <text x="390" y="108">Pipes are too wide open</text>
                            <text x="390" y="125" font-weight="bold">Hemodynamics:</text>
                            <text x="390" y="140">CO: HIGH (early) or LOW (late)</text>
                            <text x="390" y="155">Preload: LOW (relative)</text>
                            <text x="390" y="170">SVR: LOW (vasodilation)</text>
                            <text x="390" y="190" font-weight="bold" fill="#dd6b20">Treatment:</text>
                            <text x="390" y="205">Fluids first, then vasopressors</text>
                            <text x="390" y="220">(norepinephrine = first-line)</text>
                            <text x="390" y="232" fill="#c53030" font-weight="bold">Tighten the pipes</text>
                        </g>

                        <!-- OBSTRUCTION -->
                        <rect x="560" y="40" width="140" height="200" rx="10" fill="#e2e8f0" stroke="#4a5568"
                            stroke-width="3" />
                        <text x="630" y="65" font-size="13" fill="#4a5568" text-anchor="middle"
                            font-weight="bold">BLOCKED</text>
                        <text x="630" y="82" font-size="10" fill="#4a5568" text-anchor="middle">Obstructive</text>
                        <line x1="570" y1="90" x2="690" y2="90" stroke="#4a5568" stroke-width="1" />
                        <g font-size="9" fill="#1a202c">
                            <text x="570" y="108">Something blocking flow</text>
                            <text x="570" y="125" font-weight="bold">Hemodynamics:</text>
                            <text x="570" y="140">CO: LOW</text>
                            <text x="570" y="155">Preload: varies by cause</text>
                            <text x="570" y="170">SVR: HIGH (compensating)</text>
                            <text x="570" y="190" font-weight="bold" fill="#4a5568">Treatment:</text>
                            <text x="570" y="205">Remove the obstruction</text>
                            <text x="570" y="220">PE: anticoagulate</text>
                            <text x="570" y="232" fill="#c53030" font-weight="bold">Fix the blockage</text>
                        </g>

                        <!-- Bottom: connecting formula -->
                        <rect x="120" y="260" width="480" height="50" rx="8" fill="#1a365d" />
                        <text x="360" y="282" font-size="12" fill="white" text-anchor="middle" font-weight="bold">CO =
                            HR x SV &nbsp;&nbsp;|&nbsp;&nbsp; BP = CO x SVR</text>
                        <text x="360" y="300" font-size="10" fill="#ebf8ff" text-anchor="middle">All shock types
                            ultimately reduce CO or BP ‚Äî the question is WHERE in the equation</text>

                        <!-- Subtypes under distributive -->
                        <g font-size="9" fill="#1a202c">
                            <rect x="380" y="320" width="160" height="55" rx="5" fill="#fff5f5" stroke="#dd6b20"
                                stroke-width="1" />
                            <text x="390" y="337" font-weight="bold" fill="#dd6b20">Subtypes:</text>
                            <text x="390" y="352">Septic (most common)</text>
                            <text x="390" y="367">Anaphylactic | Neurogenic</text>
                        </g>

                        <!-- Subtypes under obstructive -->
                        <g font-size="9" fill="#1a202c">
                            <rect x="560" y="320" width="140" height="55" rx="5" fill="#f7fafc" stroke="#4a5568"
                                stroke-width="1" />
                            <text x="570" y="337" font-weight="bold" fill="#4a5568">Causes:</text>
                            <text x="570" y="352">PE, tension pneumo,</text>
                            <text x="570" y="367">cardiac tamponade</text>
                        </g>
                    </svg>

                    <div class="callout pearl">
                        <strong>The treatment follows the broken piece.</strong> Pump broken? Strengthen it (inotropes).
                        Tank empty? Fill it (fluids/blood). Pipes too wide? Tighten them (vasopressors). Something
                        blocking? Remove it. If you can identify what's broken, you know the treatment direction ‚Äî even
                        before you remember specific drugs.
                    </div>

                    <h4>Shock Types ‚Äî Detailed Comparison</h4>

                    <table>
                        <tr>
                            <th>Type</th>
                            <th>What's Broken</th>
                            <th>Causes</th>
                            <th>CO</th>
                            <th>Preload</th>
                            <th>SVR</th>
                            <th>Treatment Direction</th>
                        </tr>
                        <tr>
                            <td><strong>Hypovolemic</strong></td>
                            <td>Volume (tank empty)</td>
                            <td>Hemorrhage, dehydration, burns, third-spacing</td>
                            <td>&darr;</td>
                            <td>&darr;</td>
                            <td>&uarr;</td>
                            <td>Replace volume: crystalloids (LR), blood if hemorrhage</td>
                        </tr>
                        <tr>
                            <td><strong>Cardiogenic</strong></td>
                            <td>Pump (heart failing)</td>
                            <td>MI, cardiomyopathy, arrhythmias</td>
                            <td>&darr;</td>
                            <td>&uarr;</td>
                            <td>&uarr;</td>
                            <td>Support pump: inotropes, IABP; avoid excess fluid</td>
                        </tr>
                        <tr>
                            <td><strong>Distributive ‚Äî Septic</strong></td>
                            <td>Pipes (vasodilation)</td>
                            <td>Infection &rarr; systemic inflammatory response</td>
                            <td>&uarr; early / &darr; late</td>
                            <td>&darr;</td>
                            <td>&darr;</td>
                            <td>Antibiotics + fluids (30 mL/kg) + vasopressors (norepinephrine)</td>
                        </tr>
                        <tr>
                            <td><strong>Distributive ‚Äî Anaphylactic</strong></td>
                            <td>Pipes (massive vasodilation + capillary leak)</td>
                            <td>Allergen exposure (drugs, food, insect stings)</td>
                            <td>&darr;</td>
                            <td>&darr;</td>
                            <td>&darr;</td>
                            <td><strong>Epinephrine IM</strong> (0.3-0.5 mg) ‚Äî FIRST action; then fluids,
                                antihistamines, steroids</td>
                        </tr>
                        <tr>
                            <td><strong>Distributive ‚Äî Neurogenic</strong></td>
                            <td>Pipes (loss of vasomotor tone)</td>
                            <td>Spinal cord injury above T6</td>
                            <td>&darr;</td>
                            <td>&darr;</td>
                            <td>&darr;</td>
                            <td>Fluids + vasopressors; <strong>bradycardia</strong> (not tachycardia ‚Äî lost SNS tone)
                            </td>
                        </tr>
                        <tr>
                            <td><strong>Obstructive</strong></td>
                            <td>Blockage (mechanical)</td>
                            <td>PE, tension pneumothorax, cardiac tamponade</td>
                            <td>&darr;</td>
                            <td>Varies</td>
                            <td>&uarr;</td>
                            <td>Remove obstruction: anticoagulate, needle decompress, pericardiocentesis</td>
                        </tr>
                    </table>

                    <div class="callout warning">
                        <strong>Neurogenic shock is the outlier:</strong> Every other shock type presents with
                        tachycardia (compensatory SNS response). Neurogenic shock presents with <strong>bradycardia and
                            warm, dry skin</strong> because the SNS itself is knocked out by the spinal cord injury. If
                        you see "shock + bradycardia + warm skin" ‚Üí think neurogenic.
                    </div>

                    <h3>12.2 Stages of Shock <span class="slide-ref">üìë W2 Slides 99‚Äì105</span></h3>

                    <!-- Shock Stages Flowchart -->
                    <svg viewBox="0 0 700 220" style="max-width: 700px;">
                        <!-- Stage 1: Compensatory -->
                        <rect x="20" y="40" width="200" height="140" rx="10" fill="#d4edda" stroke="#38a169"
                            stroke-width="3" />
                        <text x="120" y="65" font-size="13" fill="#38a169" text-anchor="middle"
                            font-weight="bold">COMPENSATORY</text>
                        <text x="120" y="82" font-size="9" fill="#38a169" text-anchor="middle">(Best prognosis!)</text>
                        <line x1="30" y1="90" x2="210" y2="90" stroke="#38a169" stroke-width="1" />
                        <g font-size="9" fill="#1a202c">
                            <text x="30" y="105">‚Ä¢ SNS activation</text>
                            <text x="30" y="120">‚Ä¢ ‚ÜëHR, vasoconstriction</text>
                            <text x="30" y="135">‚Ä¢ BP still NORMAL</text>
                            <text x="30" y="150">‚Ä¢ Cool, clammy skin</text>
                            <text x="30" y="165">‚Ä¢ ‚ÜìUrine output</text>
                            <text x="30" y="180">‚Ä¢ Mild anxiety</text>
                        </g>

                        <!-- Arrow 1 -->
                        <path d="M225,110 L255,110" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)" />
                        <text x="240" y="130" font-size="8" fill="#666" text-anchor="middle">untreated</text>

                        <!-- Stage 2: Progressive -->
                        <rect x="260" y="40" width="200" height="140" rx="10" fill="#fff3cd" stroke="#dd6b20"
                            stroke-width="3" />
                        <text x="360" y="65" font-size="13" fill="#dd6b20" text-anchor="middle"
                            font-weight="bold">PROGRESSIVE</text>
                        <text x="360" y="82" font-size="9" fill="#dd6b20" text-anchor="middle">(Decompensation
                            begins)</text>
                        <line x1="270" y1="90" x2="450" y2="90" stroke="#dd6b20" stroke-width="1" />
                        <g font-size="9" fill="#1a202c">
                            <text x="270" y="105">‚Ä¢ Compensation FAILING</text>
                            <text x="270" y="120">‚Ä¢ SBP &lt;100 or ‚Üì40 baseline</text>
                            <text x="270" y="135">‚Ä¢ All organs hypoperfused</text>
                            <text x="270" y="150">‚Ä¢ Mental status ‚Üì‚Üì</text>
                            <text x="270" y="165">‚Ä¢ Worsening acidosis</text>
                            <text x="270" y="180">‚Ä¢ Organ damage starting</text>
                        </g>

                        <!-- Arrow 2 -->
                        <path d="M465,110 L495,110" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)" />
                        <text x="480" y="130" font-size="8" fill="#666" text-anchor="middle">untreated</text>

                        <!-- Stage 3: Irreversible -->
                        <rect x="500" y="40" width="180" height="140" rx="10" fill="#f8d7da" stroke="#c53030"
                            stroke-width="3" />
                        <text x="590" y="65" font-size="13" fill="#c53030" text-anchor="middle"
                            font-weight="bold">IRREVERSIBLE</text>
                        <text x="590" y="82" font-size="9" fill="#c53030" text-anchor="middle">(Cannot survive)</text>
                        <line x1="510" y1="90" x2="670" y2="90" stroke="#c53030" stroke-width="1" />
                        <g font-size="9" fill="#1a202c">
                            <text x="510" y="105">‚Ä¢ Multiple organ failure</text>
                            <text x="510" y="120">‚Ä¢ ARDS, AKI</text>
                            <text x="510" y="135">‚Ä¢ Hepatic failure</text>
                            <text x="510" y="150">‚Ä¢ DIC</text>
                            <text x="510" y="165">‚Ä¢ Determined only</text>
                            <text x="510" y="180"> in retrospect</text>
                        </g>

                        <!-- Title and MAP goal -->
                        <text x="350" y="20" font-size="14" fill="#1a365d" text-anchor="middle"
                            font-weight="bold">Stages of Shock Progression</text>
                        <rect x="250" y="195" width="200" height="25" rx="5" fill="#1a365d" />
                        <text x="350" y="213" font-size="11" fill="white" text-anchor="middle" font-weight="bold">Goal
                            MAP ‚â•65 mmHg</text>
                    </svg>

                    <table>
                        <tr>
                            <th>Stage</th>
                            <th>Pathophysiology</th>
                            <th>Clinical Signs</th>
                        </tr>
                        <tr>
                            <td><strong>Compensatory</strong><br><span style="color: green;">(BEST PROGNOSIS IF TREATED
                                    HERE)</span></td>
                            <td>SNS activation maintains BP and CO through vasoconstriction, ‚ÜëHR, ‚Üëcontractility</td>
                            <td>
                                ‚Ä¢ Tachycardia<br>
                                ‚Ä¢ Cool, clammy skin<br>
                                ‚Ä¢ ‚ÜìUrine output<br>
                                ‚Ä¢ Hypoactive bowel sounds<br>
                                ‚Ä¢ Mild anxiety/confusion<br>
                                ‚Ä¢ BP still normal (compensated)
                            </td>
                        </tr>
                        <tr>
                            <td><strong>Progressive</strong></td>
                            <td>Compensatory mechanisms failing; MAP cannot maintain tissue perfusion</td>
                            <td>
                                ‚Ä¢ SBP &lt;100 or ‚Üì40 from baseline<br>
                                ‚Ä¢ All organs hypoperfused<br>
                                ‚Ä¢ Mental status deterioration<br>
                                ‚Ä¢ Worsening acidosis
                            </td>
                        </tr>
                        <tr>
                            <td><strong>Irreversible</strong></td>
                            <td>Organ damage so severe patient cannot survive</td>
                            <td>
                                ‚Ä¢ Multiple organ failure<br>
                                ‚Ä¢ ARDS, AKI, hepatic failure<br>
                                ‚Ä¢ Determined only in retrospect
                            </td>
                        </tr>
                    </table>

                    <div class="callout warning">
                        <strong>Goal MAP:</strong> ‚â•65 mmHg<br>
                        <strong>Formula:</strong> MAP = (SBP + 2√óDBP) √∑ 3
                    </div>

                    <h3>12.3 Shock Management</h3>

                    <p><strong>General principles:</strong></p>
                    <ul>
                        <li>Early identification and treatment</li>
                        <li>Identify and treat underlying cause</li>
                        <li>Optimize oxygenation</li>
                        <li>Fluid resuscitation (crystalloids: LR preferred over NS)</li>
                        <li>Vasoactive medications</li>
                        <li>Nutritional support</li>
                    </ul>

                    <p><strong>Fluid resuscitation:</strong> 30 mL/kg crystalloid bolus for septic shock; monitor for
                        fluid overload</p>

                    <p><strong>Vasoactive medications:</strong></p>
                    <ul>
                        <li><strong>Norepinephrine:</strong> First-line vasopressor for septic shock</li>
                        <li>Give through central line when possible (tissue necrosis with infiltration)</li>
                        <li>Titrate to MAP ‚â•65 mmHg</li>
                    </ul>

                    <h3>12.4 Anaphylactic Shock</h3>

                    <p>A severe, life-threatening Type I (IgE-mediated) hypersensitivity reaction causing massive
                        vasodilation and increased capillary permeability. <strong>Onset within minutes</strong> of
                        allergen exposure.</p>

                    <p><strong>Common triggers:</strong> Medications (antibiotics, NSAIDs), foods (nuts, shellfish),
                        insect stings/bites, latex, contrast dye</p>

                    <p><strong>Pathophysiology:</strong> Allergen triggers massive histamine and leukotriene release ‚Üí
                        widespread vasodilation (pipes wide open) + capillary leak (fluid escapes vessels) +
                        bronchospasm (airway narrows)</p>

                    <p><strong>Signs and symptoms:</strong></p>
                    <ul>
                        <li><strong>Skin:</strong> Urticaria (hives), angioedema (facial/lip/tongue swelling), flushing,
                            pruritus</li>
                        <li><strong>Respiratory:</strong> Stridor, wheezing, dyspnea, laryngeal edema ‚Üí airway
                            obstruction</li>
                        <li><strong>Cardiovascular:</strong> Hypotension, tachycardia, weak pulse, shock</li>
                        <li><strong>GI:</strong> Nausea, vomiting, abdominal cramping, diarrhea</li>
                    </ul>

                    <div class="callout warning">
                        <strong>Anaphylaxis Treatment Priority:</strong><br>
                        1. <strong>EPINEPHRINE IM 0.3-0.5 mg</strong> (anterolateral thigh) ‚Äî FIRST and MOST IMPORTANT
                        action<br>
                        2. Call for help / activate rapid response<br>
                        3. Position supine with legs elevated (unless respiratory distress)<br>
                        4. High-flow oxygen; prepare for intubation if airway compromise<br>
                        5. IV access, IV fluids (1-2 L NS bolus)<br>
                        6. Diphenhydramine (Benadryl) IV ‚Äî H1 blocker<br>
                        7. Famotidine IV ‚Äî H2 blocker<br>
                        8. Methylprednisolone IV ‚Äî prevents biphasic reaction<br>
                        9. Albuterol nebulizer for bronchospasm<br><br>
                        <strong>May repeat epinephrine every 5-15 minutes if no improvement.</strong>
                    </div>

                    <div class="callout pearl">
                        Epinephrine reverses ALL three pathologic processes simultaneously: vasoconstriction (counters
                        vasodilation), bronchodilation (opens airways), and decreased capillary permeability (stops
                        fluid leak). No other single drug does all three ‚Äî that's why it's always first.
                    </div>

                    <h3>12.5 Neurogenic Shock</h3>

                    <p>Results from loss of sympathetic nervous system tone, typically from <strong>spinal cord injury
                            above T6</strong>. Can also follow spinal anesthesia or severe brain injury.</p>

                    <p><strong>Pathophysiology:</strong> Loss of SNS input to blood vessels ‚Üí unopposed parasympathetic
                        tone ‚Üí massive vasodilation + bradycardia. Unlike all other shock types, the SNS cannot
                        compensate because it IS the damaged system.</p>

                    <div class="callout warning">
                        <strong>Neurogenic shock is the OUTLIER ‚Äî know the unique presentation:</strong>
                        <table style="margin: 0.5rem 0;">
                            <tr>
                                <th>Feature</th>
                                <th>All Other Shock Types</th>
                                <th>Neurogenic Shock</th>
                            </tr>
                            <tr>
                                <td>Heart rate</td>
                                <td>Tachycardia (compensatory)</td>
                                <td><strong>BRADYCARDIA</strong></td>
                            </tr>
                            <tr>
                                <td>Skin</td>
                                <td>Cool, clammy, pale</td>
                                <td><strong>Warm, dry, flushed</strong> (below injury)</td>
                            </tr>
                            <tr>
                                <td>Mechanism</td>
                                <td>SNS activated as compensation</td>
                                <td><strong>SNS is knocked out</strong></td>
                            </tr>
                        </table>
                        <strong>Exam trap:</strong> "Shock + bradycardia + warm skin" ‚Üí neurogenic. Every other shock
                        type has tachycardia.
                    </div>

                    <p><strong>Treatment:</strong></p>
                    <ul>
                        <li><strong>IV fluids</strong> (cautious ‚Äî won't address root cause)</li>
                        <li><strong>Vasopressors</strong> (norepinephrine, phenylephrine) to restore vascular tone</li>
                        <li><strong>Atropine</strong> for symptomatic bradycardia</li>
                        <li>Maintain spinal immobilization</li>
                        <li>Monitor for hypothermia (loss of thermoregulation below injury)</li>
                        <li>Watch for autonomic dysreflexia in chronic phase</li>
                    </ul>

                    <h3>12.6 Sepsis <span class="slide-ref">üìë W2 Slides 108‚Äì115</span></h3>

                    <!-- Sepsis Progression Diagram -->
                    <svg viewBox="0 0 700 180" style="max-width: 700px;">
                        <!-- SIRS -->
                        <rect x="20" y="40" width="140" height="100" rx="10" fill="#fff3cd" stroke="#dd6b20"
                            stroke-width="2" />
                        <text x="90" y="65" font-size="12" fill="#dd6b20" text-anchor="middle"
                            font-weight="bold">SIRS</text>
                        <text x="90" y="80" font-size="8" fill="#666" text-anchor="middle">(2+ criteria)</text>
                        <g font-size="8" fill="#1a202c">
                            <text x="30" y="98">‚Ä¢ Temp &gt;38¬∞ or &lt;36¬∞C</text>
                            <text x="30" y="111">‚Ä¢ HR &gt;90</text>
                            <text x="30" y="124">‚Ä¢ RR &gt;20</text>
                            <text x="30" y="137">‚Ä¢ WBC abnormal</text>
                        </g>

                        <!-- Arrow + Infection -->
                        <path d="M165,90 L195,90" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)" />
                        <text x="180" y="80" font-size="8" fill="#c53030" text-anchor="middle">+ infection</text>

                        <!-- Sepsis -->
                        <rect x="200" y="40" width="140" height="100" rx="10" fill="#feebc8" stroke="#dd6b20"
                            stroke-width="3" />
                        <text x="270" y="65" font-size="12" fill="#dd6b20" text-anchor="middle"
                            font-weight="bold">SEPSIS</text>
                        <text x="270" y="85" font-size="9" fill="#1a202c" text-anchor="middle">SIRS + suspected</text>
                        <text x="270" y="100" font-size="9" fill="#1a202c" text-anchor="middle">or confirmed</text>
                        <text x="270" y="115" font-size="9" fill="#1a202c" text-anchor="middle">INFECTION</text>

                        <!-- Arrow + organ dysfunction -->
                        <path d="M345,90 L375,90" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)" />
                        <text x="360" y="80" font-size="8" fill="#c53030" text-anchor="middle">+ organ</text>
                        <text x="360" y="108" font-size="8" fill="#c53030" text-anchor="middle">dysfunction</text>

                        <!-- Severe Sepsis -->
                        <rect x="380" y="40" width="140" height="100" rx="10" fill="#fed7d7" stroke="#c53030"
                            stroke-width="3" />
                        <text x="450" y="60" font-size="11" fill="#c53030" text-anchor="middle"
                            font-weight="bold">SEVERE</text>
                        <text x="450" y="75" font-size="11" fill="#c53030" text-anchor="middle"
                            font-weight="bold">SEPSIS</text>
                        <g font-size="8" fill="#1a202c">
                            <text x="390" y="95">‚Ä¢ Lactate ‚â•4</text>
                            <text x="390" y="108">‚Ä¢ AKI, ‚ÜìLOC</text>
                            <text x="390" y="121">‚Ä¢ Coagulopathy</text>
                            <text x="390" y="134">‚Ä¢ Hepatic dysfunction</text>
                        </g>

                        <!-- Arrow + hypotension -->
                        <path d="M525,90 L555,90" stroke="#666" stroke-width="2" marker-end="url(#arrowhead)" />
                        <text x="540" y="80" font-size="8" fill="#c53030" text-anchor="middle">+ refractory</text>
                        <text x="540" y="108" font-size="8" fill="#c53030" text-anchor="middle">hypotension</text>

                        <!-- Septic Shock -->
                        <rect x="560" y="40" width="130" height="100" rx="10" fill="#c53030" stroke="#742a2a"
                            stroke-width="3" />
                        <text x="625" y="60" font-size="11" fill="white" text-anchor="middle"
                            font-weight="bold">SEPTIC</text>
                        <text x="625" y="75" font-size="11" fill="white" text-anchor="middle"
                            font-weight="bold">SHOCK</text>
                        <g font-size="8" fill="white">
                            <text x="570" y="95">‚Ä¢ Hypotension despite</text>
                            <text x="570" y="108"> fluid resuscitation</text>
                            <text x="570" y="125">‚Ä¢ Needs vasopressors</text>
                            <text x="570" y="138">‚Ä¢ HIGH mortality</text>
                        </g>

                        <!-- Title -->
                        <text x="350" y="20" font-size="14" fill="#1a365d" text-anchor="middle"
                            font-weight="bold">Sepsis Progression - Every Hour of Delay Increases Mortality</text>
                        <text x="350" y="165" font-size="10" fill="#c53030" text-anchor="middle"
                            font-weight="bold">HOUR-1 BUNDLE: Lactate ‚Üí Blood cultures ‚Üí Antibiotics ‚Üí Fluids ‚Üí
                            Vasopressors</text>
                    </svg>

                    <p><strong>SIRS criteria (2 or more):</strong></p>
                    <ul>
                        <li>Temperature &gt;38¬∞C (100.4¬∞F) or &lt;36¬∞C (96.8¬∞F)</li>
                        <li>Heart rate &gt;90 bpm</li>
                        <li>Respiratory rate &gt;20 or PaCO2 &lt;32 mmHg</li>
                        <li>WBC &gt;12,000 or &lt;4,000 or &gt;10% bands (left shift)</li>
                    </ul>

                    <p><strong>Progression:</strong> SIRS ‚Üí Sepsis (SIRS + infection) ‚Üí Severe Sepsis (organ
                        dysfunction) ‚Üí Septic Shock (hypotension despite fluids)</p>

                    <div class="callout warning">
                        <strong>Sepsis Hour-1 Bundle:</strong><br>
                        1. Measure lactate (repeat if &gt;2 mmol/L)<br>
                        2. Obtain blood cultures BEFORE antibiotics<br>
                        3. Administer broad-spectrum antibiotics<br>
                        4. Begin 30 mL/kg crystalloid for hypotension or lactate ‚â•4<br>
                        5. Start vasopressors if hypotensive during/after fluids<br><br>
                        <strong>Every hour of delay in antibiotics increases mortality.</strong>
                    </div>

                    <h3>12.7 DIC (Disseminated Intravascular Coagulopathy)</h3>

                    <p>Paradoxical condition of simultaneous clotting AND bleeding due to consumption of clotting
                        factors.</p>

                    <p><strong>Always secondary to:</strong> Shock, sepsis, massive transfusion, trauma, burns,
                        malignancy</p>

                    <p><strong>First indication:</strong> Petechiae (platelet dysfunction)</p>

                    <p><strong>Labs:</strong></p>
                    <ul>
                        <li>‚ÜìPlatelets (&lt;100,000)</li>
                        <li>‚ÜìFibrinogen (&lt;200)</li>
                        <li>‚ÜëPT (&gt;15), ‚ÜëPTT (&gt;60-90)</li>
                        <li>‚ÜëD-Dimer, ‚ÜëFDP</li>
                    </ul>

                    <p><strong>Management:</strong> Treat underlying cause; blood products; heparin may be used to stop
                        micro-clotting</p>

                    <h3>12.8 Gerontologic Considerations in Shock</h3>
                    <ul>
                        <li>May NOT mount febrile response (infection without fever)</li>
                        <li>Beta-blockers may mask tachycardia (hiding compensatory response)</li>
                        <li>Mental status changes may be misinterpreted as dementia</li>
                        <li>Reduced respiratory reserve ‚Üí rapid decompensation</li>
                        <li><strong>Sudden mental status change ‚Üí assess for infection/delirium</strong></li>
                    </ul>

                </section>

                <!-- DIAGNOSTIC STUDIES REFERENCE -->
                <section id="diagnostics">
                    <h2>Reference: Diagnostic Studies</h2>

                    <h3>Cardiac Biomarkers</h3>
                    <table>
                        <tr>
                            <th>Marker</th>
                            <th>Rises</th>
                            <th>Peaks</th>
                            <th>Clinical Use</th>
                        </tr>
                        <tr>
                            <td><strong>Troponin</strong></td>
                            <td>3 hours</td>
                            <td>12-24 hours; elevated up to 2 weeks</td>
                            <td>Gold standard for MI; highly sensitive</td>
                        </tr>
                        <tr>
                            <td><strong>CK-MB</strong></td>
                            <td>3-6 hours</td>
                            <td>24 hours</td>
                            <td>Cardiac-specific enzyme</td>
                        </tr>
                        <tr>
                            <td><strong>Myoglobin</strong></td>
                            <td>1-3 hours</td>
                            <td>12 hours</td>
                            <td>Rules OUT MI (not diagnostic for MI)</td>
                        </tr>
                        <tr>
                            <td><strong>BNP</strong></td>
                            <td>N/A</td>
                            <td>N/A</td>
                            <td>&gt;100 pg/mL indicates HF</td>
                        </tr>
                        <tr>
                            <td><strong>CRP</strong></td>
                            <td>N/A</td>
                            <td>N/A</td>
                            <td>Inflammatory marker; indicates CVD risk</td>
                        </tr>
                    </table>

                    <h3>Coagulation Studies</h3>
                    <table>
                        <tr>
                            <th>Test</th>
                            <th>Monitors</th>
                            <th>Normal</th>
                            <th>Therapeutic Goal</th>
                        </tr>
                        <tr>
                            <td><strong>aPTT</strong></td>
                            <td>Unfractionated heparin (intrinsic pathway)</td>
                            <td>21-35 seconds</td>
                            <td>1.5-2.5√ó baseline</td>
                        </tr>
                        <tr>
                            <td><strong>PT</strong></td>
                            <td>Warfarin (extrinsic pathway)</td>
                            <td>11-13 seconds</td>
                            <td>Varies</td>
                        </tr>
                        <tr>
                            <td><strong>INR</strong></td>
                            <td>Warfarin (standardized)</td>
                            <td>0.8-1.2</td>
                            <td>2.0-3.5 (varies by indication)</td>
                        </tr>
                        <tr>
                            <td><strong>Anti-Xa</strong></td>
                            <td>Low-molecular-weight heparin (enoxaparin)</td>
                            <td>Varies by lab</td>
                            <td>0.5-1.0 IU/mL (per protocol)</td>
                        </tr>
                    </table>

                    <div class="callout warning">
                        <strong>Anticoagulant Reversal Agents:</strong><br>
                        ‚Ä¢ <strong>Heparin</strong> ‚Üí <strong>Protamine sulfate</strong><br>
                        ‚Ä¢ <strong>Warfarin (Coumadin)</strong> ‚Üí <strong>Vitamin K (phytonadione)</strong>; for acute
                        bleeding: fresh frozen plasma or PCC<br>
                        ‚Ä¢ <strong>DOACs</strong> (dabigatran) ‚Üí <strong>Idarucizumab (Praxbind)</strong>;
                        (rivaroxaban/apixaban) ‚Üí <strong>Andexanet alfa (Andexxa)</strong>
                    </div>

                    <div class="callout pearl">
                        <strong>aPTT Dose Adjustment Guide:</strong> When titrating heparin drip:<br>
                        ‚Ä¢ aPTT <strong>&lt;50 seconds</strong> ‚Üí <strong>increase</strong> heparin dose<br>
                        ‚Ä¢ aPTT <strong>&gt;100 seconds</strong> ‚Üí <strong>decrease</strong> heparin dose (or hold)<br>
                        ‚Ä¢ Goal: maintain aPTT at 1.5-2.5√ó baseline
                    </div>

                    <h4>Direct Oral Anticoagulants (DOACs)</h4>
                    <p>DOACs do <strong>NOT require routine daily lab monitoring</strong> ‚Äî a major advantage over
                        warfarin. They have fewer drug-food interactions and more predictable pharmacokinetics.</p>

                    <table>
                        <tr>
                            <th>DOAC</th>
                            <th>Brand Name</th>
                            <th>Target</th>
                            <th>Key Points</th>
                        </tr>
                        <tr>
                            <td><strong>Dabigatran</strong></td>
                            <td>Pradaxa</td>
                            <td>Direct thrombin inhibitor</td>
                            <td>Reversal: idarucizumab (Praxbind); store in original bottle (moisture-sensitive)</td>
                        </tr>
                        <tr>
                            <td><strong>Rivaroxaban</strong></td>
                            <td>Xarelto</td>
                            <td>Factor Xa inhibitor</td>
                            <td>Take with evening meal (improves absorption); once daily</td>
                        </tr>
                        <tr>
                            <td><strong>Apixaban</strong></td>
                            <td>Eliquis</td>
                            <td>Factor Xa inhibitor</td>
                            <td>Twice daily; preferred in elderly/renal impairment; lower bleeding risk</td>
                        </tr>
                    </table>

                    <h3>Hemodynamic Monitoring <span class="slide-ref">üìë W1 Slides 29‚Äì31</span></h3>

                    <p>Hemodynamic monitoring provides continuous, real-time data about cardiovascular function. The
                        nurse sets up, maintains, and troubleshoots these systems.</p>

                    <h4>System Setup</h4>
                    <ul>
                        <li><strong>Pressure bag</strong> with NS (500 mL or 1000 mL) maintained at <span
                                class="key-value">300 mmHg</span></li>
                        <li>Continuous flush at <strong>3-5 mL/hr</strong> to maintain line patency</li>
                        <li>Tubing, stopcocks, flush system, transducer</li>
                        <li>Keep transducer at the <strong>phlebostatic axis</strong> (4th intercostal space,
                            mid-axillary line)</li>
                        <li><strong>Zero the line</strong> to atmospheric pressure before use and with position changes
                        </li>
                        <li>Keep air out of the line (air embolus risk)</li>
                        <li>Can draw blood from these devices</li>
                        <li>Risk for <strong>CLABSI</strong> ‚Äî strict aseptic technique; remove lines as soon as no
                            longer needed</li>
                    </ul>

                    <h4>Central Venous Pressure (CVP)</h4>
                    <p>Measures pressure in the right atrium, vena cava, and right ventricle (which are equal at end of
                        diastole). <strong>CVP reflects right-sided preload.</strong></p>

                    <table>
                        <tr>
                            <th>CVP Value</th>
                            <th>Interpretation</th>
                            <th>Common Causes</th>
                        </tr>
                        <tr>
                            <td><span class="key-value">&lt;2 mmHg</span></td>
                            <td>LOW preload</td>
                            <td>Hypovolemia, dehydration, hemorrhage, vasodilation (sepsis), negative-pressure breathing
                            </td>
                        </tr>
                        <tr>
                            <td><span class="key-value">2-6 mmHg</span></td>
                            <td>NORMAL</td>
                            <td>Adequate volume status</td>
                        </tr>
                        <tr>
                            <td><span class="key-value">&gt;6 mmHg</span></td>
                            <td>HIGH preload</td>
                            <td>Fluid overload, right-sided HF, tricuspid insufficiency, cardiac tamponade, PE,
                                positive-pressure ventilation</td>
                        </tr>
                    </table>

                    <div class="callout memory">
                        <strong>CVP shortcut:</strong> Low CVP = low volume (fill the tank). High CVP = high volume
                        (diurese or investigate obstruction).
                    </div>

                    <h4>Pulmonary Artery (PA) Catheter / Wedge Pressure</h4>
                    <ul>
                        <li>Assesses <strong>left ventricular function</strong> and measures cardiac output</li>
                        <li>Inserted through subclavian vein via a sheath; fluoroscopy-guided</li>
                        <li>Proximal port opens to RA ‚Äî used for medication administration or CVP measurement</li>
                        <li>Balloon inflated (1.5-5 mL air) to measure <strong>left ventricular filling pressures
                                (preload)</strong></li>
                        <li>Balloon inflation <strong>maximum 15 seconds</strong></li>
                    </ul>

                    <div class="callout warning">
                        <strong>Nurses do NOT wedge the PA catheter.</strong> Balloon inflation is NOT an independent
                        nursing intervention. Follow facility policy. Prolonged inflation risks pulmonary artery
                        rupture.
                    </div>

                    <h4>Intra-Arterial Blood Pressure Monitoring</h4>
                    <ul>
                        <li>Provides direct, continuous BP measurement</li>
                        <li>Used for hemodynamically unstable patients and frequent ABG sampling</li>
                        <li><strong>Modified Allen test</strong> required before radial artery cannulation:
                            <ol>
                                <li>Elevate hand, have patient make a fist</li>
                                <li>Occlude both radial and ulnar arteries</li>
                                <li>Have patient open hand, release ulnar artery</li>
                                <li>Hand turns pink in <strong>‚â§7 seconds</strong> = ulnar circulation intact (safe to
                                    cannulate radial)</li>
                            </ol>
                        </li>
                        <li>Doppler ultrasound may also assess artery blood flow</li>
                    </ul>

                    <h4>Hemodynamic Values Reference</h4>
                    <table>
                        <tr>
                            <th>Parameter</th>
                            <th>Normal Value</th>
                            <th>Clinical Significance</th>
                        </tr>
                        <tr>
                            <td><strong>CVP</strong></td>
                            <td>2-6 mmHg</td>
                            <td>Reflects RA pressure/preload; &lt;2 = hypovolemia; &gt;6 = hypervolemia or R-HF</td>
                        </tr>
                        <tr>
                            <td><strong>MAP</strong></td>
                            <td>‚â•65 mmHg</td>
                            <td>Organ perfusion pressure</td>
                        </tr>
                        <tr>
                            <td><strong>Cardiac Output</strong></td>
                            <td>4-6 L/min</td>
                            <td>Total blood pumped per minute</td>
                        </tr>
                        <tr>
                            <td><strong>Ejection Fraction</strong></td>
                            <td>55-65%</td>
                            <td>&lt;40% = HFrEF</td>
                        </tr>
                    </table>

                    <h4>Echocardiography: TTE vs. TEE</h4>

                    <table class="comparison-table">
                        <tr>
                            <th>Feature</th>
                            <th>TTE (Transthoracic)</th>
                            <th>TEE (Transesophageal)</th>
                        </tr>
                        <tr>
                            <td><strong>Approach</strong></td>
                            <td>Ultrasound probe on chest wall</td>
                            <td>Probe inserted into esophagus</td>
                        </tr>
                        <tr>
                            <td><strong>Invasiveness</strong></td>
                            <td>Noninvasive</td>
                            <td>Semi-invasive (requires sedation)</td>
                        </tr>
                        <tr>
                            <td><strong>Image quality</strong></td>
                            <td>Good; may be limited by body habitus, lung disease</td>
                            <td>Superior ‚Äî closer to heart structures</td>
                        </tr>
                        <tr>
                            <td><strong>Key uses</strong></td>
                            <td>EF, valve function, wall motion, pericardial effusion</td>
                            <td><span class="highlight">Rule out atrial clots before cardioversion</span>; valve
                                vegetations; prosthetic valve assessment</td>
                        </tr>
                        <tr>
                            <td><strong>Preparation</strong></td>
                            <td>None</td>
                            <td>NPO 6-8 hours; IV sedation; obtain consent</td>
                        </tr>
                        <tr>
                            <td><strong>Post-procedure</strong></td>
                            <td>N/A</td>
                            <td>NPO until gag reflex returns; monitor for esophageal perforation</td>
                        </tr>
                    </table>

                    <div class="callout pearl">
                        <strong>When is TEE used?</strong> Before cardioversion for atrial fibrillation/flutter to
                        ensure no clots are present in the left atrial appendage. If a clot is found, cardioversion is
                        postponed and anticoagulation is continued.
                    </div>

                </section>

                <!-- PRACTICE QUESTIONS SECTION -->
                <section id="practice">
                    <h2>Practice Questions</h2>

                    <p><em>NCLEX-style questions covering high-yield topics. Click an answer to reveal the
                            rationale.</em></p>

                    <style>
                        .q-block {
                            background: var(--light-bg);
                            border: 1px solid var(--border);
                            border-radius: 8px;
                            padding: 1.5rem;
                            margin: 1.5rem 0;
                        }

                        .q-block h4 {
                            margin-top: 0;
                            color: var(--primary);
                        }

                        .q-options {
                            list-style: none;
                            padding: 0;
                            margin: 1rem 0;
                        }

                        .q-options li {
                            padding: 0.6rem 1rem;
                            margin: 0.4rem 0;
                            border: 2px solid var(--border);
                            border-radius: 6px;
                            cursor: pointer;
                            transition: all 0.2s;
                        }

                        .q-options li:hover {
                            border-color: var(--accent);
                            background: #ebf8ff;
                        }

                        .q-options li.correct {
                            border-color: #38a169;
                            background: #d4edda;
                        }

                        .q-options li.incorrect {
                            border-color: #c53030;
                            background: #fff5f5;
                        }

                        .q-options li.highlight-correct {
                            border-color: #38a169;
                            background: #d4edda;
                        }

                        .q-rationale {
                            display: none;
                            padding: 1rem;
                            margin-top: 0.5rem;
                            background: var(--memory-bg);
                            border-left: 4px solid var(--memory-border);
                            border-radius: 4px;
                        }

                        .q-rationale.show {
                            display: block;
                        }

                        .q-rationale strong {
                            color: var(--memory-border);
                        }

                        .sata-note {
                            font-size: 0.85rem;
                            color: var(--accent);
                            font-style: italic;
                            margin-bottom: 0.5rem;
                        }

                        .q-submit {
                            display: none;
                            padding: 0.5rem 1.5rem;
                            background: var(--accent);
                            color: white;
                            border: none;
                            border-radius: 6px;
                            cursor: pointer;
                            font-size: 0.95rem;
                            margin-top: 0.5rem;
                        }

                        .q-submit:hover {
                            background: var(--secondary);
                        }

                        .q-submit.show {
                            display: inline-block;
                        }
                    </style>

                    <!-- Q1: HF Priority -->
                    <div class="q-block" id="q1">
                        <h4>Question 1 ‚Äî Heart Failure Priority</h4>
                        <p>A patient with heart failure is admitted with worsening dyspnea, crackles bilateral bases,
                            SpO2 88%, and 3+ pitting edema. Which nursing action is the HIGHEST PRIORITY?</p>
                        <ul class="q-options" data-correct="c" data-type="mcq">
                            <li data-choice="a">A. Weigh the patient and document I&O</li>
                            <li data-choice="b">B. Administer furosemide 40 mg IV as ordered</li>
                            <li data-choice="c">C. Position upright with legs dependent and apply O2</li>
                            <li data-choice="d">D. Restrict sodium intake and educate about diet</li>
                        </ul>
                        <div class="q-rationale" id="q1-rationale">
                            <strong>Correct: C</strong><br>
                            <strong>Rationale:</strong> ABC priority ‚Äî this patient has impaired gas exchange (SpO2
                            88%). The immediate action is to optimize oxygenation by positioning upright (decreases
                            venous return/preload, moves fluid away from lungs) and applying supplemental O2. This
                            addresses the most life-threatening problem first.<br><br>
                            <strong>Why not B?</strong> Furosemide is appropriate and will be given, but positioning and
                            oxygenation come first ‚Äî they provide immediate relief while you prepare the diuretic.
                            <strong>Why not A?</strong> Important for monitoring but not the priority when the patient
                            is hypoxic. <strong>Why not D?</strong> Teaching is never the priority in an acute
                            situation.
                        </div>
                    </div>

                    <!-- Q2: Shock Differentiation -->
                    <div class="q-block" id="q2">
                        <h4>Question 2 ‚Äî Shock Differentiation</h4>
                        <p>A trauma patient with a spinal cord injury at T4 has BP 78/50, HR 52, and warm dry skin.
                            Which type of shock should the nurse suspect?</p>
                        <ul class="q-options" data-correct="d" data-type="mcq">
                            <li data-choice="a">A. Hypovolemic shock</li>
                            <li data-choice="b">B. Cardiogenic shock</li>
                            <li data-choice="c">C. Septic shock</li>
                            <li data-choice="d">D. Neurogenic shock</li>
                        </ul>
                        <div class="q-rationale" id="q2-rationale">
                            <strong>Correct: D</strong><br>
                            <strong>Rationale:</strong> The triad of hypotension + <strong>bradycardia</strong> + warm,
                            dry skin is the hallmark of neurogenic shock. SCI above T6 disrupts sympathetic outflow,
                            causing unopposed parasympathetic tone ‚Üí vasodilation (warm skin) and bradycardia. Every
                            other shock type presents with tachycardia (compensatory SNS activation).<br><br>
                            <strong>Why not A?</strong> Hypovolemic shock presents with tachycardia, cool/clammy skin.
                            <strong>Why not B?</strong> Cardiogenic shock also has tachycardia, cool/pale skin, JVD.
                            <strong>Why not C?</strong> Early septic shock has warm skin but tachycardia, not
                            bradycardia. The bradycardia is the differentiator.
                        </div>
                    </div>

                    <!-- Q3: Medication SATA -->
                    <div class="q-block" id="q3">
                        <h4>Question 3 ‚Äî HF Medications (Select All That Apply)</h4>
                        <p class="sata-note">Select ALL that apply. Click each correct option, then click Submit.</p>
                        <p>A patient with HFrEF (EF 30%) is on lisinopril, carvedilol, furosemide, and digoxin. The
                            nurse reviews morning labs: K+ 3.1 mEq/L, digoxin level 1.8 ng/mL. Which actions are
                            appropriate?</p>
                        <ul class="q-options" data-correct="a,b,c,e" data-type="sata">
                            <li data-choice="a">A. Hold the furosemide</li>
                            <li data-choice="b">B. Hold the digoxin</li>
                            <li data-choice="c">C. Notify the provider</li>
                            <li data-choice="d">D. Administer all medications as prescribed</li>
                            <li data-choice="e">E. Assess for digoxin toxicity symptoms (N/V, visual changes,
                                bradycardia)</li>
                        </ul>
                        <button class="q-submit" id="q3-submit">Submit</button>
                        <div class="q-rationale" id="q3-rationale">
                            <strong>Correct: A, B, C, E</strong><br>
                            <strong>Rationale:</strong> K+ 3.1 is hypokalemia. Furosemide (loop diuretic) worsens
                            potassium loss ‚Äî hold it. <strong>Hypokalemia dramatically increases digoxin toxicity
                                risk</strong> even when the digoxin level is technically within range (0.5-2.0 ng/mL).
                            At 1.8 with K+ 3.1, toxicity risk is high ‚Äî hold digoxin, assess for toxicity symptoms, and
                            notify the provider for potassium replacement orders.<br><br>
                            <strong>Why not D?</strong> Administering furosemide would worsen hypokalemia, and giving
                            digoxin with low K+ risks fatal arrhythmias. This is a critical drug-electrolyte
                            interaction.
                        </div>
                    </div>

                    <!-- Q4: ECG Interpretation -->
                    <div class="q-block" id="q4">
                        <h4>Question 4 ‚Äî ECG Interpretation</h4>
                        <p>A patient's rhythm strip shows an irregularly irregular rhythm with no discernible P waves
                            and a ventricular rate of 142 bpm. Which rhythm does this describe?</p>
                        <ul class="q-options" data-correct="b" data-type="mcq">
                            <li data-choice="a">A. Atrial flutter</li>
                            <li data-choice="b">B. Atrial fibrillation with rapid ventricular response</li>
                            <li data-choice="c">C. Ventricular tachycardia</li>
                            <li data-choice="d">D. Second-degree AV block Type I</li>
                        </ul>
                        <div class="q-rationale" id="q4-rationale">
                            <strong>Correct: B</strong><br>
                            <strong>Rationale:</strong> The two key identifiers of A-fib are: (1) <strong>irregularly
                                irregular</strong> rhythm and (2) <strong>no P waves</strong> (fibrillatory waves
                            instead). Rate &gt;100 bpm = "rapid ventricular response" (RVR), indicating the AV node is
                            conducting too many impulses through.<br><br>
                            <strong>Why not A?</strong> Flutter has sawtooth F waves and is usually regular. <strong>Why
                                not C?</strong> V-tach is regular with wide QRS. <strong>Why not D?</strong> Wenckebach
                            has visible P waves with progressive PR lengthening.
                        </div>
                    </div>

                    <!-- Q5: Cardiac Cath -->
                    <div class="q-block" id="q5">
                        <h4>Question 5 ‚Äî Post-Cardiac Catheterization</h4>
                        <p>Two hours after a left heart catheterization via the femoral artery, the nurse assesses the
                            patient. Which finding requires IMMEDIATE intervention?</p>
                        <ul class="q-options" data-correct="c" data-type="mcq">
                            <li data-choice="a">A. Patient reports mild soreness at the groin site</li>
                            <li data-choice="b">B. Patient's creatinine increased from 1.0 to 1.2 mg/dL</li>
                            <li data-choice="c">C. Affected foot is cool and pale with diminished dorsalis pedis pulse
                            </li>
                            <li data-choice="d">D. Patient requests to elevate the head of bed to 45 degrees</li>
                        </ul>
                        <div class="q-rationale" id="q5-rationale">
                            <strong>Correct: C</strong><br>
                            <strong>Rationale:</strong> A cool, pale extremity with diminished pulses after femoral
                            artery access indicates <strong>arterial compromise</strong> ‚Äî potential thrombus, embolism,
                            or arterial occlusion. This is a vascular emergency requiring immediate provider
                            notification.<br><br>
                            <strong>Why not A?</strong> Mild soreness is expected. <strong>Why not B?</strong> Small
                            creatinine increase is expected; CIN is defined as ‚â•25% increase. <strong>Why not
                                D?</strong> HOB should be ‚â§30¬∞ during bed rest, but this is a positional request, not an
                            emergency.
                        </div>
                    </div>

                    <!-- Q6: A-fib Management -->
                    <div class="q-block" id="q6">
                        <h4>Question 6 ‚Äî A-fib Clinical Judgment</h4>
                        <p>A patient in new-onset atrial fibrillation for 3 days is scheduled for elective
                            cardioversion. Which nursing concern takes PRIORITY before the procedure?</p>
                        <ul class="q-options" data-correct="b" data-type="mcq">
                            <li data-choice="a">A. Ensuring the patient has been NPO for 4 hours</li>
                            <li data-choice="b">B. Verifying adequate anticoagulation has been achieved</li>
                            <li data-choice="c">C. Placing oxygen and suction at bedside</li>
                            <li data-choice="d">D. Holding digoxin for 48 hours</li>
                        </ul>
                        <div class="q-rationale" id="q6-rationale">
                            <strong>Correct: B</strong><br>
                            <strong>Rationale:</strong> A-fib &gt;48 hours carries high risk of atrial thrombus
                            formation from blood stasis. Cardioversion can dislodge a clot ‚Üí stroke. Therefore,
                            <strong>anticoagulation must be verified before cardioversion</strong> when A-fib duration
                            exceeds 48 hours. This is the most life-threatening risk if missed.<br><br>
                            <strong>Why not others?</strong> All are important preparation steps, but the risk of stroke
                            from cardioverting an inadequately anticoagulated patient is the greatest safety concern.
                        </div>
                    </div>

                    <!-- Q7: Compensatory Mechanisms -->
                    <div class="q-block" id="q7">
                        <h4>Question 7 ‚Äî HF Pathophysiology</h4>
                        <p>A student asks why patients with heart failure are prescribed both a beta-blocker AND an ACE
                            inhibitor when "the heart is already weak." Which response demonstrates the best
                            understanding?</p>
                        <ul class="q-options" data-correct="d" data-type="mcq">
                            <li data-choice="a">A. "Both medications directly strengthen the heart muscle to improve
                                ejection fraction."</li>
                            <li data-choice="b">B. "They work together to increase heart rate and cardiac output."</li>
                            <li data-choice="c">C. "The ACE inhibitor replaces the function that the beta-blocker
                                suppresses."</li>
                            <li data-choice="d">D. "Each blocks a different harmful compensatory mechanism ‚Äî SNS and
                                RAAS ‚Äî that worsens HF long-term."</li>
                        </ul>
                        <div class="q-rationale" id="q7-rationale">
                            <strong>Correct: D</strong><br>
                            <strong>Rationale:</strong> This is the core concept of HF pharmacotherapy. When CO drops,
                            the body activates compensatory mechanisms (SNS and RAAS) that help short-term but cause
                            long-term harm: increased afterload, fluid retention, myocardial remodeling, and increased
                            O2 demand. <strong>Beta-blockers interrupt SNS activation</strong>; <strong>ACE inhibitors
                                interrupt RAAS</strong>. Together, they break the vicious cycle at two different
                            points.<br><br>
                            <strong>Why not A?</strong> Beta-blockers are actually negative inotropes ‚Äî they don't
                            strengthen the heart directly. <strong>Why not B?</strong> Both actually decrease HR.
                            <strong>Why not C?</strong> They target different cascades, not compensating for each other.
                        </div>
                    </div>

                    <!-- Q8: Hemodynamic Monitoring -->
                    <div class="q-block" id="q8">
                        <h4>Question 8 ‚Äî Hemodynamic Monitoring</h4>
                        <p>A patient in the ICU has a CVP of 1 mmHg, HR 118, BP 82/60, and cool clammy skin. Based on
                            these findings, which type of shock is MOST likely, and what is the priority intervention?
                        </p>
                        <ul class="q-options" data-correct="a" data-type="mcq">
                            <li data-choice="a">A. Hypovolemic shock; administer IV crystalloid bolus</li>
                            <li data-choice="b">B. Cardiogenic shock; start dobutamine infusion</li>
                            <li data-choice="c">C. Septic shock; start norepinephrine infusion</li>
                            <li data-choice="d">D. Obstructive shock; prepare for pericardiocentesis</li>
                        </ul>
                        <div class="q-rationale" id="q8-rationale">
                            <strong>Correct: A</strong><br>
                            <strong>Rationale:</strong> CVP of 1 mmHg (&lt;2 = low) indicates <strong>decreased preload
                                ‚Äî the tank is empty</strong>. Combined with tachycardia (compensatory), hypotension, and
                            cool/clammy skin (SNS vasoconstriction), this is classic hypovolemic shock. Treatment: fill
                            the tank with IV crystalloids (LR preferred).<br><br>
                            <strong>Why not B?</strong> Cardiogenic shock would have HIGH CVP (&gt;6) because blood
                            backs up. <strong>Why not C?</strong> Early septic shock would have warm, flushed skin
                            (vasodilation); fluids come before vasopressors anyway. <strong>Why not D?</strong> Cardiac
                            tamponade shows JVD and elevated CVP, not low CVP.
                        </div>
                    </div>

                    <!-- Q9: Nitroglycerin -->
                    <div class="q-block" id="q9">
                        <h4>Question 9 ‚Äî Medication Administration</h4>
                        <p>A patient reports angina and requests nitroglycerin. BP is 86/54 mmHg. What is the nurse's
                            BEST action?</p>
                        <ul class="q-options" data-correct="c" data-type="mcq">
                            <li data-choice="a">A. Administer one NTG tablet sublingually and reassess</li>
                            <li data-choice="b">B. Give the NTG and call the provider afterward</li>
                            <li data-choice="c">C. Withhold NTG and notify the provider immediately</li>
                            <li data-choice="d">D. Administer NTG with the patient in Trendelenburg position</li>
                        </ul>
                        <div class="q-rationale" id="q9-rationale">
                            <strong>Correct: C</strong><br>
                            <strong>Rationale:</strong> NTG is a potent <strong>vasodilator that decreases preload and
                                afterload</strong>. Giving it to a hypotensive patient (BP 86/54) risks severe
                            hypotension, syncope, and cardiovascular collapse. <strong>Hold NTG when SBP &lt;90
                                mmHg</strong> and notify the provider for alternative pain management orders.<br><br>
                            <strong>Why not A or B?</strong> Giving NTG with BP this low is dangerous. <strong>Why not
                                D?</strong> Trendelenburg doesn't make it safe to give a vasodilator to a hypotensive
                            patient.
                        </div>
                    </div>

                    <!-- Q10: Sepsis SATA -->
                    <div class="q-block" id="q10">
                        <h4>Question 10 ‚Äî Sepsis Management (Select All That Apply)</h4>
                        <p class="sata-note">Select ALL that apply. Click each correct option, then click Submit.</p>
                        <p>A patient presents with temp 39.2¬∞C, HR 112, RR 24, BP 88/52, WBC 18,000, and lactate 4.2
                            mmol/L. The provider suspects septic shock. Which interventions should the nurse anticipate?
                            Select all that apply.</p>
                        <ul class="q-options" data-correct="a,c,d,e" data-type="sata">
                            <li data-choice="a">A. Obtain blood cultures before antibiotic administration</li>
                            <li data-choice="b">B. Administer a fluid bolus of 10 mL/kg</li>
                            <li data-choice="c">C. Initiate 30 mL/kg crystalloid fluid bolus</li>
                            <li data-choice="d">D. Administer broad-spectrum antibiotics within 1 hour</li>
                            <li data-choice="e">E. Prepare norepinephrine infusion if hypotension persists after fluids
                            </li>
                        </ul>
                        <button class="q-submit" id="q10-submit">Submit</button>
                        <div class="q-rationale" id="q10-rationale">
                            <strong>Correct: A, C, D, E</strong><br>
                            <strong>Rationale:</strong> This patient meets septic shock criteria (SIRS + infection +
                            hypotension + elevated lactate). The <strong>Hour-1 Bundle</strong> includes: (1) blood
                            cultures BEFORE antibiotics, (2) broad-spectrum antibiotics ASAP (within 1 hour ‚Äî every hour
                            of delay increases mortality), (3) 30 mL/kg crystalloid for hypotension or lactate ‚â•4, and
                            (4) vasopressors (norepinephrine = first-line) if hypotension persists after adequate fluid
                            resuscitation.<br><br>
                            <strong>Why not B?</strong> The correct septic shock fluid bolus is <strong>30
                                mL/kg</strong>, not 10 mL/kg. Undertreating with inadequate volume is a common and
                            dangerous error.
                        </div>
                    </div>

                </section>

                <script>
                    // Practice question interactivity
                    document.querySelectorAll('.q-options[data-type="mcq"]').forEach(ul => {
                        ul.querySelectorAll('li').forEach(li => {
                            li.addEventListener('click', () => {
                                if (ul.dataset.answered) return;
                                ul.dataset.answered = 'true';
                                const correct = ul.dataset.correct;
                                const chosen = li.dataset.choice;
                                if (chosen === correct) {
                                    li.classList.add('correct');
                                } else {
                                    li.classList.add('incorrect');
                                    ul.querySelector(`[data-choice="${correct}"]`).classList.add('highlight-correct');
                                }
                                const qBlock = ul.closest('.q-block');
                                qBlock.querySelector('.q-rationale').classList.add('show');
                            });
                        });
                    });

                    // SATA questions
                    document.querySelectorAll('.q-options[data-type="sata"]').forEach(ul => {
                        const submitBtn = ul.nextElementSibling;
                        if (submitBtn && submitBtn.classList.contains('q-submit')) submitBtn.classList.add('show');
                        ul.querySelectorAll('li').forEach(li => {
                            li.addEventListener('click', () => {
                                if (ul.dataset.answered) return;
                                li.classList.toggle('selected');
                                li.style.borderColor = li.classList.contains('selected') ? 'var(--accent)' : '';
                                li.style.background = li.classList.contains('selected') ? '#ebf8ff' : '';
                            });
                        });
                        if (submitBtn) {
                            submitBtn.addEventListener('click', () => {
                                if (ul.dataset.answered) return;
                                ul.dataset.answered = 'true';
                                submitBtn.style.display = 'none';
                                const correctSet = new Set(ul.dataset.correct.split(','));
                                ul.querySelectorAll('li').forEach(li => {
                                    const choice = li.dataset.choice;
                                    const isCorrect = correctSet.has(choice);
                                    const isSelected = li.classList.contains('selected');
                                    li.classList.remove('selected');
                                    li.style.borderColor = '';
                                    li.style.background = '';
                                    if (isCorrect) li.classList.add('highlight-correct');
                                    if (isSelected && !isCorrect) li.classList.add('incorrect');
                                });
                                const qBlock = ul.closest('.q-block');
                                qBlock.querySelector('.q-rationale').classList.add('show');
                            });
                        }
                    });
                </script>

                <footer
                    style="margin-top: 3rem; padding: 2rem; background: var(--light-bg); border-radius: 8px; text-align: center;">
                    <p><strong>Cardiac Output & Perfusion Study Guide</strong></p>
                    <p>Generated from N8 Week 1 & Week 2 Lecture Slides</p>
                    <p><em>Content prioritized by lecture emphasis. [HEAVY IN SLIDES] indicates topics with extensive
                            lecture coverage.</em></p>
                </footer>

            </div><!-- end content-inner -->
        </main><!-- end main-content -->
    </div><!-- end page-wrapper -->

    <script>
        // Mobile sidebar toggle
        const sidebar = document.getElementById('sidebar');
        const toggle = document.getElementById('sidebarToggle');

        toggle.addEventListener('click', () => {
            sidebar.classList.toggle('open');
            toggle.textContent = sidebar.classList.contains('open') ? '‚úï' : '‚ò∞';
        });

        // Close sidebar when clicking a link (mobile)
        document.querySelectorAll('.nav-toc a').forEach(link => {
            link.addEventListener('click', () => {
                if (window.innerWidth <= 1024) {
                    sidebar.classList.remove('open');
                    toggle.textContent = '‚ò∞';
                }
            });
        });

        // Close sidebar when clicking outside (mobile)
        document.addEventListener('click', (e) => {
            if (window.innerWidth <= 1024 &&
                !sidebar.contains(e.target) &&
                !toggle.contains(e.target) &&
                sidebar.classList.contains('open')) {
                sidebar.classList.remove('open');
                toggle.textContent = '‚ò∞';
            }
        });
    </script>

</body>

</html>